NL2037620A - Fragrance compositions cross-reference to related application - Google Patents
Fragrance compositions cross-reference to related application Download PDFInfo
- Publication number
- NL2037620A NL2037620A NL2037620A NL2037620A NL2037620A NL 2037620 A NL2037620 A NL 2037620A NL 2037620 A NL2037620 A NL 2037620A NL 2037620 A NL2037620 A NL 2037620A NL 2037620 A NL2037620 A NL 2037620A
- Authority
- NL
- Netherlands
- Prior art keywords
- fragrance
- fragrance composition
- composition
- methyl
- dimethyl
- Prior art date
Links
- 239000003205 fragrance Substances 0.000 title claims abstract description 404
- 239000000203 mixture Substances 0.000 title claims abstract description 263
- 239000000284 extract Substances 0.000 claims abstract description 77
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 35
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 34
- 235000002195 Nymphaea caerulea Nutrition 0.000 claims abstract description 11
- 240000009085 Nymphaea caerulea Species 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims description 174
- -1 polycitronellol Chemical compound 0.000 claims description 166
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 238000009472 formulation Methods 0.000 claims description 24
- 229920000858 Cyclodextrin Polymers 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 14
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 11
- WQKLGQXWHKQTPO-UXRZSMILSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol;2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WQKLGQXWHKQTPO-UXRZSMILSA-N 0.000 claims description 10
- 229940116393 ppg-20 methyl glucose ether Drugs 0.000 claims description 10
- 229920005862 polyol Polymers 0.000 claims description 9
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 8
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 8
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 6
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 6
- 241000207199 Citrus Species 0.000 claims description 5
- 235000020971 citrus fruits Nutrition 0.000 claims description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 5
- 239000013522 chelant Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 229960002903 benzyl benzoate Drugs 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 claims description 3
- 230000014759 maintenance of location Effects 0.000 claims description 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 1
- 125000006659 (C1-C20) hydrocarbyl group Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 239000000126 substance Substances 0.000 description 67
- 206010034719 Personality change Diseases 0.000 description 65
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 63
- 229940022663 acetate Drugs 0.000 description 53
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 45
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 41
- 239000003921 oil Substances 0.000 description 39
- 239000000243 solution Substances 0.000 description 32
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 31
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 30
- 150000002148 esters Chemical class 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 26
- 239000002304 perfume Substances 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- 238000000034 method Methods 0.000 description 24
- CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 22
- 239000002537 cosmetic Substances 0.000 description 22
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- 125000004494 ethyl ester group Chemical group 0.000 description 21
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 20
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 18
- 235000019260 propionic acid Nutrition 0.000 description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 17
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 16
- 239000000523 sample Substances 0.000 description 16
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 14
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 14
- 229960004373 acetylcholine Drugs 0.000 description 14
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 14
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 14
- 239000005711 Benzoic acid Substances 0.000 description 13
- 241000196324 Embryophyta Species 0.000 description 13
- 208000008454 Hyperhidrosis Diseases 0.000 description 13
- 235000010233 benzoic acid Nutrition 0.000 description 13
- 230000008859 change Effects 0.000 description 13
- 239000000470 constituent Substances 0.000 description 13
- 231100000673 dose–response relationship Toxicity 0.000 description 13
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 230000004913 activation Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 12
- 150000004702 methyl esters Chemical class 0.000 description 12
- 241000894007 species Species 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 231100000121 skin sensitizing Toxicity 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 210000000715 neuromuscular junction Anatomy 0.000 description 9
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 9
- 230000035900 sweating Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 8
- YGCZTXZTJXYWCO-UHFFFAOYSA-N 3-phenylpropanal Chemical compound O=CCCC1=CC=CC=C1 YGCZTXZTJXYWCO-UHFFFAOYSA-N 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 8
- 150000001299 aldehydes Chemical class 0.000 description 8
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 229960004063 propylene glycol Drugs 0.000 description 8
- 235000013772 propylene glycol Nutrition 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 125000003386 piperidinyl group Chemical group 0.000 description 7
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 7
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 6
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 6
- VKZRWSNIWNFCIQ-UHFFFAOYSA-N 2-[2-(1,2-dicarboxyethylamino)ethylamino]butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NCCNC(C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-UHFFFAOYSA-N 0.000 description 6
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 6
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 6
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 6
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 6
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 6
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 150000002170 ethers Chemical class 0.000 description 6
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- NMRPBPVERJPACX-UHFFFAOYSA-N octan-3-ol Chemical compound CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 6
- 229960003424 phenylacetic acid Drugs 0.000 description 6
- 229960001860 salicylate Drugs 0.000 description 6
- 210000002374 sebum Anatomy 0.000 description 6
- 231100000202 sensitizing Toxicity 0.000 description 6
- 230000001235 sensitizing effect Effects 0.000 description 6
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 5
- ZCHHRLHTBGRGOT-SNAWJCMRSA-N (E)-hex-2-en-1-ol Chemical compound CCC\C=C\CO ZCHHRLHTBGRGOT-SNAWJCMRSA-N 0.000 description 5
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 5
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 5
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 5
- FSAMVJAGJWGWTQ-UHFFFAOYSA-N 2-hexadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCOCCO FSAMVJAGJWGWTQ-UHFFFAOYSA-N 0.000 description 5
- MBDOYVRWFFCFHM-UHFFFAOYSA-N 2-hexenal Chemical compound CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 5
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 5
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 5
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 5
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical compound CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 5
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 5
- 206010070835 Skin sensitisation Diseases 0.000 description 5
- MLUCVPSAIODCQM-UHFFFAOYSA-N but-2-enal Chemical compound CC=CC=O MLUCVPSAIODCQM-UHFFFAOYSA-N 0.000 description 5
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 150000002576 ketones Chemical class 0.000 description 5
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 description 5
- 210000000663 muscle cell Anatomy 0.000 description 5
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 5
- UMRZSTCPUPJPOJ-UHFFFAOYSA-N norbornane Chemical compound C1CC2CCC1C2 UMRZSTCPUPJPOJ-UHFFFAOYSA-N 0.000 description 5
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 5
- 231100000370 skin sensitisation Toxicity 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 210000004243 sweat Anatomy 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- BJIOGJUNALELMI-ONEGZZNKSA-N trans-isoeugenol Chemical compound COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 4
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 4
- ZIJRVWRFZGXKMY-UHFFFAOYSA-N 2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCO)C=C1 ZIJRVWRFZGXKMY-UHFFFAOYSA-N 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 4
- YVHAIVPPUIZFBA-UHFFFAOYSA-N Cyclopentylacetic acid Chemical compound OC(=O)CC1CCCC1 YVHAIVPPUIZFBA-UHFFFAOYSA-N 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N Eugenol Natural products COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 4
- KMPQYAYAQWNLME-UHFFFAOYSA-N Undecanal Natural products CCCCCCCCCCC=O KMPQYAYAQWNLME-UHFFFAOYSA-N 0.000 description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Natural products CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
- VJMAITQRABEEKP-UHFFFAOYSA-N [6-(phenylmethoxymethyl)-1,4-dioxan-2-yl]methyl acetate Chemical compound O1C(COC(=O)C)COCC1COCC1=CC=CC=C1 VJMAITQRABEEKP-UHFFFAOYSA-N 0.000 description 4
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 4
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- GTABBGRXERZUAH-UHFFFAOYSA-N hexadecan-1-ol;2-methyloxirane;oxirane Chemical compound C1CO1.CC1CO1.CCCCCCCCCCCCCCCCO GTABBGRXERZUAH-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 4
- CFNJLPHOBMVMNS-UHFFFAOYSA-N pentyl butyrate Chemical compound CCCCCOC(=O)CCC CFNJLPHOBMVMNS-UHFFFAOYSA-N 0.000 description 4
- 229920000058 polyacrylate Polymers 0.000 description 4
- 229920000193 polymethacrylate Polymers 0.000 description 4
- SXBRULKJHUOQCD-UHFFFAOYSA-N propanoic acid Chemical compound CCC(O)=O.CCC(O)=O SXBRULKJHUOQCD-UHFFFAOYSA-N 0.000 description 4
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 210000002027 skeletal muscle Anatomy 0.000 description 4
- 125000003003 spiro group Chemical group 0.000 description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 3
- JQQDKNVOSLONRS-JEGFTUTRSA-N (3e,5e)-undeca-1,3,5-triene Chemical compound CCCCC\C=C\C=C\C=C JQQDKNVOSLONRS-JEGFTUTRSA-N 0.000 description 3
- OSLCPZYIPCXBMS-HWKANZROSA-N (6e)-octa-1,6-dien-3-ol Chemical compound C\C=C\CCC(O)C=C OSLCPZYIPCXBMS-HWKANZROSA-N 0.000 description 3
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 3
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 3
- OOWQBDFWEXAXPB-IBGZPJMESA-N 1-O-hexadecyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](O)CO OOWQBDFWEXAXPB-IBGZPJMESA-N 0.000 description 3
- ZITVKGIRQCDOSX-UHFFFAOYSA-N 1h-cyclopropa[a]naphthalene Chemical compound C1=CC=CC2=C3CC3=CC=C21 ZITVKGIRQCDOSX-UHFFFAOYSA-N 0.000 description 3
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 3
- DNRJTBAOUJJKDY-UHFFFAOYSA-N 2-Acetyl-3,5,5,6,8,8-hexamethyl-5,6,7,8- tetrahydronaphthalene Chemical compound CC(=O)C1=C(C)C=C2C(C)(C)C(C)CC(C)(C)C2=C1 DNRJTBAOUJJKDY-UHFFFAOYSA-N 0.000 description 3
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 3
- FSVRFCBLVIJHQY-UHFFFAOYSA-N 2-[2-(2-hexadecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCO FSVRFCBLVIJHQY-UHFFFAOYSA-N 0.000 description 3
- ZNVICELHBCNKIF-UHFFFAOYSA-N 2-[2-[2-(2-octadec-9-enoxyethoxy)ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCC=CCCCCCCCCOCCOCCOCCOCCO ZNVICELHBCNKIF-UHFFFAOYSA-N 0.000 description 3
- OJCFEGKCRWEVSN-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCO OJCFEGKCRWEVSN-UHFFFAOYSA-N 0.000 description 3
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 3
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 3
- CETWDUZRCINIHU-UHFFFAOYSA-N 2-heptanol Chemical compound CCCCCC(C)O CETWDUZRCINIHU-UHFFFAOYSA-N 0.000 description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 3
- BUIXEGYUDCDLCD-UHFFFAOYSA-N 3-(2-methylpropoxy)propan-1-ol Chemical compound CC(C)COCCCO BUIXEGYUDCDLCD-UHFFFAOYSA-N 0.000 description 3
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- HSHUHVOEMVTVRS-UHFFFAOYSA-N 7-octen-2-ol Chemical compound CC(O)CCCCC=C HSHUHVOEMVTVRS-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- CYHBDKTZDLSRMY-UHFFFAOYSA-N Hexyl 2-methylpropanoate Chemical compound CCCCCCOC(=O)C(C)C CYHBDKTZDLSRMY-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- XXIKYCPRDXIMQM-UHFFFAOYSA-N Isopentenyl acetate Chemical compound CC(C)=CCOC(C)=O XXIKYCPRDXIMQM-UHFFFAOYSA-N 0.000 description 3
- UUQHKWMIDYRWHH-UHFFFAOYSA-N Methyl beta-orcinolcarboxylate Chemical compound COC(=O)C1=C(C)C=C(O)C(C)=C1O UUQHKWMIDYRWHH-UHFFFAOYSA-N 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 241000209504 Poaceae Species 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- 101000916532 Rattus norvegicus Zinc finger and BTB domain-containing protein 38 Proteins 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N acetaldehyde dimethyl acetal Natural products COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 3
- LDECUSDQMXVUMP-UHFFFAOYSA-N benzyl 3-[6-[[2-(butylamino)-1-[3-methoxycarbonyl-4-(2-methoxy-2-oxoethoxy)phenyl]-2-oxoethyl]-hexylamino]-6-oxohexyl]-4-methyl-2-oxo-6-(4-phenylphenyl)-1,6-dihydropyrimidine-5-carboxylate Chemical compound O=C1NC(C=2C=CC(=CC=2)C=2C=CC=CC=2)C(C(=O)OCC=2C=CC=CC=2)=C(C)N1CCCCCC(=O)N(CCCCCC)C(C(=O)NCCCC)C1=CC=C(OCC(=O)OC)C(C(=O)OC)=C1 LDECUSDQMXVUMP-UHFFFAOYSA-N 0.000 description 3
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 3
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 3
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 3
- KSMVZQYAVGTKIV-UHFFFAOYSA-N caprinaldehyde Natural products CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 3
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 3
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- MMFCJPPRCYDLLZ-UHFFFAOYSA-N dec-2-enal Chemical compound CCCCCCCC=CC=O MMFCJPPRCYDLLZ-UHFFFAOYSA-N 0.000 description 3
- 125000006182 dimethyl benzyl group Chemical group 0.000 description 3
- ZANQMOGWQBCGBN-UHFFFAOYSA-N ethyl 2,6,6-trimethylcyclohexa-2,4-diene-1-carboxylate Chemical compound CCOC(=O)C1C(C)=CC=CC1(C)C ZANQMOGWQBCGBN-UHFFFAOYSA-N 0.000 description 3
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 3
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 3
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 3
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 229960003082 galactose Drugs 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 3
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- OTGHWLKHGCENJV-UHFFFAOYSA-N glycidic acid Chemical compound OC(=O)C1CO1 OTGHWLKHGCENJV-UHFFFAOYSA-N 0.000 description 3
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Chemical compound CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 3
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 3
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 3
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N methyl monoether Natural products COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 230000008447 perception Effects 0.000 description 3
- MDHYEMXUFSJLGV-UHFFFAOYSA-N phenethyl acetate Chemical compound CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 3
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 3
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical compound NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 description 3
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- CZCBTSFUTPZVKJ-UHFFFAOYSA-N rose oxide Chemical compound CC1CCOC(C=C(C)C)C1 CZCBTSFUTPZVKJ-UHFFFAOYSA-N 0.000 description 3
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 208000013460 sweaty Diseases 0.000 description 3
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 3
- 229940075466 undecylenate Drugs 0.000 description 3
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 3
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (+)-β-citronellol Chemical compound OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- XJRIDJAGAYGJCK-UHFFFAOYSA-N (1-acetyl-5-bromoindol-3-yl) acetate Chemical compound C1=C(Br)C=C2C(OC(=O)C)=CN(C(C)=O)C2=C1 XJRIDJAGAYGJCK-UHFFFAOYSA-N 0.000 description 2
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 2
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical compound O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 description 2
- MMFCJPPRCYDLLZ-CMDGGOBGSA-N (2E)-dec-2-enal Chemical compound CCCCCCC\C=C\C=O MMFCJPPRCYDLLZ-CMDGGOBGSA-N 0.000 description 2
- HZYHMHHBBBSGHB-ODYTWBPASA-N (2E,6Z)-nona-2,6-dienal Chemical compound CC\C=C/CC\C=C\C=O HZYHMHHBBBSGHB-ODYTWBPASA-N 0.000 description 2
- ONYJRUXYOCZIAW-BLWKUPHCSA-N (2e,6e)-octa-2,6-dien-1-ol Chemical compound C\C=C\CC\C=C\CO ONYJRUXYOCZIAW-BLWKUPHCSA-N 0.000 description 2
- CBXNRMOWVZUZQA-BLWKUPHCSA-N (2e,6e)-octa-2,6-dienal Chemical compound C\C=C\CC\C=C\C=O CBXNRMOWVZUZQA-BLWKUPHCSA-N 0.000 description 2
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 2
- VCVKIIDXVWEWSZ-YFKPBYRVSA-N (2s)-2-[bis(carboxymethyl)amino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O VCVKIIDXVWEWSZ-YFKPBYRVSA-N 0.000 description 2
- KHWTYGFHPHRQMP-UHFFFAOYSA-N (4-propan-2-ylcyclohexyl)methanol Chemical compound CC(C)C1CCC(CO)CC1 KHWTYGFHPHRQMP-UHFFFAOYSA-N 0.000 description 2
- GQVMHMFBVWSSPF-SOYUKNQTSA-N (4E,6E)-2,6-dimethylocta-2,4,6-triene Chemical compound C\C=C(/C)\C=C\C=C(C)C GQVMHMFBVWSSPF-SOYUKNQTSA-N 0.000 description 2
- QQPBNXSJUXIDLT-CLFYSBASSA-N (4z)-1,3,3a,6,7,8,9,10,11,12,13,13a-dodecahydrocyclododeca[c]furan Chemical compound C/1=C/CCCCCCCCC2COCC2\1 QQPBNXSJUXIDLT-CLFYSBASSA-N 0.000 description 2
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 2
- 239000001306 (7E,9E,11E,13E)-pentadeca-7,9,11,13-tetraen-1-ol Substances 0.000 description 2
- 239000001714 (E)-hex-2-en-1-ol Substances 0.000 description 2
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 2
- XEJGJTYRUWUFFD-FNORWQNLSA-N (e)-1-(2,6,6-trimethyl-1-cyclohex-3-enyl)but-2-en-1-one Chemical compound C\C=C\C(=O)C1C(C)C=CCC1(C)C XEJGJTYRUWUFFD-FNORWQNLSA-N 0.000 description 2
- CWRKZMLUDFBPAO-VOTSOKGWSA-N (e)-dec-4-enal Chemical compound CCCCC\C=C\CCC=O CWRKZMLUDFBPAO-VOTSOKGWSA-N 0.000 description 2
- RNLHVODSMDJCBR-VURMDHGXSA-N (z)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol Chemical compound CC(O)C(C)\C=C/C1CC=C(C)C1(C)C RNLHVODSMDJCBR-VURMDHGXSA-N 0.000 description 2
- YGFGZTXGYTUXBA-UHFFFAOYSA-N (±)-2,6-dimethyl-5-heptenal Chemical compound O=CC(C)CCC=C(C)C YGFGZTXGYTUXBA-UHFFFAOYSA-N 0.000 description 2
- FVUGZKDGWGKCFE-UHFFFAOYSA-N 1-(2,3,8,8-tetramethyl-1,3,4,5,6,7-hexahydronaphthalen-2-yl)ethanone Chemical compound CC1(C)CCCC2=C1CC(C(C)=O)(C)C(C)C2 FVUGZKDGWGKCFE-UHFFFAOYSA-N 0.000 description 2
- KBHWKXNXTURZCD-UHFFFAOYSA-N 1-Methoxy-4-propylbenzene Chemical compound CCCC1=CC=C(OC)C=C1 KBHWKXNXTURZCD-UHFFFAOYSA-N 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 2
- OFHHDSQXFXLTKC-UHFFFAOYSA-N 10-undecenal Chemical compound C=CCCCCCCCCC=O OFHHDSQXFXLTKC-UHFFFAOYSA-N 0.000 description 2
- PUKWIVZFEZFVAT-UHFFFAOYSA-N 2,2,5-trimethyl-5-pentylcyclopentan-1-one Chemical compound CCCCCC1(C)CCC(C)(C)C1=O PUKWIVZFEZFVAT-UHFFFAOYSA-N 0.000 description 2
- FYMOBFDUZIDKMI-UHFFFAOYSA-N 2,2-dimethyl-3-(3-methylphenyl)propan-1-ol Chemical compound CC1=CC=CC(CC(C)(C)CO)=C1 FYMOBFDUZIDKMI-UHFFFAOYSA-N 0.000 description 2
- KVGYAHNHKCCHSP-UHFFFAOYSA-N 2,2-dimethyloctanal Chemical compound CCCCCCC(C)(C)C=O KVGYAHNHKCCHSP-UHFFFAOYSA-N 0.000 description 2
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
- JEPWTUCYPWOCQV-UHFFFAOYSA-N 2,4-dimethyl-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-1,3-dioxolane Chemical compound O1C(C)COC1(C)C1=CC=C2C(C)(C)CCC(C)(C)C2=C1 JEPWTUCYPWOCQV-UHFFFAOYSA-N 0.000 description 2
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 2
- AZLWQVJVINEILY-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCOCCOCCO AZLWQVJVINEILY-UHFFFAOYSA-N 0.000 description 2
- KUXGUCNZFCVULO-UHFFFAOYSA-N 2-(4-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCO)C=C1 KUXGUCNZFCVULO-UHFFFAOYSA-N 0.000 description 2
- RYPKRALMXUUNKS-UHFFFAOYSA-N 2-Hexene Natural products CCCC=CC RYPKRALMXUUNKS-UHFFFAOYSA-N 0.000 description 2
- COJBCAMFZDFGFK-VCSGLWQLSA-N 2-O-sulfo-alpha-L-idopyranuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1OS(O)(=O)=O COJBCAMFZDFGFK-VCSGLWQLSA-N 0.000 description 2
- SJWKGDGUQTWDRV-UHFFFAOYSA-N 2-Propenyl heptanoate Chemical compound CCCCCCC(=O)OCC=C SJWKGDGUQTWDRV-UHFFFAOYSA-N 0.000 description 2
- RCSBILYQLVXLJG-UHFFFAOYSA-N 2-Propenyl hexanoate Chemical compound CCCCCC(=O)OCC=C RCSBILYQLVXLJG-UHFFFAOYSA-N 0.000 description 2
- ZNSALEJHPSBXDK-JLHYYAGUSA-N 2-[(2e)-3,7-dimethylocta-2,6-dienyl] cyclopentan-1-one Chemical compound CC(C)=CCC\C(C)=C\CC1CCCC1=O ZNSALEJHPSBXDK-JLHYYAGUSA-N 0.000 description 2
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 2
- GVZNXUAPPLHUOM-UHFFFAOYSA-N 2-[1-(1-methoxypropan-2-yloxy)propan-2-yloxy]propan-1-ol Chemical compound COCC(C)OCC(C)OC(C)CO GVZNXUAPPLHUOM-UHFFFAOYSA-N 0.000 description 2
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 2
- NBPXCCCUFZBDQE-UHFFFAOYSA-N 2-[2-(2-tetradecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCOCCOCCOCCO NBPXCCCUFZBDQE-UHFFFAOYSA-N 0.000 description 2
- CACXEVGZNASLOU-UHFFFAOYSA-N 2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCO CACXEVGZNASLOU-UHFFFAOYSA-N 0.000 description 2
- KGULFLCOPRYBEV-KTKRTIGZSA-N 2-[2-[2-[(z)-octadec-9-enoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCO KGULFLCOPRYBEV-KTKRTIGZSA-N 0.000 description 2
- UTXPMECBRCEYCI-UHFFFAOYSA-N 2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCO)C=C1 UTXPMECBRCEYCI-UHFFFAOYSA-N 0.000 description 2
- GLGQRQQFWLTGES-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-decoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCOCCOCCOCCOCCOCCOCCO GLGQRQQFWLTGES-UHFFFAOYSA-N 0.000 description 2
- PITRRWWILGYENJ-UHFFFAOYSA-N 2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCO)C=C1 PITRRWWILGYENJ-UHFFFAOYSA-N 0.000 description 2
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 2
- DXFSRFBWOGMMJP-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DXFSRFBWOGMMJP-UHFFFAOYSA-N 0.000 description 2
- ATBQNLZREVOGBO-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 ATBQNLZREVOGBO-UHFFFAOYSA-N 0.000 description 2
- XXPRRHYTDCWGRP-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 XXPRRHYTDCWGRP-UHFFFAOYSA-N 0.000 description 2
- OLOHNJXENGJYTB-UHFFFAOYSA-N 2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCO)C=C1 OLOHNJXENGJYTB-UHFFFAOYSA-N 0.000 description 2
- DKELNUBFYRNPMB-UHFFFAOYSA-N 2-decoxyethanol;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCOCCO DKELNUBFYRNPMB-UHFFFAOYSA-N 0.000 description 2
- ATGBQPXOROALEJ-RRABGKBLSA-N 2-hexadecoxyethanol;2-[(e)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCO.CCCCCCCC\C=C\CCCCCCCCOCCO ATGBQPXOROALEJ-RRABGKBLSA-N 0.000 description 2
- ZCHHRLHTBGRGOT-UHFFFAOYSA-N 2-hexen-1-ol Chemical compound CCCC=CCO ZCHHRLHTBGRGOT-UHFFFAOYSA-N 0.000 description 2
- CFAKWWQIUFSQFU-UHFFFAOYSA-N 2-hydroxy-3-methylcyclopent-2-en-1-one Chemical compound CC1=C(O)C(=O)CC1 CFAKWWQIUFSQFU-UHFFFAOYSA-N 0.000 description 2
- CMPVUVUNJQERIT-UHFFFAOYSA-N 2-isobutylthiazole Chemical compound CC(C)CC1=NC=CS1 CMPVUVUNJQERIT-UHFFFAOYSA-N 0.000 description 2
- NGDNVOAEIVQRFH-UHFFFAOYSA-N 2-nonanol Chemical compound CCCCCCCC(C)O NGDNVOAEIVQRFH-UHFFFAOYSA-N 0.000 description 2
- YCRGMNXARTVRLB-UHFFFAOYSA-N 2h-1,5-benzodioxepine Chemical compound O1C=CCOC2=CC=CC=C21 YCRGMNXARTVRLB-UHFFFAOYSA-N 0.000 description 2
- VLFBSPUPYFTTNF-UHFFFAOYSA-N 3-(4-methoxyphenyl)-2-methylpropanal Chemical compound COC1=CC=C(CC(C)C=O)C=C1 VLFBSPUPYFTTNF-UHFFFAOYSA-N 0.000 description 2
- NMRPBPVERJPACX-QMMMGPOBSA-N 3-Octanol Natural products CCCCC[C@@H](O)CC NMRPBPVERJPACX-QMMMGPOBSA-N 0.000 description 2
- YDXQPTHHAPCTPP-UHFFFAOYSA-N 3-Octen-1-ol Natural products CCCCC=CCCO YDXQPTHHAPCTPP-UHFFFAOYSA-N 0.000 description 2
- GVSTVIASYRSHQM-RYUDHWBXSA-N 3-[(1s,5r)-6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]-2,2-dimethylpropanal Chemical compound C1[C@@]2([H])C(CC(C)(C)C=O)=CC[C@]1([H])C2(C)C GVSTVIASYRSHQM-RYUDHWBXSA-N 0.000 description 2
- XJLDYKIEURAVBW-UHFFFAOYSA-N 3-decanone Chemical compound CCCCCCCC(=O)CC XJLDYKIEURAVBW-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- JSGVZVOGOQILFM-UHFFFAOYSA-N 3-methoxy-1-butanol Chemical compound COC(C)CCO JSGVZVOGOQILFM-UHFFFAOYSA-N 0.000 description 2
- GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 2
- PODHIIGQVAJGOK-UHFFFAOYSA-N 3h-inden-5-ol Chemical compound OC1=CC=C2C=CCC2=C1 PODHIIGQVAJGOK-UHFFFAOYSA-N 0.000 description 2
- DCSCXTJOXBUFGB-UHFFFAOYSA-N 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one Chemical compound CC1=CC(=O)C2C(C)(C)C1C2 DCSCXTJOXBUFGB-UHFFFAOYSA-N 0.000 description 2
- DCSKAMGZSIRJAQ-UHFFFAOYSA-N 4-(2-methylbutan-2-yl)cyclohexan-1-one Chemical compound CCC(C)(C)C1CCC(=O)CC1 DCSKAMGZSIRJAQ-UHFFFAOYSA-N 0.000 description 2
- TZJLGGWGVLADDN-UHFFFAOYSA-N 4-(3,4-Methylenedioxyphenyl)-2-butanone Chemical compound CC(=O)CCC1=CC=C2OCOC2=C1 TZJLGGWGVLADDN-UHFFFAOYSA-N 0.000 description 2
- CHWNEIVBYREQRF-UHFFFAOYSA-N 4-Ethyl-2-methoxyphenol Chemical compound CCC1=CC=C(O)C(OC)=C1 CHWNEIVBYREQRF-UHFFFAOYSA-N 0.000 description 2
- YVBCULSIZWMTFY-UHFFFAOYSA-N 4-Heptanol Natural products CCCC(O)CCC YVBCULSIZWMTFY-UHFFFAOYSA-N 0.000 description 2
- KZZASWGRLOTITL-UHFFFAOYSA-N 4-cyclohexyl-2-methylbutan-2-ol Chemical compound CC(C)(O)CCC1CCCCC1 KZZASWGRLOTITL-UHFFFAOYSA-N 0.000 description 2
- JJWWUTCHOAKZPR-UHFFFAOYSA-N 4-methylpent-4-en-2-yl 2-methylpropanoate Chemical compound CC(C)C(=O)OC(C)CC(C)=C JJWWUTCHOAKZPR-UHFFFAOYSA-N 0.000 description 2
- MBZRJSQZCBXRGK-UHFFFAOYSA-N 4-tert-Butylcyclohexyl acetate Chemical compound CC(=O)OC1CCC(C(C)(C)C)CC1 MBZRJSQZCBXRGK-UHFFFAOYSA-N 0.000 description 2
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 description 2
- DASQRZJTRKBKPP-UHFFFAOYSA-N 5-butan-2-yl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane Chemical compound O1CC(C(C)CC)(C)COC1C1C(C)C=C(C)CC1 DASQRZJTRKBKPP-UHFFFAOYSA-N 0.000 description 2
- OSMLMQQJZVENMX-UHFFFAOYSA-N 6-butyl-2,4-dimethyl-3,6-dihydro-2h-pyran Chemical compound CCCCC1OC(C)CC(C)=C1 OSMLMQQJZVENMX-UHFFFAOYSA-N 0.000 description 2
- JXPHIHWXMBYJAU-UHFFFAOYSA-N 7-methoxy-2,2-dimethyl-3,4-dihydrochromen-6-ol Chemical compound O1C(C)(C)CCC2=C1C=C(OC)C(O)=C2 JXPHIHWXMBYJAU-UHFFFAOYSA-N 0.000 description 2
- QGFSQVPRCWJZQK-UHFFFAOYSA-N 9-Decen-1-ol Chemical compound OCCCCCCCCC=C QGFSQVPRCWJZQK-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N Benzylformate Chemical compound O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- PXIKRTCSSLJURC-UHFFFAOYSA-N Dihydroeugenol Chemical compound CCCC1=CC=C(O)C(OC)=C1 PXIKRTCSSLJURC-UHFFFAOYSA-N 0.000 description 2
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VXCUURYYWGCLIH-UHFFFAOYSA-N Dodecanenitrile Chemical compound CCCCCCCCCCCC#N VXCUURYYWGCLIH-UHFFFAOYSA-N 0.000 description 2
- 101100229963 Drosophila melanogaster grau gene Proteins 0.000 description 2
- HZPKNSYIDSNZKW-UHFFFAOYSA-N Ethyl 2-methylpentanoate Chemical compound CCCC(C)C(=O)OCC HZPKNSYIDSNZKW-UHFFFAOYSA-N 0.000 description 2
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N Ethyl salicylate Chemical compound CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- JUWUWIGZUVEFQB-UHFFFAOYSA-N Fenchyl acetate Chemical compound C1CC2C(C)(C)C(OC(=O)C)C1(C)C2 JUWUWIGZUVEFQB-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- MEJYWDUBOCZFFS-FENWIEIGSA-N Labienoxime Chemical compound CC(C)C(=N\O)\C(C)(C)C\C=C(/C)C=C MEJYWDUBOCZFFS-FENWIEIGSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- BMZVXYKKNCVBBF-RXSVEWSESA-N NC(=O)NC1NC(=O)NC1=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O Chemical compound NC(=O)NC1NC(=O)NC1=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O BMZVXYKKNCVBBF-RXSVEWSESA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- HIGQPQRQIQDZMP-DHZHZOJOSA-N Neryl acetate Natural products CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 2
- MSFLYJIWLHSQLG-UHFFFAOYSA-N Octahydro-2H-1-benzopyran-2-one Chemical compound C1CCCC2OC(=O)CCC21 MSFLYJIWLHSQLG-UHFFFAOYSA-N 0.000 description 2
- 101710176384 Peptide 1 Proteins 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- VONGZNXBKCOUHB-UHFFFAOYSA-N Phenylmethyl butanoate Chemical compound CCCC(=O)OCC1=CC=CC=C1 VONGZNXBKCOUHB-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004146 Propane-1,2-diol Substances 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000977603 Swertia chirayita Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 241000589499 Thermus thermophilus Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- ZSBOMYJPSRFZAL-JLHYYAGUSA-N [(2e)-3,7-dimethylocta-2,6-dienyl] butanoate Chemical compound CCCC(=O)OC\C=C(/C)CCC=C(C)C ZSBOMYJPSRFZAL-JLHYYAGUSA-N 0.000 description 2
- CRFQQFDSKWNZIZ-YYDJUVGSSA-N [(2e)-3,7-dimethylocta-2,6-dienyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)CCC=C(C)C CRFQQFDSKWNZIZ-YYDJUVGSSA-N 0.000 description 2
- LDHHCYCOENSXIM-IHWYPQMZSA-N [(4z)-cyclooct-4-en-1-yl] methyl carbonate Chemical compound COC(=O)OC1CCC\C=C/CC1 LDHHCYCOENSXIM-IHWYPQMZSA-N 0.000 description 2
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- IGODOXYLBBXFDW-UHFFFAOYSA-N alpha-Terpinyl acetate Chemical compound CC(=O)OC(C)(C)C1CCC(C)=CC1 IGODOXYLBBXFDW-UHFFFAOYSA-N 0.000 description 2
- JKRWZLOCPLZZEI-UHFFFAOYSA-N alpha-Trichloromethylbenzyl acetate Chemical compound CC(=O)OC(C(Cl)(Cl)Cl)C1=CC=CC=C1 JKRWZLOCPLZZEI-UHFFFAOYSA-N 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 229940064062 alpha-glucan oligosaccharide Drugs 0.000 description 2
- YPZUZOLGGMJZJO-UHFFFAOYSA-N ambrofix Natural products C1CC2C(C)(C)CCCC2(C)C2C1(C)OCC2 YPZUZOLGGMJZJO-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001449 anionic compounds Chemical class 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000008365 aqueous carrier Substances 0.000 description 2
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- HIEOGLNFUKBFCF-UHFFFAOYSA-N bis(3-methylbutyl) hexanedioate Chemical compound CC(C)CCOC(=O)CCCCC(=O)OCCC(C)C HIEOGLNFUKBFCF-UHFFFAOYSA-N 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- RADAAKRXEPVXBU-UHFFFAOYSA-N buccoxime Chemical compound C1CCC2(C)CCC1(C)C2=NO RADAAKRXEPVXBU-UHFFFAOYSA-N 0.000 description 2
- XSIFPSYPOVKYCO-UHFFFAOYSA-N butyl benzoate Chemical compound CCCCOC(=O)C1=CC=CC=C1 XSIFPSYPOVKYCO-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 150000001767 cationic compounds Chemical class 0.000 description 2
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- OOWQBDFWEXAXPB-UHFFFAOYSA-N chimyl alcohol Natural products CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 125000000853 cresyl group Chemical group C1(=CC=C(C=C1)C)* 0.000 description 2
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 2
- WCASXYBKJHWFMY-UHFFFAOYSA-N crotyl alcohol Chemical compound CC=CCO WCASXYBKJHWFMY-UHFFFAOYSA-N 0.000 description 2
- DDTBPAQBQHZRDW-UHFFFAOYSA-N cyclododecane Chemical compound C1CCCCCCCCCCC1 DDTBPAQBQHZRDW-UHFFFAOYSA-N 0.000 description 2
- 125000004652 decahydroisoquinolinyl group Chemical group C1(NCCC2CCCCC12)* 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- XSNQECSCDATQEL-UHFFFAOYSA-N dihydromyrcenol Chemical compound C=CC(C)CCCC(C)(C)O XSNQECSCDATQEL-UHFFFAOYSA-N 0.000 description 2
- 229930008394 dihydromyrcenol Natural products 0.000 description 2
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 2
- 229940117973 dimethylmethoxy chromanol Drugs 0.000 description 2
- 229940085632 distearyl ether Drugs 0.000 description 2
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 2
- SSNZFFBDIMUILS-UHFFFAOYSA-N dodec-2-enal Chemical compound CCCCCCCCCC=CC=O SSNZFFBDIMUILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000003182 dose-response assay Methods 0.000 description 2
- WFEISWUNAJPLRX-ONNFQVAWSA-N dupical Chemical compound C12CCCC2C2C\C(=C/CCC=O)C1C2 WFEISWUNAJPLRX-ONNFQVAWSA-N 0.000 description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 2
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 2
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 2
- HLVRJBRPDSSDRC-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid;1-(2-prop-2-enoxyethoxy)octadecane Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C.CCCCCCCCCCCCCCCCCCOCCOCC=C HLVRJBRPDSSDRC-UHFFFAOYSA-N 0.000 description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940074076 glycerol formal Drugs 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- NGAZZOYFWWSOGK-UHFFFAOYSA-N heptan-3-one Chemical compound CCCCC(=O)CC NGAZZOYFWWSOGK-UHFFFAOYSA-N 0.000 description 2
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FRYYDDOUGYKZSA-UHFFFAOYSA-N hexadecyl nonanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCC FRYYDDOUGYKZSA-UHFFFAOYSA-N 0.000 description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 description 2
- 230000003116 impacting effect Effects 0.000 description 2
- 150000008040 ionic compounds Chemical class 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- GJRQTCIYDGXPES-UHFFFAOYSA-N isobutyl acetate Chemical compound CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- UXUPPWPIGVTVQI-UHFFFAOYSA-N isobutyl hexanoate Chemical compound CCCCCC(=O)OCC(C)C UXUPPWPIGVTVQI-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- 229940095045 isopulegol Drugs 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229940057905 laureth-3 Drugs 0.000 description 2
- LAPRIVJANDLWOK-UHFFFAOYSA-N laureth-5 Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCO LAPRIVJANDLWOK-UHFFFAOYSA-N 0.000 description 2
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- DLMYZQZLWRLQNN-UHFFFAOYSA-N methyl 2-(2-methylpentylideneamino)benzoate Chemical compound CCCC(C)C=NC1=CC=CC=C1C(=O)OC DLMYZQZLWRLQNN-UHFFFAOYSA-N 0.000 description 2
- KVWWIYGFBYDJQC-QWRGUYRKSA-N methyl 2-[(1s,2s)-3-oxo-2-pentylcyclopentyl]acetate Chemical compound CCCCC[C@H]1[C@H](CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-QWRGUYRKSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- JZRWBNHLJVOEAT-UHFFFAOYSA-N molecular iodine;2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound II.CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 JZRWBNHLJVOEAT-UHFFFAOYSA-N 0.000 description 2
- 229930008383 myrcenol Natural products 0.000 description 2
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N neral Chemical compound CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- LVQCRSHIONXSCD-UHFFFAOYSA-N nona-1,6-dien-3-ol Chemical compound CCC=CCCC(O)C=C LVQCRSHIONXSCD-UHFFFAOYSA-N 0.000 description 2
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 2
- 229920004918 nonoxynol-9 Polymers 0.000 description 2
- 229940087419 nonoxynol-9 Drugs 0.000 description 2
- 229940082947 nymphaea caerulea flower extract Drugs 0.000 description 2
- BOPPSUHPZARXTH-UHFFFAOYSA-N ocean propanal Chemical compound O=CC(C)CC1=CC=C2OCOC2=C1 BOPPSUHPZARXTH-UHFFFAOYSA-N 0.000 description 2
- SHPVOXFREBUEHB-UHFFFAOYSA-N oct-6-en-1-ol Chemical compound CC=CCCCCCO SHPVOXFREBUEHB-UHFFFAOYSA-N 0.000 description 2
- GLZWNFNQMJAZGY-UHFFFAOYSA-N octaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCO GLZWNFNQMJAZGY-UHFFFAOYSA-N 0.000 description 2
- OXUCOTSGWGNWGC-UHFFFAOYSA-N octane Chemical compound CCCCCCC[CH2-] OXUCOTSGWGNWGC-UHFFFAOYSA-N 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229940101267 panthenol Drugs 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- PETXWIMJICIQTQ-UHFFFAOYSA-N phenylmethoxymethanol Chemical compound OCOCC1=CC=CC=C1 PETXWIMJICIQTQ-UHFFFAOYSA-N 0.000 description 2
- 229960005235 piperonyl butoxide Drugs 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 229940096956 ppg-11 stearyl ether Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 231100000489 sensitizer Toxicity 0.000 description 2
- 210000002363 skeletal muscle cell Anatomy 0.000 description 2
- 239000000176 sodium gluconate Substances 0.000 description 2
- 229940005574 sodium gluconate Drugs 0.000 description 2
- 235000012207 sodium gluconate Nutrition 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 2
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 2
- 229940061605 tetrasodium glutamate diacetate Drugs 0.000 description 2
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- WJSDHUCWMSHDCR-VMPITWQZSA-N trans-cinnamyl acetate Chemical compound CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 2
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 2
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229960002703 undecylenic acid Drugs 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- ZFNVDHOSLNRHNN-UHFFFAOYSA-N xi-3-(4-Isopropylphenyl)-2-methylpropanal Chemical compound O=CC(C)CC1=CC=C(C(C)C)C=C1 ZFNVDHOSLNRHNN-UHFFFAOYSA-N 0.000 description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N α-citronellol Chemical compound OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-JTQLQIEISA-N (-)-Citronellol Chemical compound OCC[C@@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-JTQLQIEISA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- ULDHMXUKGWMISQ-SECBINFHSA-N (-)-carvone Chemical compound CC(=C)[C@@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-SECBINFHSA-N 0.000 description 1
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 1
- NFLGAXVYCFJBMK-BDAKNGLRSA-N (-)-menthone Chemical compound CC(C)[C@@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-BDAKNGLRSA-N 0.000 description 1
- 239000001563 (1,5,5-trimethyl-6-bicyclo[2.2.1]heptanyl) acetate Substances 0.000 description 1
- YWEWWNPYDDHZDI-JJKKTNRVSA-N (1r)-1-[(4r,4ar,8as)-2,6-bis(3,4-dimethylphenyl)-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C1=C(C)C(C)=CC=C1C1O[C@H]2[C@@H]([C@H](O)CO)OC(C=3C=C(C)C(C)=CC=3)O[C@H]2CO1 YWEWWNPYDDHZDI-JJKKTNRVSA-N 0.000 description 1
- FMZUHGYZWYNSOA-VVBFYGJXSA-N (1r)-1-[(4r,4ar,8as)-2,6-diphenyl-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C([C@@H]1OC(O[C@@H]([C@@H]1O1)[C@H](O)CO)C=2C=CC=CC=2)OC1C1=CC=CC=C1 FMZUHGYZWYNSOA-VVBFYGJXSA-N 0.000 description 1
- AJVKAPQCJKEUSG-IEBDPFPHSA-N (1r,3r,4r)-2,2,3,4-tetramethylbicyclo[2.2.1]heptan-3-ol Chemical compound C1C[C@@]2(C)[C@](O)(C)C(C)(C)[C@H]1C2 AJVKAPQCJKEUSG-IEBDPFPHSA-N 0.000 description 1
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (1s,4r,6r)-1,7,7-trimethylbicyclo[2.2.1]heptan-6-ol Chemical compound C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 1
- YYJOTFQPYNOYAB-UHFFFAOYSA-N (2,2,3-trimethylcyclopent-3-en-1-yl)acetonitrile Chemical compound CC1=CCC(CC#N)C1(C)C YYJOTFQPYNOYAB-UHFFFAOYSA-N 0.000 description 1
- YXJFCJJDNPANPU-UHFFFAOYSA-N (2-methoxyphenyl) 2-methylpropanoate Chemical compound COC1=CC=CC=C1OC(=O)C(C)C YXJFCJJDNPANPU-UHFFFAOYSA-N 0.000 description 1
- MSZIFHJZHDLYCE-UHFFFAOYSA-N (2-methylphenyl) butanoate Chemical compound CCCC(=O)OC1=CC=CC=C1C MSZIFHJZHDLYCE-UHFFFAOYSA-N 0.000 description 1
- HZYHMHHBBBSGHB-UHFFFAOYSA-N (2E,6E)-2,6-Nonadienal Natural products CCC=CCCC=CC=O HZYHMHHBBBSGHB-UHFFFAOYSA-N 0.000 description 1
- JZOMOBUGVZDCPA-YNVOBBJPSA-N (2Z)-nona-2,6-diene Chemical compound C\C=C/CCC=CCC JZOMOBUGVZDCPA-YNVOBBJPSA-N 0.000 description 1
- CGMDPTNRMYIZTM-NKYSMPERSA-N (2e,4e,6e)-octa-2,4,6-triene Chemical compound C\C=C\C=C\C=C\C CGMDPTNRMYIZTM-NKYSMPERSA-N 0.000 description 1
- LAGGTOBQMQHXON-GGWOSOGESA-N (2e,6e)-octa-2,6-diene Chemical compound C\C=C\CC\C=C\C LAGGTOBQMQHXON-GGWOSOGESA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- ULDAPNVYSDTSFM-VDWCLKJHSA-N (2r,3s,4s,5r)-2-(hydroxymethyl)-6-undecoxyoxane-3,4,5-triol Chemical compound CCCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ULDAPNVYSDTSFM-VDWCLKJHSA-N 0.000 description 1
- GKGOLPMYJJXRGD-SFYZADRCSA-N (2r,4s)-2-methyl-4-propyl-1,3-oxathiane Chemical compound CCC[C@H]1CCO[C@@H](C)S1 GKGOLPMYJJXRGD-SFYZADRCSA-N 0.000 description 1
- CYVGAJHMMVDTDZ-JQWIXIFHSA-N (2s)-2-methyl-4-[(1s)-2,2,3-trimethylcyclopent-3-en-1-yl]butan-1-ol Chemical compound OC[C@@H](C)CC[C@H]1CC=C(C)C1(C)C CYVGAJHMMVDTDZ-JQWIXIFHSA-N 0.000 description 1
- DSOXXQLCMAEPEZ-UTUPVWNLSA-N (2z,6e)-nona-2,6-dienenitrile Chemical compound CC\C=C\CC\C=C/C#N DSOXXQLCMAEPEZ-UTUPVWNLSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001147 (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran Substances 0.000 description 1
- PKHBEGZTQNOZLP-YDFGWWAZSA-N (3e,6e)-octa-1,3,6-triene Chemical compound C\C=C\C\C=C\C=C PKHBEGZTQNOZLP-YDFGWWAZSA-N 0.000 description 1
- PICGPEBVZGCYBV-CWWKMNTPSA-N (3z,6z)-nona-3,6-dien-1-ol Chemical compound CC\C=C/C\C=C/CCO PICGPEBVZGCYBV-CWWKMNTPSA-N 0.000 description 1
- QLRNLHNEZFMRSR-SOFGYWHQSA-N (4e)-3,7-dimethylocta-4,6-dien-3-ol Chemical compound CCC(C)(O)\C=C\C=C(C)C QLRNLHNEZFMRSR-SOFGYWHQSA-N 0.000 description 1
- CBQXHTWJSZXYSK-DFTQQVSXSA-N (4e)-4-[(e)-but-2-enylidene]-3,5,5-trimethylcyclohex-2-en-1-one Chemical compound C\C=C\C=C1\C(C)=CC(=O)CC1(C)C CBQXHTWJSZXYSK-DFTQQVSXSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- ZTJZJYUGOJYHCU-RMKNXTFCSA-N (5r,6s)-5,6-epoxy-7-megastigmen-9-one Chemical compound C1CCC(C)(C)C2(/C=C/C(=O)C)C1(C)O2 ZTJZJYUGOJYHCU-RMKNXTFCSA-N 0.000 description 1
- FQTLCLSUCSAZDY-SDNWHVSQSA-N (6E)-nerolidol Chemical compound CC(C)=CCC\C(C)=C\CCC(C)(O)C=C FQTLCLSUCSAZDY-SDNWHVSQSA-N 0.000 description 1
- RJUCIROUEDJQIB-GQCTYLIASA-N (6e)-octa-1,6-diene Chemical compound C\C=C\CCCC=C RJUCIROUEDJQIB-GQCTYLIASA-N 0.000 description 1
- SHEOKDCVBGTHJG-QMMMGPOBSA-N (8s)-1,5,8-trimethyl-8,9-dihydro-7h-benzo[e][1]benzofuran-6-one Chemical compound C1=C2OC=C(C)C2=C2C[C@H](C)CC(=O)C2=C1C SHEOKDCVBGTHJG-QMMMGPOBSA-N 0.000 description 1
- 239000001674 (E)-1-(2,6,6-trimethyl-1-cyclohexenyl)but-2-en-1-one Substances 0.000 description 1
- ADLXTJMPCFOTOO-UHFFFAOYSA-N (E)-2-Nonenoic acid Natural products CCCCCCC=CC(O)=O ADLXTJMPCFOTOO-UHFFFAOYSA-N 0.000 description 1
- BTSIZIIPFNVMHF-ONEGZZNKSA-N (E)-2-penten-1-ol Chemical compound CC\C=C\CO BTSIZIIPFNVMHF-ONEGZZNKSA-N 0.000 description 1
- PANBRUWVURLWGY-MDZDMXLPSA-N (E)-2-undecenal Chemical compound CCCCCCCC\C=C\C=O PANBRUWVURLWGY-MDZDMXLPSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ONEGZZNKSA-N (E)-3-Hexenol Natural products CC\C=C\CCO UFLHIIWVXFIJGU-ONEGZZNKSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- SSNZFFBDIMUILS-ZHACJKMWSA-N (E)-dodec-2-enal Chemical compound CCCCCCCCC\C=C\C=O SSNZFFBDIMUILS-ZHACJKMWSA-N 0.000 description 1
- 239000001602 (E)-hex-3-enoic acid Substances 0.000 description 1
- ADLXTJMPCFOTOO-BQYQJAHWSA-N (E)-non-2-enoic acid Chemical compound CCCCCC\C=C\C(O)=O ADLXTJMPCFOTOO-BQYQJAHWSA-N 0.000 description 1
- DCSCXTJOXBUFGB-JGVFFNPUSA-N (R)-(+)-Verbenone Natural products CC1=CC(=O)[C@@H]2C(C)(C)[C@H]1C2 DCSCXTJOXBUFGB-JGVFFNPUSA-N 0.000 description 1
- DCSCXTJOXBUFGB-SFYZADRCSA-N (R)-(+)-verbenone Chemical compound CC1=CC(=O)[C@H]2C(C)(C)[C@@H]1C2 DCSCXTJOXBUFGB-SFYZADRCSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 229930004024 (S)-(-)-citronellol Natural products 0.000 description 1
- 235000018285 (S)-(-)-citronellol Nutrition 0.000 description 1
- 239000000267 (Z)-hex-3-en-1-ol Substances 0.000 description 1
- 239000001586 (Z)-pent-2-en-1-ol Substances 0.000 description 1
- FJCQUJKUMKZEMH-YRNVUSSQSA-N (e)-2-methyl-4-(2,6,6-trimethylcyclohexen-1-yl)but-2-enal Chemical compound O=CC(/C)=C/CC1=C(C)CCCC1(C)C FJCQUJKUMKZEMH-YRNVUSSQSA-N 0.000 description 1
- MTVBNJVZZAQKRV-DJTWPOEFSA-N (e)-2-methyl-4-[(1r)-2,2,3-trimethylcyclopent-3-en-1-yl]but-2-en-1-ol Chemical compound OCC(/C)=C/C[C@H]1CC=C(C)C1(C)C MTVBNJVZZAQKRV-DJTWPOEFSA-N 0.000 description 1
- ZWKNLRXFUTWSOY-QPJJXVBHSA-N (e)-3-phenylprop-2-enenitrile Chemical compound N#C\C=C\C1=CC=CC=C1 ZWKNLRXFUTWSOY-QPJJXVBHSA-N 0.000 description 1
- MDVPRIBCAFEROC-BQYQJAHWSA-N (e)-oct-1-en-1-ol Chemical compound CCCCCC\C=C\O MDVPRIBCAFEROC-BQYQJAHWSA-N 0.000 description 1
- CBVWMGCJNPPAAR-HJWRWDBZSA-N (nz)-n-(5-methylheptan-3-ylidene)hydroxylamine Chemical compound CCC(C)C\C(CC)=N/O CBVWMGCJNPPAAR-HJWRWDBZSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- JHEPBQHNVNUAFL-WAYWQWQTSA-N (z)-hex-1-en-1-ol Chemical compound CCCC\C=C/O JHEPBQHNVNUAFL-WAYWQWQTSA-N 0.000 description 1
- BFHKYHMIVDBCPC-UHFFFAOYSA-N 1,3,5,7-tetrahydro-[1,3]oxazolo[3,4-c][1,3]oxazol-7a-ylmethanol Chemical compound C1OCN2COCC21CO BFHKYHMIVDBCPC-UHFFFAOYSA-N 0.000 description 1
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 description 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 1
- BOHGAOWOIJMTPZ-UHFFFAOYSA-N 1,3-dioxolan-4-ylmethanol Chemical compound OCC1COCO1 BOHGAOWOIJMTPZ-UHFFFAOYSA-N 0.000 description 1
- QVFHFKPGBODJJB-UHFFFAOYSA-N 1,3-oxathiane Chemical compound C1COCSC1 QVFHFKPGBODJJB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- ZCCPVTVGEQLONB-UHFFFAOYSA-N 1-(1,3-dioxolan-2-yl)-n-methylmethanamine Chemical compound CNCC1OCCO1 ZCCPVTVGEQLONB-UHFFFAOYSA-N 0.000 description 1
- WGYZMNBUZFHYRX-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-ol Chemical compound COCC(C)OCC(C)O WGYZMNBUZFHYRX-UHFFFAOYSA-N 0.000 description 1
- FGQQNXIDKFMEOU-UHFFFAOYSA-N 1-(1-methyl-4-propan-2-ylcyclohexyl)oxypropan-2-ol Chemical compound CC(O)COC1(C)CCC(C(C)C)CC1 FGQQNXIDKFMEOU-UHFFFAOYSA-N 0.000 description 1
- BGTBFNDXYDYBEY-UHFFFAOYSA-N 1-(2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-one Chemical compound CC=CC(=O)C1=C(C)CCCC1(C)C BGTBFNDXYDYBEY-UHFFFAOYSA-N 0.000 description 1
- PPTTUVSOUFHJFR-UHFFFAOYSA-N 1-(2-ethylhexoxy)propane-1,1-diol Chemical compound CCCCC(CC)COC(O)(O)CC PPTTUVSOUFHJFR-UHFFFAOYSA-N 0.000 description 1
- IDKLTESMXSAQGI-UHFFFAOYSA-N 1-(2-hydroxyethoxy)-2,2,4-trimethylpentan-3-ol Chemical compound CC(C)C(O)C(C)(C)COCCO IDKLTESMXSAQGI-UHFFFAOYSA-N 0.000 description 1
- KZOSFTIGNZAWQS-UHFFFAOYSA-N 1-(3,3-dimethylcyclohexyl)ethyl 2-acetyloxyacetate Chemical compound CC(OC(=O)COC(C)=O)C1CCCC(C)(C)C1 KZOSFTIGNZAWQS-UHFFFAOYSA-N 0.000 description 1
- MTNZPWYMBRSDTL-UHFFFAOYSA-N 1-(3-methyl-1-benzofuran-2-yl)ethanone Chemical compound C1=CC=C2C(C)=C(C(=O)C)OC2=C1 MTNZPWYMBRSDTL-UHFFFAOYSA-N 0.000 description 1
- NEHPIUGJDUWSRR-UHFFFAOYSA-N 1-(4-propan-2-ylcyclohexyl)ethanol Chemical compound CC(C)C1CCC(C(C)O)CC1 NEHPIUGJDUWSRR-UHFFFAOYSA-N 0.000 description 1
- IRICXAFZMINCTB-UHFFFAOYSA-N 1-Methyl-4-(1-methyl-2-propenyl)-benzene Chemical compound CC=CC1=CC(C(C)C)=CC=C1C IRICXAFZMINCTB-UHFFFAOYSA-N 0.000 description 1
- QWAUHUKNKGMBBD-GDAKKANCSA-N 1-[(2z,5z,9z)-2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl]ethanone Chemical compound CC(=O)C1CC\C(C)=C/CC\C(C)=C/C\C=C1\C QWAUHUKNKGMBBD-GDAKKANCSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- YBUIAJZFOGJGLJ-SWRJLBSHSA-N 1-cedr-8-en-9-ylethanone Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1C(C)=C(C(C)=O)C2 YBUIAJZFOGJGLJ-SWRJLBSHSA-N 0.000 description 1
- OGFVNEOHORRBTH-UHFFFAOYSA-N 1-cyclooctylazocane-2,3-dione Chemical compound O=C1C(=O)CCCCCN1C1CCCCCCC1 OGFVNEOHORRBTH-UHFFFAOYSA-N 0.000 description 1
- RNXNMGPFJLESKN-UHFFFAOYSA-N 1-oxaspiro[4.5]decane Chemical compound C1CCOC21CCCCC2 RNXNMGPFJLESKN-UHFFFAOYSA-N 0.000 description 1
- CSHOPPGMNYULAD-UHFFFAOYSA-N 1-tridecoxytridecane Chemical compound CCCCCCCCCCCCCOCCCCCCCCCCCCC CSHOPPGMNYULAD-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- JGGNJDKQZHDKHQ-UHFFFAOYSA-N 1H-indole Chemical compound C1=CC=C2NC=CC2=C1.C1=CC=C2NC=CC2=C1 JGGNJDKQZHDKHQ-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- BMRGTCJDJUHASV-UHFFFAOYSA-N 1h-inden-5-ol Chemical compound OC1=CC=C2CC=CC2=C1 BMRGTCJDJUHASV-UHFFFAOYSA-N 0.000 description 1
- CCRRYHDVZLKVNQ-UHFFFAOYSA-N 1h-indene-2-carbaldehyde Chemical compound C1=CC=C2CC(C=O)=CC2=C1 CCRRYHDVZLKVNQ-UHFFFAOYSA-N 0.000 description 1
- RTPMDRYHLHGFGT-UHFFFAOYSA-N 2',2',8',8'-tetramethylspiro[1,3-dioxolane-2,10'-octahydro-1h-2,4a-methanonapthalene] Chemical compound CC1(C)C(C2)CCC2(C(CC2)(C)C)C1C12OCCO1 RTPMDRYHLHGFGT-UHFFFAOYSA-N 0.000 description 1
- IMHQFVGHBDXALM-UHFFFAOYSA-N 2,2-diethylhexanoic acid Chemical compound CCCCC(CC)(CC)C(O)=O IMHQFVGHBDXALM-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- VSHIRTNKIXRXMI-UHFFFAOYSA-N 2,2-dimethyl-1,3-oxazolidine Chemical compound CC1(C)NCCO1 VSHIRTNKIXRXMI-UHFFFAOYSA-N 0.000 description 1
- LIMXJCIGROLRED-SOFGYWHQSA-N 2,2-dimethyl-3-[(2e)-3-methylpenta-2,4-dienyl]oxirane Chemical compound C=CC(/C)=C/CC1OC1(C)C LIMXJCIGROLRED-SOFGYWHQSA-N 0.000 description 1
- RIZUCYSQUWMQLX-UHFFFAOYSA-N 2,3-dimethylbenzoic acid Chemical compound CC1=CC=CC(C(O)=O)=C1C RIZUCYSQUWMQLX-UHFFFAOYSA-N 0.000 description 1
- PZIGSXDUIYRWCE-UHFFFAOYSA-N 2,4-dimethylfuran-3-one Chemical compound CC1OC=C(C)C1=O PZIGSXDUIYRWCE-UHFFFAOYSA-N 0.000 description 1
- GPVOTKFXWGURGP-UHFFFAOYSA-N 2,5,5-trimethyl-1,3,4,4a,6,7-hexahydronaphthalen-2-ol Chemical compound C1C(C)(O)CCC2C1=CCCC2(C)C GPVOTKFXWGURGP-UHFFFAOYSA-N 0.000 description 1
- UEGBWDUVDAKUGA-UHFFFAOYSA-N 2,6,10-trimethylundec-9-enal Chemical compound CC(C)=CCCC(C)CCCC(C)C=O UEGBWDUVDAKUGA-UHFFFAOYSA-N 0.000 description 1
- GTMKUOPSEMUACB-UHFFFAOYSA-N 2-(1-methyl-4-propan-2-ylcyclohexyl)oxyethanol Chemical compound CC(C)C1CCC(C)(OCCO)CC1 GTMKUOPSEMUACB-UHFFFAOYSA-N 0.000 description 1
- NMSBTWLFBGNKON-UHFFFAOYSA-N 2-(2-hexadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCO NMSBTWLFBGNKON-UHFFFAOYSA-N 0.000 description 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
- UBIOGWACKKDBPW-UHFFFAOYSA-N 2-(3-methylphenyl)butanamide Chemical compound CC=1C=C(C=CC=1)C(C(=O)N)CC UBIOGWACKKDBPW-UHFFFAOYSA-N 0.000 description 1
- VVUMWAHNKOLVSN-UHFFFAOYSA-N 2-(4-ethoxyanilino)-n-propylpropanamide Chemical compound CCCNC(=O)C(C)NC1=CC=C(OCC)C=C1 VVUMWAHNKOLVSN-UHFFFAOYSA-N 0.000 description 1
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Substances 0.000 description 1
- AWNOGHRWORTNEI-UHFFFAOYSA-N 2-(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)ethyl acetate Chemical compound CC(=O)OCCC1=CCC2C(C)(C)C1C2 AWNOGHRWORTNEI-UHFFFAOYSA-N 0.000 description 1
- IXQGCWUGDFDQMF-UHFFFAOYSA-N 2-Ethylphenol Chemical compound CCC1=CC=CC=C1O IXQGCWUGDFDQMF-UHFFFAOYSA-N 0.000 description 1
- XLQKQWFHQUWKPL-KTKRTIGZSA-N 2-[2-(2-hydroxyethoxy)ethyl-[(z)-octadec-9-enyl]amino]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCN(CCO)CCOCCO XLQKQWFHQUWKPL-KTKRTIGZSA-N 0.000 description 1
- KLFVDTRVIFNWIH-UHFFFAOYSA-N 2-[2-(2-tridecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCCOCCOCCOCCO KLFVDTRVIFNWIH-UHFFFAOYSA-N 0.000 description 1
- BLXVTZPGEOGTGG-UHFFFAOYSA-N 2-[2-(4-nonylphenoxy)ethoxy]ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCOCCO)C=C1 BLXVTZPGEOGTGG-UHFFFAOYSA-N 0.000 description 1
- JKXYOQDLERSFPT-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO JKXYOQDLERSFPT-UHFFFAOYSA-N 0.000 description 1
- HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 1
- LBCZOTMMGHGTPH-UHFFFAOYSA-N 2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCO)C=C1 LBCZOTMMGHGTPH-UHFFFAOYSA-N 0.000 description 1
- HBHLHEJVEMYNOX-UHFFFAOYSA-N 2-[2-dodecoxyethyl(2-hydroxyethyl)amino]ethanol Chemical compound CCCCCCCCCCCCOCCN(CCO)CCO HBHLHEJVEMYNOX-UHFFFAOYSA-N 0.000 description 1
- JNHVXLWUCMXUNL-KTKRTIGZSA-N 2-[2-hydroxyethoxy-[(z)-octadec-9-enyl]amino]oxyethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCN(OCCO)OCCO JNHVXLWUCMXUNL-KTKRTIGZSA-N 0.000 description 1
- CBVDPTYIDMQDEO-UHFFFAOYSA-N 2-decoxyethanol Chemical compound CCCCCCCCCCOCCO CBVDPTYIDMQDEO-UHFFFAOYSA-N 0.000 description 1
- DVCHJFSLGUNEQZ-UHFFFAOYSA-M 2-ethenyl-2,6-dimethylhept-5-enoate Chemical compound CC(C)=CCCC(C)(C=C)C([O-])=O DVCHJFSLGUNEQZ-UHFFFAOYSA-M 0.000 description 1
- TXVAOITYBBWKMG-HWKANZROSA-N 2-hepten-4-one Chemical compound CCCC(=O)\C=C\C TXVAOITYBBWKMG-HWKANZROSA-N 0.000 description 1
- 239000001725 2-hexylcyclopent-2-en-1-one Substances 0.000 description 1
- QGCDCQXHCJKJHS-UHFFFAOYSA-N 2-hydroxypropanoate;morpholin-4-ium Chemical compound CC(O)C([O-])=O.C1COCC[NH2+]1 QGCDCQXHCJKJHS-UHFFFAOYSA-N 0.000 description 1
- BFWRTWBSOCPDQX-UHFFFAOYSA-N 2-hydroxypropanoate;n-(3-morpholin-4-ium-4-ylpropyl)octadecanamide Chemical compound CC(O)C(O)=O.CCCCCCCCCCCCCCCCCC(=O)NCCCN1CCOCC1 BFWRTWBSOCPDQX-UHFFFAOYSA-N 0.000 description 1
- HTWIZMNMTWYQRN-UHFFFAOYSA-N 2-methyl-1,3-dioxolane Chemical compound CC1OCCO1 HTWIZMNMTWYQRN-UHFFFAOYSA-N 0.000 description 1
- YCOHHRPARVZBHK-UHFFFAOYSA-N 2-methyl-3-[(4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)oxy]propan-1-ol Chemical compound C1CC2(C)C(OCC(CO)C)CC1C2(C)C YCOHHRPARVZBHK-UHFFFAOYSA-N 0.000 description 1
- YCOHHRPARVZBHK-JOEFCEOISA-N 2-methyl-3-[[(1S,2R,4S)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]oxy]propan-1-ol Chemical compound CC(CO)CO[C@@H]1C[C@@H]2CC[C@]1(C2(C)C)C YCOHHRPARVZBHK-JOEFCEOISA-N 0.000 description 1
- CYVGAJHMMVDTDZ-UHFFFAOYSA-N 2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)butan-1-ol Chemical compound OCC(C)CCC1CC=C(C)C1(C)C CYVGAJHMMVDTDZ-UHFFFAOYSA-N 0.000 description 1
- MXNVWZZDDFIWHW-UHFFFAOYSA-N 2-methyl-4-(2,6,6-trimethylcyclohexen-1-yl)butanal Chemical compound O=CC(C)CCC1=C(C)CCCC1(C)C MXNVWZZDDFIWHW-UHFFFAOYSA-N 0.000 description 1
- DRTBYQJIHFSKDT-UHFFFAOYSA-N 2-methyl-5-phenylpentan-1-ol Chemical compound OCC(C)CCCC1=CC=CC=C1 DRTBYQJIHFSKDT-UHFFFAOYSA-N 0.000 description 1
- DIVBBSLQUDHECU-UHFFFAOYSA-N 2-methyloctan-3-ol Chemical compound CCCCCC(O)C(C)C DIVBBSLQUDHECU-UHFFFAOYSA-N 0.000 description 1
- QNYWMNCOJRYQJB-UHFFFAOYSA-N 2-methyloxirane;1-octadecoxyoctadecane;oxirane Chemical compound C1CO1.CC1CO1.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC QNYWMNCOJRYQJB-UHFFFAOYSA-N 0.000 description 1
- JMMZCWZIJXAGKW-UHFFFAOYSA-N 2-methylpent-2-ene Chemical compound CCC=C(C)C JMMZCWZIJXAGKW-UHFFFAOYSA-N 0.000 description 1
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 1
- ZAWLBSATNLQTON-UHFFFAOYSA-N 2-nonynoic acid Chemical compound CCCCCCC#CC(O)=O ZAWLBSATNLQTON-UHFFFAOYSA-N 0.000 description 1
- BQDKCWCMDBMLEH-UHFFFAOYSA-N 2-octynoic acid Chemical compound CCCCCC#CC(O)=O BQDKCWCMDBMLEH-UHFFFAOYSA-N 0.000 description 1
- DPVYDTACPLLHCF-UHFFFAOYSA-N 2-phenylethyl pivalate Chemical compound CC(C)(C)C(=O)OCCC1=CC=CC=C1 DPVYDTACPLLHCF-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical compound O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 1
- JIDPHLLCKDISON-UHFFFAOYSA-N 2h-pyran-4-ol Chemical compound OC1=CCOC=C1 JIDPHLLCKDISON-UHFFFAOYSA-N 0.000 description 1
- MTDAKBBUYMYKAR-UHFFFAOYSA-N 3,7-dimethyloct-6-enenitrile Chemical compound N#CCC(C)CCC=C(C)C MTDAKBBUYMYKAR-UHFFFAOYSA-N 0.000 description 1
- DCNFPFNLHFFBFM-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxypropan-1-ol Chemical compound CC(C)C1CCC(C)(OCCCO)CC1 DCNFPFNLHFFBFM-UHFFFAOYSA-N 0.000 description 1
- OHRBQTOZYGEWCJ-UHFFFAOYSA-N 3-(3-propan-2-ylphenyl)butanal Chemical compound CC(C)C1=CC=CC(C(C)CC=O)=C1 OHRBQTOZYGEWCJ-UHFFFAOYSA-N 0.000 description 1
- JFTSYAALCNQOKO-UHFFFAOYSA-N 3-(4-ethylphenyl)-2,2-dimethylpropanal Chemical compound CCC1=CC=C(CC(C)(C)C=O)C=C1 JFTSYAALCNQOKO-UHFFFAOYSA-N 0.000 description 1
- JHHZQADGLDKIPM-AATRIKPKSA-N 3-Hepten-2-one Chemical compound CCC\C=C\C(C)=O JHHZQADGLDKIPM-AATRIKPKSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- WGKYSFRFMQHMOF-UHFFFAOYSA-N 3-bromo-5-methylpyridine-2-carbonitrile Chemical compound CC1=CN=C(C#N)C(Br)=C1 WGKYSFRFMQHMOF-UHFFFAOYSA-N 0.000 description 1
- CLYAQFSQLQTVNO-UHFFFAOYSA-N 3-cyclohexylpropan-1-ol Chemical compound OCCCC1CCCCC1 CLYAQFSQLQTVNO-UHFFFAOYSA-N 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- NGYMOTOXXHCHOC-UHFFFAOYSA-N 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol Chemical compound CC(O)C(C)CCC1CC=C(C)C1(C)C NGYMOTOXXHCHOC-UHFFFAOYSA-N 0.000 description 1
- VBARHQQFLPIUTB-UHFFFAOYSA-N 3-methyl-5-phenylhexan-1-ol Chemical compound CC(CCO)CC(C)c1ccccc1 VBARHQQFLPIUTB-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- YDXQPTHHAPCTPP-WAYWQWQTSA-N 3Z-Octen-1-ol Chemical compound CCCC\C=C/CCO YDXQPTHHAPCTPP-WAYWQWQTSA-N 0.000 description 1
- NHHCOVSYOYGSNY-UHFFFAOYSA-N 3h-naphthalen-2-one Chemical compound C1=CC=CC2=CC(=O)CC=C21 NHHCOVSYOYGSNY-UHFFFAOYSA-N 0.000 description 1
- QKQMGQBOXLMCRD-UHFFFAOYSA-N 4-(1-methyl-4-propan-2-ylcyclohexyl)oxybutan-1-ol Chemical compound CC(C)C1CCC(C)(OCCCCO)CC1 QKQMGQBOXLMCRD-UHFFFAOYSA-N 0.000 description 1
- HFNGYHHRRMSKEU-UHFFFAOYSA-N 4-Methoxybenzyl acetate Chemical compound COC1=CC=C(COC(C)=O)C=C1 HFNGYHHRRMSKEU-UHFFFAOYSA-N 0.000 description 1
- QUMSUJWRUHPEEJ-UHFFFAOYSA-N 4-Pentenal Chemical compound C=CCCC=O QUMSUJWRUHPEEJ-UHFFFAOYSA-N 0.000 description 1
- JTENOSOCIALYPN-UHFFFAOYSA-N 4-cyclohexylbutanal Chemical compound O=CCCCC1CCCCC1 JTENOSOCIALYPN-UHFFFAOYSA-N 0.000 description 1
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 1
- YVSNOTITPICPTB-UHFFFAOYSA-N 4-methyl-2-(2-methylpropyl)oxan-4-ol Chemical compound CC(C)CC1CC(C)(O)CCO1 YVSNOTITPICPTB-UHFFFAOYSA-N 0.000 description 1
- SWOPLXXJAVYFPY-UHFFFAOYSA-N 4-methyl-2-phenyl-3,6-dihydro-2h-pyran Chemical compound C1C(C)=CCOC1C1=CC=CC=C1 SWOPLXXJAVYFPY-UHFFFAOYSA-N 0.000 description 1
- ICMVGKQFVMTRLB-UHFFFAOYSA-N 4-phenylbutanenitrile Chemical compound N#CCCCC1=CC=CC=C1 ICMVGKQFVMTRLB-UHFFFAOYSA-N 0.000 description 1
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 1
- QYFVEEMPFRRFNN-UHFFFAOYSA-N 5,5-dimethylhexan-1-ol Chemical compound CC(C)(C)CCCCO QYFVEEMPFRRFNN-UHFFFAOYSA-N 0.000 description 1
- NYNSNUNMTUNAEO-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalene-2-carbaldehyde Chemical compound C1CCCC2=CC(C=O)=CC=C21 NYNSNUNMTUNAEO-UHFFFAOYSA-N 0.000 description 1
- ZKKXUOROLFBYGR-UHFFFAOYSA-N 5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol Chemical compound CC(O)CCCC1CC=C(C)C1(C)C ZKKXUOROLFBYGR-UHFFFAOYSA-N 0.000 description 1
- MWSQHVUUIHWHBM-UHFFFAOYSA-N 5-(2-hydroxyethyl)-1,3-thiazole Chemical compound OCCC1=CN=CS1 MWSQHVUUIHWHBM-UHFFFAOYSA-N 0.000 description 1
- BKAWJIRCKVUVED-UHFFFAOYSA-N 5-(2-hydroxyethyl)-4-methylthiazole Chemical compound CC=1N=CSC=1CCO BKAWJIRCKVUVED-UHFFFAOYSA-N 0.000 description 1
- RTYRONIMTRDBLT-ONEGZZNKSA-N 5-Hepten-2-one Chemical compound C\C=C\CCC(C)=O RTYRONIMTRDBLT-ONEGZZNKSA-N 0.000 description 1
- ARJWAURHQDJJAC-UHFFFAOYSA-N 5-Methyl-2-hepten-4-one Natural products CCC(C)C(=O)C=CC ARJWAURHQDJJAC-UHFFFAOYSA-N 0.000 description 1
- DPZMVZIQRMVBBW-UHFFFAOYSA-N 5-Phenyl-1-pentanol Chemical compound OCCCCCC1=CC=CC=C1 DPZMVZIQRMVBBW-UHFFFAOYSA-N 0.000 description 1
- FINOPSACFXSAKB-UHFFFAOYSA-N 5-phenylpentanal Chemical compound O=CCCCCC1=CC=CC=C1 FINOPSACFXSAKB-UHFFFAOYSA-N 0.000 description 1
- UBALJTRHSDXCPY-WAPJZHGLSA-N 6-ethylideneoctahydro-5,8-methano-2h-benzo-1-pyran Chemical compound C12CCCOC2C2C/C(=C/C)C1C2 UBALJTRHSDXCPY-WAPJZHGLSA-N 0.000 description 1
- CWJWFQLLHBGAOJ-UHFFFAOYSA-N 6-methylhept-5-en-2-yl 2-methylpropanoate Chemical compound CC(C)C(=O)OC(C)CCC=C(C)C CWJWFQLLHBGAOJ-UHFFFAOYSA-N 0.000 description 1
- AZUVBPVDRHGGEP-UHFFFAOYSA-N 6a,9a-dimethyl-4,5,7,8,9,9a-hexahydro-6aH-dipyrrolo(2,3-b;3',2',1'-hi)indole Natural products CC(=C)C1CCC(C)=CCCC(C)=CCCC(C)=CC1O AZUVBPVDRHGGEP-UHFFFAOYSA-N 0.000 description 1
- LJSJTXAZFHYHMM-UHFFFAOYSA-N 7-methyloctyl acetate Chemical compound CC(C)CCCCCCOC(C)=O LJSJTXAZFHYHMM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- COWIMPXRUUJKQF-UHFFFAOYSA-N 8-methyl-1-oxaspiro[4.5]decan-2-one Chemical compound C1CC(C)CCC11OC(=O)CC1 COWIMPXRUUJKQF-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- ZFMUIJVOIVHGCF-NSCUHMNNSA-N 9-undecenal Chemical compound C\C=C\CCCCCCCC=O ZFMUIJVOIVHGCF-NSCUHMNNSA-N 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- WUNJOFRDOLDAOY-AATRIKPKSA-N Anapear Chemical compound COC(=O)CC\C=C\CC=C WUNJOFRDOLDAOY-AATRIKPKSA-N 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- ROCGEVCZBBJDPU-UHFFFAOYSA-N C(C=CCCCCCC)=O.C(C=CCCCCCC)=O Chemical compound C(C=CCCCCCC)=O.C(C=CCCCCCC)=O ROCGEVCZBBJDPU-UHFFFAOYSA-N 0.000 description 1
- KWEKLXFQYNUNQK-UHFFFAOYSA-N C1CCC2CCC2OCC2CC21 Chemical compound C1CCC2CCC2OCC2CC21 KWEKLXFQYNUNQK-UHFFFAOYSA-N 0.000 description 1
- JQEIKIBVTDBGFL-UHFFFAOYSA-N CCCCCCCCC=CC=O.CCCCCCCCC=CC=O Chemical compound CCCCCCCCC=CC=O.CCCCCCCCC=CC=O JQEIKIBVTDBGFL-UHFFFAOYSA-N 0.000 description 1
- ONAIRGOTKJCYEY-XXDXYRHBSA-N CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ONAIRGOTKJCYEY-XXDXYRHBSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- XXHDAWYDNSXJQM-UHFFFAOYSA-N Chloride-3-Hexenoic acid Natural products CCC=CCC(O)=O XXHDAWYDNSXJQM-UHFFFAOYSA-N 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000581364 Clinitrachus argentatus Species 0.000 description 1
- YEVACTAGDANHRH-UHFFFAOYSA-N Coniferan Chemical compound CCC(C)(C)C1CCCCC1OC(C)=O YEVACTAGDANHRH-UHFFFAOYSA-N 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- RZTOWFMDBDPERY-UHFFFAOYSA-N Delta-Hexanolactone Chemical compound CC1CCCC(=O)O1 RZTOWFMDBDPERY-UHFFFAOYSA-N 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 239000001534 FEMA 4201 Substances 0.000 description 1
- OVGORFFCBUIFIA-UHFFFAOYSA-N Fenipentol Chemical compound CCCCC(O)C1=CC=CC=C1 OVGORFFCBUIFIA-UHFFFAOYSA-N 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- JQQDKNVOSLONRS-UHFFFAOYSA-N Galbanolene Natural products CCCCCC=CC=CC=C JQQDKNVOSLONRS-UHFFFAOYSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- DRFSOBZVMGLICQ-SGMGOOAPSA-N Guaiol acetate Chemical compound C1([C@H](CC[C@H](C2)C(C)(C)OC(C)=O)C)=C2[C@@H](C)CC1 DRFSOBZVMGLICQ-SGMGOOAPSA-N 0.000 description 1
- CATSNJVOTSVZJV-UHFFFAOYSA-N Heptan-2-one Natural products CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- FPCCDPXRNNVUOM-UHFFFAOYSA-N Hydroxycitronellol Chemical compound OCCC(C)CCCC(C)(C)O FPCCDPXRNNVUOM-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- DIRDKDDFAMNBNY-UHFFFAOYSA-N Isopropyl 2-methylbutanoate Chemical compound CCC(C)C(=O)OC(C)C DIRDKDDFAMNBNY-UHFFFAOYSA-N 0.000 description 1
- 229930186686 Jasmolactone Natural products 0.000 description 1
- BVQAARKEKMVAKI-UHFFFAOYSA-N Khusimol Natural products CC1(C)C2CCC(=C)C3CCC(CO)C13C2 BVQAARKEKMVAKI-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 241000234269 Liliales Species 0.000 description 1
- BRHDDEIRQPDPMG-UHFFFAOYSA-N Linalyl oxide Chemical compound CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 description 1
- JBVVONYMRFACPQ-UHFFFAOYSA-N Linalylformate Natural products CC(=C)CCCC(C)(OC=O)C=C JBVVONYMRFACPQ-UHFFFAOYSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- ZBJCYZPANVLBRK-UHFFFAOYSA-N Menthone 1,2-glyceryl ketal Chemical compound CC(C)C1CCC(C)CC11OC(CO)CO1 ZBJCYZPANVLBRK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- ZWNPUELCBZVMDA-CMDGGOBGSA-N Methyl 2-nonenoate Chemical compound CCCCCC\C=C\C(=O)OC ZWNPUELCBZVMDA-CMDGGOBGSA-N 0.000 description 1
- ICBJCVRQDSQPGI-UHFFFAOYSA-N Methyl hexyl ether Chemical compound CCCCCCOC ICBJCVRQDSQPGI-UHFFFAOYSA-N 0.000 description 1
- UAGJVSRUFNSIHR-UHFFFAOYSA-N Methyl levulinate Chemical compound COC(=O)CCC(C)=O UAGJVSRUFNSIHR-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- SHEOKDCVBGTHJG-UHFFFAOYSA-N Myrrhone Natural products C1=C2OC=C(C)C2=C2CC(C)CC(=O)C2=C1C SHEOKDCVBGTHJG-UHFFFAOYSA-N 0.000 description 1
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- 235000005807 Nelumbo Nutrition 0.000 description 1
- 241000209445 Nelumbonaceae Species 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- 229920000873 Nonoxynol-9 iodine Polymers 0.000 description 1
- 235000010710 Nymphaea lotus Nutrition 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- GPMLJOOQCIHFET-UHFFFAOYSA-N Rhubafuran Chemical compound C1OC(C)CC1(C)C1=CC=CC=C1 GPMLJOOQCIHFET-UHFFFAOYSA-N 0.000 description 1
- CGMDPTNRMYIZTM-UHFFFAOYSA-N Sarohornene Natural products CC=CC=CC=CC CGMDPTNRMYIZTM-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- OOYRHNIVDZZGQV-UHFFFAOYSA-N Tricyclovetivenol Natural products C=C1C(C)(C)C(C2)CCC32C(CO)CCC31 OOYRHNIVDZZGQV-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- KGEKLUUHTZCSIP-JFGNBEQYSA-N [(1r,3s,4s)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@@H](OC(=O)C)C[C@@H]1C2(C)C KGEKLUUHTZCSIP-JFGNBEQYSA-N 0.000 description 1
- IIUKCYITROTKFB-HNNXBMFYSA-N [(1s)-3-(4-methylpent-3-enyl)cyclohex-3-en-1-yl]methyl acetate Chemical compound CC(C)=CCCC1=CCC[C@H](COC(C)=O)C1 IIUKCYITROTKFB-HNNXBMFYSA-N 0.000 description 1
- HLLPKVARTYKIJB-MCQPFKOBSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical compound O[C@H]1[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O1 HLLPKVARTYKIJB-MCQPFKOBSA-N 0.000 description 1
- FOLJTMYCYXSPFQ-CJKAUBRRSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOLJTMYCYXSPFQ-CJKAUBRRSA-N 0.000 description 1
- BMHNFXNMWLKAIM-VDZNHIKYSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-2-dodecanoyloxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@]1(OC(=O)CCCCCCCCCCC)[C@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 BMHNFXNMWLKAIM-VDZNHIKYSA-N 0.000 description 1
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 1
- UEYVMVXJVDAGBB-ZHBLIPIOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl tetradecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O UEYVMVXJVDAGBB-ZHBLIPIOSA-N 0.000 description 1
- IVSZEHYDOLAREK-PKNBQFBNSA-N [(6e)-3,7-dimethylnona-1,6-dien-3-yl] acetate Chemical compound CC\C(C)=C\CCC(C)(C=C)OC(C)=O IVSZEHYDOLAREK-PKNBQFBNSA-N 0.000 description 1
- WUEJOVNIQISNHV-BQYQJAHWSA-N [(E)-hex-1-enyl] 2-methylpropanoate Chemical compound CCCC\C=C\OC(=O)C(C)C WUEJOVNIQISNHV-BQYQJAHWSA-N 0.000 description 1
- XJXFLRWMYHIIKV-CLFAGFIQSA-N [2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[(z)-octadec-9-enoyl]oxypropoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COC(=O)CCCCCCC\C=C/CCCCCCCC XJXFLRWMYHIIKV-CLFAGFIQSA-N 0.000 description 1
- NGHUOSKIZOQGBY-PMDAXIHYSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-[2,3-bis[[(Z)-octadec-9-enoyl]oxy]propoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC NGHUOSKIZOQGBY-PMDAXIHYSA-N 0.000 description 1
- VNWNJCZJWTXLEI-UHFFFAOYSA-N acetic acid 3-phenylprop-2-enoic acid Chemical compound CC(O)=O.CC(O)=O.OC(=O)C=Cc1ccccc1 VNWNJCZJWTXLEI-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- ZNBBXMOLCMPOCC-UHFFFAOYSA-N acetic acid;2-phenylacetic acid Chemical compound CC(O)=O.OC(=O)CC1=CC=CC=C1 ZNBBXMOLCMPOCC-UHFFFAOYSA-N 0.000 description 1
- 102000034337 acetylcholine receptors Human genes 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- YTJZRHVGZOVOMX-UHFFFAOYSA-N azulen-5-ylmethanol Chemical compound OCC1=CC=CC2=CC=CC2=C1 YTJZRHVGZOVOMX-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- BHLWLVTYEDJFGZ-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1.O=CC1=CC=CC=C1 BHLWLVTYEDJFGZ-UHFFFAOYSA-N 0.000 description 1
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 229950011260 betanaphthol Drugs 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- LPCWKMYWISGVSK-UHFFFAOYSA-N bicyclo[3.2.1]octane Chemical compound C1C2CCC1CCC2 LPCWKMYWISGVSK-UHFFFAOYSA-N 0.000 description 1
- WNTGVOIBBXFMLR-UHFFFAOYSA-N bicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1C2 WNTGVOIBBXFMLR-UHFFFAOYSA-N 0.000 description 1
- QEGGPUAKCVWNOT-UHFFFAOYSA-N bicyclo[4.3.1]decane Chemical compound C1C2CCCC1CCCC2 QEGGPUAKCVWNOT-UHFFFAOYSA-N 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- JCTHGPXQXLMSDK-UHFFFAOYSA-N bis(Benzyloxy)methane Chemical compound C=1C=CC=CC=1COCOCC1=CC=CC=C1 JCTHGPXQXLMSDK-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- WTJFFWCRIVCPED-UHFFFAOYSA-N butan-2-yl 2-hydroxybenzoate Chemical compound CCC(C)OC(=O)C1=CC=CC=C1O WTJFFWCRIVCPED-UHFFFAOYSA-N 0.000 description 1
- LOCHFZBWPCLPAN-UHFFFAOYSA-N butane-2-thiol Chemical compound CCC(C)S LOCHFZBWPCLPAN-UHFFFAOYSA-N 0.000 description 1
- 229940050484 c10-16 pareth-1 Drugs 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- LDVVMCZRFWMZSG-UHFFFAOYSA-N captan Chemical compound C1C=CCC2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C21 LDVVMCZRFWMZSG-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- MIZGSAALSYARKU-UHFFFAOYSA-N cashmeran Chemical compound CC1(C)C(C)C(C)(C)C2=C1C(=O)CCC2 MIZGSAALSYARKU-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- 229940081620 ceteth-2 Drugs 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 231100000778 chemical safety assessment Toxicity 0.000 description 1
- BIWJNBZANLAXMG-YQELWRJZSA-N chloordaan Chemical compound ClC1=C(Cl)[C@@]2(Cl)C3CC(Cl)C(Cl)C3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-YQELWRJZSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 description 1
- GQVMHMFBVWSSPF-UHFFFAOYSA-N cis-alloocimene Natural products CC=C(C)C=CC=C(C)C GQVMHMFBVWSSPF-UHFFFAOYSA-N 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- MLUCVPSAIODCQM-NSCUHMNNSA-N crotonaldehyde Chemical compound C\C=C\C=O MLUCVPSAIODCQM-NSCUHMNNSA-N 0.000 description 1
- ABZZOPIABWYXSN-UHFFFAOYSA-N cyclohex-3-en-1-ol Chemical compound OC1CCC=CC1 ABZZOPIABWYXSN-UHFFFAOYSA-N 0.000 description 1
- QYQADNCHXSEGJT-UHFFFAOYSA-N cyclohexane-1,1-dicarboxylate;hydron Chemical compound OC(=O)C1(C(O)=O)CCCCC1 QYQADNCHXSEGJT-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- GCFAUZGWPDYAJN-UHFFFAOYSA-N cyclohexyl 3-phenylprop-2-enoate Chemical compound C=1C=CC=CC=1C=CC(=O)OC1CCCCC1 GCFAUZGWPDYAJN-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 1
- GMZOTIHIRLYWPF-UHFFFAOYSA-N cyclopenta[h][1,3]benzodioxine Chemical compound C1=CC2=CC=CC2=C2OCOC=C21 GMZOTIHIRLYWPF-UHFFFAOYSA-N 0.000 description 1
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 1
- GUDMZGLFZNLYEY-UHFFFAOYSA-N cyclopropylmethanol Chemical compound OCC1CC1 GUDMZGLFZNLYEY-UHFFFAOYSA-N 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- IOOVSELFISXCIG-UHFFFAOYSA-N dec-3-en-5-ol Chemical compound CCCCCC(O)C=CCC IOOVSELFISXCIG-UHFFFAOYSA-N 0.000 description 1
- INCUADDKTZVEMH-UHFFFAOYSA-N deca-4,9-dienal Chemical compound C=CCCCC=CCCC=O INCUADDKTZVEMH-UHFFFAOYSA-N 0.000 description 1
- 125000004856 decahydroquinolinyl group Chemical group N1(CCCC2CCCCC12)* 0.000 description 1
- FBYYWBUKHICADY-UHFFFAOYSA-N decanoic acid;2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol;octanoic acid;pentanoic acid Chemical compound CCCCC(O)=O.CCCCCCCC(O)=O.CCCCCCCCCC(O)=O.OCC(CO)(CO)COCC(CO)(CO)CO FBYYWBUKHICADY-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 1
- 208000028919 diffuse intrinsic pontine glioma Diseases 0.000 description 1
- POCFBDFTJMJWLG-UHFFFAOYSA-N dihydrosinapic acid methyl ester Natural products COC(=O)CCC1=CC(OC)=C(O)C(OC)=C1 POCFBDFTJMJWLG-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- WTOYNNBCKUYIKC-UHFFFAOYSA-N dl-nootkatone Natural products C1CC(C(C)=C)CC2(C)C(C)CC(=O)C=C21 WTOYNNBCKUYIKC-UHFFFAOYSA-N 0.000 description 1
- WRZXKWFJEFFURH-UHFFFAOYSA-N dodecaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO WRZXKWFJEFFURH-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- TUEUDXZEBRMJEV-UWVGGRQHSA-N ethyl (1r,6s)-2,2,6-trimethylcyclohexane-1-carboxylate Chemical compound CCOC(=O)[C@@H]1[C@@H](C)CCCC1(C)C TUEUDXZEBRMJEV-UWVGGRQHSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 229940005667 ethyl salicylate Drugs 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 239000001734 eugenia caryophyllata l. bud oleoresin Substances 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- ARJWAURHQDJJAC-GQCTYLIASA-N filbertone Chemical compound CCC(C)C(=O)\C=C\C ARJWAURHQDJJAC-GQCTYLIASA-N 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 1
- ONKNPOPIGWHAQC-UHFFFAOYSA-N galaxolide Chemical compound C1OCC(C)C2=C1C=C1C(C)(C)C(C)C(C)(C)C1=C2 ONKNPOPIGWHAQC-UHFFFAOYSA-N 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- FQMZVFJYMPNUCT-UHFFFAOYSA-N geraniol formate Natural products CC(C)=CCCC(C)=CCOC=O FQMZVFJYMPNUCT-UHFFFAOYSA-N 0.000 description 1
- NHCQMVNKPJAQJZ-UHFFFAOYSA-N geranyl n-butyrate Natural products CCCCOCC=C(C)CCC=C(C)C NHCQMVNKPJAQJZ-UHFFFAOYSA-N 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- CBAGROYOJMZIRK-UHFFFAOYSA-N hepta-1,6-dien-3-one Chemical compound C=CCCC(=O)C=C CBAGROYOJMZIRK-UHFFFAOYSA-N 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000004634 hexahydroazepinyl group Chemical group N1(CCCCCC1)* 0.000 description 1
- MHKMJVOJQZUOTO-UHFFFAOYSA-N hexyl hexanoate Chemical compound CCCCCCOC(=O)CCCCC.CCCCCCOC(=O)CCCCC MHKMJVOJQZUOTO-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- SNWQUNCRDLUDEX-UHFFFAOYSA-N inden-1-one Chemical compound C1=CC=C2C(=O)C=CC2=C1 SNWQUNCRDLUDEX-UHFFFAOYSA-N 0.000 description 1
- VLQPTWRGZFDXMO-UHFFFAOYSA-N inden-4-one Chemical compound O=C1C=CC=C2C=CC=C12 VLQPTWRGZFDXMO-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- 229940113096 isoceteth 20 Drugs 0.000 description 1
- 229940010298 isoceteth-10 Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- NBCMACYORPIYNY-UHFFFAOYSA-N jasmolactone Chemical compound CC=CCCC1CCCC(=O)O1 NBCMACYORPIYNY-UHFFFAOYSA-N 0.000 description 1
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 1
- 239000008633 juniper tar Substances 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- OOYRHNIVDZZGQV-BHPKHCPMSA-N khusimol Chemical compound C=C1C(C)(C)[C@@H](C2)CC[C@]32[C@@H](CO)CC[C@@H]31 OOYRHNIVDZZGQV-BHPKHCPMSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940031726 laureth-10 Drugs 0.000 description 1
- 229940100491 laureth-2 Drugs 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- HYNGAVZPWWXQIU-UHFFFAOYSA-N lavandulyl acetate Natural products CC(C)=CCC(C(C)=C)COC(C)=O HYNGAVZPWWXQIU-UHFFFAOYSA-N 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- 102000005861 leptin receptors Human genes 0.000 description 1
- 108010019813 leptin receptors Proteins 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- HPTIDIPGIUCQFC-UHFFFAOYSA-N methoxymethoxycyclododecane Chemical compound COCOC1CCCCCCCCCCC1 HPTIDIPGIUCQFC-UHFFFAOYSA-N 0.000 description 1
- OFXSXYCSPVKZPF-UHFFFAOYSA-N methoxyperoxymethane Chemical compound COOOC OFXSXYCSPVKZPF-UHFFFAOYSA-N 0.000 description 1
- KVWWIYGFBYDJQC-MNOVXSKESA-N methyl 2-[(1r,2s)-3-oxo-2-pentylcyclopentyl]acetate Chemical compound CCCCC[C@H]1[C@@H](CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-MNOVXSKESA-N 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- KYWIYKKSMDLRDC-UHFFFAOYSA-N methyl n-nonyl ketone Natural products CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- JPTOCTSNXXKSSN-UHFFFAOYSA-N methylheptenone Chemical compound CCCC=CC(=O)CC JPTOCTSNXXKSSN-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- ODLHGICHYURWBS-FOSILIAISA-N molport-023-220-444 Chemical compound CC(O)COC[C@@H]([C@@H]([C@H]([C@@H]1O)O)O[C@@H]2O[C@H]([C@H](O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O3)[C@@H](O)[C@@H]2O)COCC(O)C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@H]3O[C@H]1COCC(C)O ODLHGICHYURWBS-FOSILIAISA-N 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- DUNCVNHORHNONW-UHFFFAOYSA-N myrcenol Chemical compound CC(C)(O)CCCC(=C)C=C DUNCVNHORHNONW-UHFFFAOYSA-N 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 description 1
- ZPVFWPFBNIEHGJ-UHFFFAOYSA-N n-hexyl methyl ketone Natural products CCCCCCC(C)=O ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000706 no observed effect level Toxicity 0.000 description 1
- XJHRZBIBSSVCEL-UHFFFAOYSA-N non-6-en-1-ol Chemical compound CCC=CCCCCCO XJHRZBIBSSVCEL-UHFFFAOYSA-N 0.000 description 1
- KJJTVYPKKMBBKS-UHFFFAOYSA-N non-7-en-2-ol Chemical compound CC=CCCCCC(C)O KJJTVYPKKMBBKS-UHFFFAOYSA-N 0.000 description 1
- 231100000308 non-sensitiser Toxicity 0.000 description 1
- PICGPEBVZGCYBV-UHFFFAOYSA-N nona-3,6-dien-1-ol Chemical compound CCC=CCC=CCCO PICGPEBVZGCYBV-UHFFFAOYSA-N 0.000 description 1
- NPJQSHIVMSHSKW-UHFFFAOYSA-N nona-6,8-dien-3-one Chemical compound CCC(=O)CCC=CC=C NPJQSHIVMSHSKW-UHFFFAOYSA-N 0.000 description 1
- RCMCWKISLTXDQO-UHFFFAOYSA-N nonan-3-one Chemical compound CCCCCCC(=O)CC.CCCCCCC(=O)CC RCMCWKISLTXDQO-UHFFFAOYSA-N 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920000847 nonoxynol Polymers 0.000 description 1
- 229940073555 nonoxynol-10 Drugs 0.000 description 1
- 229940116391 nonoxynol-4 Drugs 0.000 description 1
- 229920004919 nonoxynol-6 Polymers 0.000 description 1
- 229940078482 nonoxynol-8 Drugs 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BTSIZIIPFNVMHF-UHFFFAOYSA-N nor-leaf alcohol Natural products CCC=CCO BTSIZIIPFNVMHF-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- USXILEVHWYGLKS-UHFFFAOYSA-N oct-6-enenitrile Chemical compound CC=CCCCCC#N USXILEVHWYGLKS-UHFFFAOYSA-N 0.000 description 1
- HIHGJPMEFFCGEZ-UHFFFAOYSA-N octa-2,5-dien-4-one Chemical compound CCC=CC(=O)C=CC HIHGJPMEFFCGEZ-UHFFFAOYSA-N 0.000 description 1
- FJCZSUYRNVRTFV-UHFFFAOYSA-N octa-4,6-dien-3-ol Chemical compound CCC(O)C=CC=CC FJCZSUYRNVRTFV-UHFFFAOYSA-N 0.000 description 1
- IUITWWQQPHHQAU-UHFFFAOYSA-N octadecyl nonanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCC IUITWWQQPHHQAU-UHFFFAOYSA-N 0.000 description 1
- IORLKTZOJWQNPB-UHFFFAOYSA-N octan-3-one Chemical compound CCCCCC(=O)CC.CCCCCC(=O)CC IORLKTZOJWQNPB-UHFFFAOYSA-N 0.000 description 1
- QUADBKCRXGFGAX-UHFFFAOYSA-N octane-1,7-diol Chemical compound CC(O)CCCCCCO QUADBKCRXGFGAX-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 229920004905 octoxynol-10 Polymers 0.000 description 1
- 229920004900 octoxynol-3 Polymers 0.000 description 1
- HVFSJXUIRWUHRG-UHFFFAOYSA-N oic acid Natural products C1CC2C3CC=C4CC(OC5C(C(O)C(O)C(CO)O5)O)CC(O)C4(C)C3CCC2(C)C1C(C)C(O)CC(C)=C(C)C(=O)OC1OC(COC(C)=O)C(O)C(O)C1OC(C(C1O)O)OC(COC(C)=O)C1OC1OC(CO)C(O)C(O)C1O HVFSJXUIRWUHRG-UHFFFAOYSA-N 0.000 description 1
- 229940075643 oleth-3 Drugs 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- VWMVAQHMFFZQGD-UHFFFAOYSA-N p-Hydroxybenzyl acetone Natural products CC(=O)CC1=CC=C(O)C=C1 VWMVAQHMFFZQGD-UHFFFAOYSA-N 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- ZHZCYWWNFQUZOR-UHFFFAOYSA-N pent-4-en-2-ol Chemical compound CC(O)CC=C ZHZCYWWNFQUZOR-UHFFFAOYSA-N 0.000 description 1
- TWSRVQVEYJNFKQ-UHFFFAOYSA-N pentyl propanoate Chemical compound CCCCCOC(=O)CC TWSRVQVEYJNFKQ-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- WFNDDSQUKATKNX-UHFFFAOYSA-N phenethyl butyrate Chemical compound CCCC(=O)OCCC1=CC=CC=C1 WFNDDSQUKATKNX-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 125000004591 piperonyl group Chemical group C(C1=CC=2OCOC2C=C1)* 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229920001987 poloxamine Polymers 0.000 description 1
- 239000008389 polyethoxylated castor oil Substances 0.000 description 1
- 229940110977 polyglycerin-4 Drugs 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- QWRGOHMKGNCVAC-KQHSAVHASA-N pomarose Chemical compound C\C=C\C(=O)C(\C)=C(\C)C(C)C QWRGOHMKGNCVAC-KQHSAVHASA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940023565 ppg-10 cetyl ether Drugs 0.000 description 1
- 229940089994 ppg-2 methyl ether Drugs 0.000 description 1
- DQKXQSGTHWVTAD-UHFFFAOYSA-N pramocaine Chemical compound C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 DQKXQSGTHWVTAD-UHFFFAOYSA-N 0.000 description 1
- 229960001896 pramocaine Drugs 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- IZRQAXQJHCEFNQ-UHFFFAOYSA-N prop-1-enyl 2-hydroxyacetate Chemical compound CC=COC(=O)CO IZRQAXQJHCEFNQ-UHFFFAOYSA-N 0.000 description 1
- IUXQFLRZZUQUPJ-UHFFFAOYSA-N prop-1-enyl benzoate Chemical compound CC=COC(=O)C1=CC=CC=C1 IUXQFLRZZUQUPJ-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930007790 rose oxide Natural products 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 231100000051 skin sensitiser Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940073741 steareth-7 Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- JHHZQADGLDKIPM-UHFFFAOYSA-N trans-hept-3-en-2-one Natural products CCCC=CC(C)=O JHHZQADGLDKIPM-UHFFFAOYSA-N 0.000 description 1
- XXHDAWYDNSXJQM-ONEGZZNKSA-N trans-hex-3-enoic acid Chemical compound CC\C=C\CC(O)=O XXHDAWYDNSXJQM-ONEGZZNKSA-N 0.000 description 1
- XMLSXPIVAXONDL-UHFFFAOYSA-N trans-jasmone Natural products CCC=CCC1=C(C)CCC1=O XMLSXPIVAXONDL-UHFFFAOYSA-N 0.000 description 1
- PXURBCDVKJKZNB-UHFFFAOYSA-N tricyclo[5.3.1.01,5]undeca-2,5,7,9-tetraene Chemical compound C1C2=CC=CC31C=CCC3=C2 PXURBCDVKJKZNB-UHFFFAOYSA-N 0.000 description 1
- UKUOLJBGGIXMCR-UHFFFAOYSA-N tricyclo[5.3.1.03,8]undeca-1,3(8),4,6,9-pentaene Chemical compound C12=CC=CC3=CC(=CC=C13)C2 UKUOLJBGGIXMCR-UHFFFAOYSA-N 0.000 description 1
- DXNCZXXFRKPEPY-UHFFFAOYSA-N tridecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCC(O)=O DXNCZXXFRKPEPY-UHFFFAOYSA-N 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- FBJOZYRPJMTSNP-UHFFFAOYSA-N undecanal Chemical compound CCCCCCCCCCC=O.CCCCCCCCCCC=O FBJOZYRPJMTSNP-UHFFFAOYSA-N 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- CRIGTVCBMUKRSL-ALCCZGGFSA-N α-damascone Chemical compound C\C=C/C(=O)C1C(C)=CCCC1(C)C CRIGTVCBMUKRSL-ALCCZGGFSA-N 0.000 description 1
- 229930007850 β-damascenone Natural products 0.000 description 1
- IHPKGUQCSIINRJ-UHFFFAOYSA-N β-ocimene Natural products CC(C)=CCC=C(C)C=C IHPKGUQCSIINRJ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/608—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/50—Perfumes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Fats And Perfumes (AREA)
- Seasonings (AREA)
- Cosmetics (AREA)
Abstract
Various embodiments disclosed relate to a fragrance composition. The fragrance composition includes a fragrance component and an extract solution. The extract solution includes nymphaea coerulea flower extract and nelumbo nucifera flower extract.
Description
380526.NL.02-967.475NL2
FRAGRANCE COMPOSITIONS
[1] This application claims the benefit of priority to U.S. Provisional Patent
Application Serial Nos. 63/500,388 filed May 5, 2023 entitled “Cosmetic Composition”; 63/500,382 filed May 5, 2023 entitled “Fragrance Compositions”; 63/614,226 filed December 22, 2023 entitled “Cosmetic Composition”; and NL 2035897 filed 27 Sep 2023 entitled “Fragrance
Compositions” the disclosure of which is incorporated herein in its entirety by reference.
Experimental and clmical studies have shown that fragrance oils can display varying evaporation profiles depending at least on the presence or absence of other components of the formula.. Fragrance oils can also act as prehaptens or prohaptens by forming allergens that are more potent than a parent substance by activation outside or in the skin, Activation occurs via abiotic, chemical and physical factors, or biotic activation, thus, increasing the risk of sensitization.
Some fragrance oils autoxidize on contact with air, forming potent sensitizers that can be an important source for contact allergy to fragrances and fragranced products. Some of them act as prohaptens and are activated in the skin as well.
[2] Various embodiments disclosed relate to a fragrance composition. The fragrance composition includes a fragrance component; optionally a modulator; and an extract solution capable of sebum reduction; sweat reduction; and/or acetylcholine release inhibition. The extract solution may include nymphaea coerulea flower extract and nelumbo nucifera flower extract. The synergistic effects of applying the modulator and extract solution prior to or simultaneously with application of a fragrance allergen to skin may result in decreased allergenicity.
[3] New ingredients for use as effective, active agents in compositions and formulations for application, preferably topical application, to the skin are advantageous to the industry and the consumer for a variety of uses in the areas of skin care treatment and therapy, and 1
380526.NL.02-967.475NL2 personal use products. Nelupure (INCI: Propanediol (and) Glycerin (and) Nymphaea Caerulea
Flower Extract (and) Nelumbo Nucifera Flower Extract, used interchangeably as trade name
Nelupure; INCI; “lotus flower extract”; and/or “lotus flower extract blend and/or constituents thereof” throughout) is a blended extract from two types of lotus flower, the Egyptian Lotus (Nymphaea caerulea) and the Sacred Lotus (Nelumbo nucifera). Tt has been speculated that
Nelupure (INCI: Propanediol (and) Glycerin (and) Nymphaea Caerulea Flower Extract (and)
Nelumbo Nucifera Flower Extract) acts via leptin-receptor inhibition to regulate the sebaceous glands, preventing the excess of sebum production and inflammatory processes that cause skin blemishes, and may also act to inhibit acetylcholine release.
[4] Unwind Sacred Lotus, marketed by the Naolys company, is a material consisting of active plant cells from Nelumbo nucifera whose action has been described as " modulating the skin’s neuro-system, Sacred Lotus cells have a relaxing effect that helps to restore the skin’s original balance.” https://www.unifect conv produects/anwind-sacred-lotus/
[5] Reference will now be made in detail to certain aspects of the disclosed subject matter. While the disclosed subject matter will be described in conjunction with the enumerated claims, it will be understood that the exemplified subject matter is not intended to limit the claims to the disclosed subject matter.
[6] Throughout this document, values expressed in a range format should be interpreted in a flexible manner to include not only the numerical values explicitly recited as the limits of the range, but also to include all the individual numerical values or sub-ranges encompassed within that range as if each numerical value and sub-range is explicitly recited. For example, a range of “about 0.1% to about 5%” or “about 0.1% to 5%" should be interpreted to include not just about 0.1% to about 5%, but also the individual values (e.g., 1%, 2%, 3%, and 4%) and the sub-ranges (eg, 0.1% to 0.5%, 1.1% to 2.2%, 3.3% to 4.4%) within the indicated range. The statement “about
X to Y has the same meaning as “about X to about Y,” unless indicated otherwise. Likewise, the statement “about X, Y, or about Z” has the same meaning as “about X, about Y, or about Z,” unless indicated otherwise. 2
380526.NL.02-967.475NL2
[7] In this document, the terms “a,” “an,” or “the” are used to include one or more than one unless the context clearly dictates otherwise. The term “or” is used to refer to a nonexclusive “or” unless otherwise indicated. The statement “at least one of A and B” has the same meaning as “A, B, or A and B.” In addition, it is to be understood that the phraseology or terminology employed herein, and not otherwise defined, is for the purpose of description only and not of limitation. Any use of section headings is intended to aid reading of the document and is not to be interpreted as limiting; information that is relevant to a section heading may occur within or outside of that particular section.
[8] As used herein, the term “body splash” means a body care formulation that is applied to the body. Typically, the body splash 1s applied to the body after bathing and provides a subtle hint of scent to the body. Body splashes are commonly used by consumers who prefer less strong fragrance compositions. A body splash may comprise an ethanol-free composition according to the present invention which comprises from 0.2-8 wt%, relative to the total weight of the composition, of a fragrance component. The body splash may further comprise alkyl polyglucosides as non-ionic surfactants.
[9] As used herein, the term “body spray” means a formulation comprising fragrance materials intended to be applied to the body to prevent or mask body odor caused by the bacterial breakdown of perspiration on the body (e.g., armpits, feet, and other areas of the body). The body spray may also provide a fragrance expression to the a panel of experts or professional evaluators or individual experts or professional evaluators. Typically, body spray compositions are applied as an aerosol spray in an effective amount on the skin of a consumer.
[10] As used herein, the term “composition” includes a fine fragrance composition intended for application to a body surface, such as for example, skin or hair, e.g., to impart a pleasant odor thereto, or cover a malodour thereof. They are generally in the form of perfume concentrates, perfumes, eau de parfums, eau de toilettes, aftershaves, or colognes. The fine fragrance compositions may be an ethanol-based composition. The term “composition” may also include a cosmetic composition, which comprises a fragrance material for the purposes of delivering a pleasant smell to drive consumer acceptance of the cosmetic composition. The term “composition” may also include body splashes or body sprays. The term “composition” may also include cleaning compositions, such as fabric care composition or home care compositions, 3
380526.NL.02-967.475NL2 including air care compositions (e.g., air fresheners), for use on clothing or other substrates such as hard surfaces (e.g, dishes, floors, countertops). Additional non-limiting examples of “composition” may also include facial or body powder, deodorant, foundation, body/facial oil, mousse, creams (e.g., cold creams), waxes, sunscreens and blocks, bath and shower gels, lip balms, self-tanning compositions, masks and patches.
[11] As used herein, the term “consumer” means both the user of the composition and the observer nearby or around the user.
[12] As used herein, the term “fragrance material” and “fragrance materials” relates to a perfume raw material (“PRM”), or a mixture of perfume raw materials (“PRMs”), that are used to impart an overall pleasant odor or fragrance profile to a composition. “Fragrance materials” can encompass any suitable perfume raw materials for fragrance uses, including materials such as, for example, alcohols, aldehydes, ketones, esters, ethers, acetates, nitriles, terpene hydrocarbons, nitrogenous or sulfurous heterocyclic compounds and essential oils. However, naturally occurring plant and animal oils and exudates comprising complex mixtures of various chemical components are also known for use as “fragrance materials”. The individual perfume raw materials which comprise a known natural oil can be found by reference to Journals commonly used by those skilled in the art such as “Perfume and Flavourist™ or “Journal of Essential Oil Research”, or listed in reference texts such as the book by S. Arctander, Perfume and Flavor Chemicals, 1969,
Montclair, New Jersey, USA and more recently re-published by Allured Publishing Corporation
Illinois (1994). Additionally, some perfume raw materials are supplied by the fragrance houses (Firmenich, International Flavors & Fragrances, Givaudan, Symrise) as mixtures in the form of proprietary specialty accords. Non-limiting examples of the fragrance materials useful herein include pro-fragrances such as acetal pro-fragrances, ketal pro-fragrances, ester pro-fragrances, hydrolyzable inorganic-organic pro-fragrances, and mixtures thereof. The fragrance materials may be released from the pro-fragrances in a number of ways. For example, the fragrance may be released as a result of simple hydrolysis, or by a shift in an equilibrium reaction, or by a pH-change, or by enzymatic release.
[13] As used herein, the term “fragrance profile” means the description of how the fragrance is perceived by the human nose at any moment in time. The fragrance profile may change over time. It is a result of the combination of the low, moderate and high volatile fragrance 4
380526.NL.02-967.475NL2 materials, if present, of a fragrance. A fragrance profile is composed of 2 characteristics: ‘intensity’ and ‘character’. The ‘intensity’ relates to the perceived strength whilst ‘character’ refers to the odor impression or quality of the perfume, e.g., fruity, floral, woody, etc.
[14] As used herein, the terms “modulator”, and “fragrance modulator” are used interchangeably to designate an agent having the capacity to affect the fragrance profile, such as for example, by impacting the fragrance materials’ evaporation rate. The modulator may mediate its effect by lowering the vapor pressure of the fragrance materials and increasing their adherence to the substrate (skin and/or hair) thus ensuring a longer-lasting impression of the fragrance. By incorporating the modulator, it is desired that the fragrance profile, preferably the fragrance components composition attributable to the high and moderate volatile fragrance materials, alone or individually, of the composition can be perceived by a panel of experts or professional evaluators or individual experts or professional evaluators, over a longer period of time, or the perceived harshness of overdosing of the fragrance material 1s mitigated or absent, as compared to the same perception in the absence of the modulator. As used herein “overdose” can include overdosing a moderate volatile component or high volatile component in aggregate (e.g., greater than 30 wt% of the fragrance component). The term “overdose” can further include overdosing an individual component of the moderate volatile component or the high volatile component (e.g., if the high volatile component includes three oils at least one of the oils may account for a greater wt% of the high volatile component than would be present in a traditional fragrance or a fragrance that is free of the modulators described herein). Suitable examples of the modulator are provided herein below.
[15] As used herein, “skin sensitizing potency” is defined as she relative ability of « chessicel je Induce sj sessiizaron, which i determined by the amount of chemical per unit area required for the acquisition of skin sensitization m a previously naive individual. For chemical safety assessment, it 1s of utmost importance to evaluate dose-effect relationships and to classify chermcals according to the strength of ther response. Skin sensitizing potency 18 measured by a
GARDskan dose response method. Figure 1 illustrates a summary of steps of the GARDskin dose response method. Figure 2 graphically illustrates application of the GARDskin dose response protocol in a titrated range of concentrations (n=6) starting from a determined top concentration. 5
380526.NL.02-967.475NL2
[16] As used herein, the term “substantially non-odorous” means an agent that does not impart an odor of its own when added into a composition of the present invention. For example, a “substantially non-odorous fragrance modulator” does not impart a new odor that alters the character of the fragrance profile of the composition to which it is added. The term “substantially non-odorous” also encompasses an agent that may impart a minimal or slight odor of its own when added into a composition of the present invention. However, the odor imparted by the “substantially non-odorous fragrance modulator” 1s generally undetectable or tends to not substantively alter the character of the fragrance profile of the composition to which it is added mitially or preferably over time. Furthermore, the term “substantially non-odorous” also includes materials that are perceivable only by a minority of people or those materials deemed “anosmic” to the majority of people. Furthermore, the term “substantially non-odorous” also includes materials that may, from particular suppliers, contain an odor due to impurities, such as when the materials contain the impurities at not more than about 5 wt%, preferably not more than 1 wt%, often even not more than 1 part per million (ppm). These impurities may be removed by purification techniques known 1n the art as required to make them suitable for use in fragrance compositions of the present invention.
[17] As used herein, the term “vapor pressure” means the partial pressure in air at a defined temperature (e.g., 25 °C) and standard atmospheric pressure (760 mmHg) for a given chemical species. It defines a chemical species’ desire to be in the gas phase rather than the liquid or solid state. The higher the vapor pressure the greater the proportion of the material that will, at equilibrium, be found in a closed headspace. It is also related to the rate of evaporation of a fragrance material which is defined in an open environment where material is leaving the system.
The vapor pressure is determined according to the reference program Advanced Chemistry
Development (ACD/Labs) Software Version 14.02, or preferably the latest version update).
[18] It is understood that the test methods that are disclosed in the Test Methods Section of the present application must be used to determine the respective values of the parameters of
Applicants’ inventions as described and claimed herein.
[19] In all embodiments of the present invention, all percentages are by weight of the total composition, as evident by the context, unless specifically stated otherwise. All ratios are 6
380526.NL.02-967.475NL2 weight ratios, unless specifically stated otherwise, and all measurements are made at 25 °C, unless otherwise designated.
[20] According to various aspects of the instant disclosure, a fragrance composition includes a fragrance component as well as an extract solution capable of reducing sebum production; sweat production; and / or acetylcholine release. The extract solution includes nymphaea coerulea flower extract and nelumbo nucifera flower extract. The solution is available as a product under the tradename NELUPURE (INCI: INCI: Propanediol (and) Glycerin (and)
Nymphaea Caerulea Flower Extract (and) Nelumbo Nucifera Flower Extract). The extract solution can be present in a range of from about 0.5 wt% to about 20 wt% of the fragrance composition, about 2 wt% to about 10 wt%, less than, equal to, or greater than, 0.5 wt%, 1, 1.5, 2, 25,3,35,4,45,5,55,6,65,7,75,8,85,9,10, 105,11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15, 15.5, 16, 16.5, 17, 17.5, 18, 18.5, 19, 19.5, or about 20 wt%.
[21] More specifically, the components (also referred to as active agents, constituents, ingredients, reagents, substances, or compounds herein) of this invention are extracts from the flower of one or more species of the lotus flowers, obtained from plants and the like, preferably of the Nelumbo family. These plant materials have been newly determined to be effective constituents in compositions and methods for treating, preventing, reducing, inhibiting, improving and/or eliminating wrinkles, fine lines, creases, folds, furrows, and other signs of dermatological aging due to chronological and/or hormonal aging, or due to sunlight exposure of the skin, as well for use in the treatment of hyperhidrosis; and may be useful (due to acetylcholine release inhibition and/or decreased sebum or sweat production leading to decreased inflammation) in lessening allergenic reaction to a fragrance composition applied to skin simultaneously with or subsequent to application of the lotus flower extract; and/or in modulating fragrance component evaporation when applied prior to or simultaneously with application of fragrance formulation components to the skin.
[22] According to the present invention, yet without wishing to be bound by theory, the extracts from the flower of one or more species of the lotus flower constituents exert their effects by their ability to inhibit, block, reduce, or prevent the release of acetylcholine at the neuromuscular junction (NMJ) of skeletal muscle cells and tissue, thereby relaxing muscles, for example, muscles associated with facial movement or expressions. Both nerve and muscle cells 7
380526.NL.02-967.475NL2 (skeletal muscle cells) are electrically excitable and the junctions between these types of cells are known as NMJ. It has been known for many years that the stimulation of a motor nerve innervating a skeletal muscle also causes the release of acetylcholine and that acetylcholine, in turn, stimulates the skeletal muscle to contract. Thus, acetylcholine has been identified as the neurotransmitter at the neuromuscular junction. (see, e.g., B. Alberts et al, 1989, Molecular Biology of the
Cell, 2"Ed., Chapter 19, The Nervous System, Garland Publishing, Inc., NY., pp. 1075 et seq.).
Provided by the present invention are extracts from the flower of one or more species of the lotus flower constituents which are newly described herein to inhibit, reduce, block, or prevent the release of acetylcholine at the NMJ of the skeletal muscle and thus relax the muscles, preferably those associated with facial expression or movement, particularly when employed in the compositions and methods of the invention. By being able to inhibit acetylcholine release, compositions and methods comprising the extracts from the flower of one or more species of the lotus flower constituents as described herein can reduce, treat, and/or prevent excessive sweating or perspiration.
[23] The ability of the extracts from the flower of one or more species of the lotus flower constituents to inhibit acetylcholine release by muscle cells results in a modulation of motor contraction so as to relax the muscle fibers.
[24] Thus, 1n one of its embodiments, the present invention encompasses compositions, formulations and methods containing components, preferably, extracts from the flower of one or more species of the lotus flower constituents, newly determined to be useful in the minimization of allergy elicitation associated with fragrance ingredient exposure and/or the inflammatory process.
[25] The plant-derived materials from the Lotus family may exert their effectiveness according to this invention by preferably working at the neuromuscular junctions (NMJ), such as in and around muscle and nerve cells and tissue at a site of application, e.g., the skin of face, neck, arms, feet, hands, or chest, or in the dermis layer of the skin where sweat glands are located. Prior to the present invention, these materials in combination were not previously known or recognized to inhibit acetylcholine release at NMJ of skeletal muscles.
[26] In general, for the purposes of the present invention, a substance, such as a extract from the flower of one or more species of the lotus flower constituent of the described 8
380526.NL.02-967.475NL2 compositions, is recognized as being a muscle relaxant when it elicits a relaxation effect on contracted muscle cells or on tissue, such as cutaneous or subcutaneous muscle tissue, and/or exhibits an inhibitory effect on acetylcholine release at the NMJ. Contracted muscle cells or tissue 1s associated with formation of wrinkles, fine lines, etc.
[27] It 1s another aspect of the present disclosure to provide compositions, formulations and methods utilizing materials that are newly determined to be useful in the reduction of sweating from the skin.
[28] The physiological act of sweating serves as the body's natural coolant, protecting it from overheating. When subjected to temperature increases, stress, or exercise, the body excretes sweat, a fluid comprising mostly water along with minerals, lactate and urea, to cool the body by evaporation of the water.
[29] Sweating can have adverse effects on the use of cosmetics, for example by adversely impacting the ability of foundation to maintain integrity on the skin. While occlusive agents have been uilized to decrease the amount of perspiration, such occlusive agents can also hinder the ski's ability to breathe and to release oils, which can result mm skin writation and comedogenic effects. {36} As used here, "sweating" refers to the excretion of perspiration from the pores of the skin, Sweating includes, but not houted to, non-pathological sweating, such as thermally mduced, exercise-induced, or stress-induced sweating, The mvention is useful in any area of the body where sweating occurs such as the hands, feet, face, head, torso, neck, arms, wrist, legs, or underarms {axiila}.
[31] It 15 an object of the present invention to provide a cosmetic composition that does not require the presence of an ahmmnum salt and/or an occlusive agent to debver a sweat management benefit.
[32] For use in the compositions of this invention, the extracts from the flower of one or more species of the lotus flower extracts can be chemically synthesized. Alternatively, these plant alkaloids may be extracted from plants. When extracted, they may be in a pure form, a semi- purified form, or may be a component of an unpurified plant extract. 9
380526.NL.02-967.475NL2
[33] The extracts from the flower of one or more species of the lotus flower plant materials contained in the compositions of the present invention can be chemically synthesized at industrial scale in large amounts. Alternatively, the materials may be extracted from natural raw materials from plants. Any and all methods of preparation may be used, including the use of cultured plant seed cells, as disclosed in commonly owned patent application U.S. Ser. No. 10/040,242, which is hereby incorporated by reference herein. For example, unpurified plant extracts may be employed in the present invention. Depending on the solubility of the particular plant extractin water or in organic solvent, the extraction process may differ. Two methods for extracting the materials from raw plant materials include organic solvent extraction, and aqueous- organic solvent extraction, as described in U.S. Pat. No. 6,372,239 to Wu et al. The organic extraction method involves a step of continuous washing and extracting the plant material against a stream of organic solvent. Examples of organic solvents include, but are not limited to methanol, ethanol, dichloromethane, chloroform, xylene, and petroleum ether. Alternatively, the alkaloid can be partially purified or completely purified. Chemical synthesis of the alkaloid obviates the need for extraction and purification.
[34] In accordance with this invention, the extracts from the flower of one or more species of the lotus flower constituents comprise compositions which include, without limitation, topically applied formulations, anti-oxidants, anti-inflammatories, sunscreens, cosmetics, including make-ups, anti-aging formulations, e.g., creams for fine lines and/or wrinkles, topicals, skin penetration enhancers, antiperspirants, deodorants, and the like. Also in accordance with this invention, the extracts from the flower of one or more species of the lotus flower constituents and additional ingredients comprising such compositions can be formulated in a variety of product forms. Preferably, the compositions are prepared in targeted delivery systems, e.g., transdermals, such as patches, and the like, particularly for topical administration. [BS] The present invention encompasses compositions comprising one or more extracts from the flower of one or more species of the lotus flower constituents, preferably in a pharmaceutically-acceptable cosmetic or dermatological formulation which is suitable for contact with living animal tissue, including human tissue, and for topical administration, with virtually no adverse physiological effect, e.g., irritation, to the user. Thus, the inventive compositions are especially suitable for sensitive skin. 10
380526.NL.02-967.475NL2
[36] The fragrance component can include one or more fragrant compounds. On the whole, the fragrance component present in an amount 1n a range of from about 0.04 wt% to about 40 wt% of the fragrance composition, about 0.5 wt% to about 30 wt%, less than, equal to, or greater than about 0.04 wt%, 0.5, 1,1.5,2,2.5,3,3.5,4,4.5,5,5.5,6,65,7,7.5,8,85,9,95, 10, 10.5, 11,11.5,12, 12.5, 13, 13.5, 14, 14.5, 15, 15.5, 16, 16.5, 17, 17.5, 18, 18.5, 19, 19.5, 20, 20.5, 21, 21.5,22,22.5,23,23.5, 24, 24.5, 25, 25.5, 26, 26.5, 27, 27.5, 28, 28.5, 29, 29.5, 30, 30.5, 31, 31.5, 32,32.5, 33, 33.5, 34, 34.5, 35, 35.5, 36, 36.5, 37, 37.5, 38, 38.5, 39, 39.5, or about 40 wt%.
[37] The fragrance component can include a wide variety of fragrance materials. The fragrance materials can be grouped in terms of their volatility. Generally, the materials can be grouped as low volatile fragrance materials, moderate volatile fragrance materials, and high volatile fragrance materials. Each group of materials can be associated with various perceptions by a panel of experts or professional evaluators or individual experts or professional evaluators.
While not so limited, a high volatile fragrance may be associated with a citrus character; a moderate volatile fragrance may be associated with a spicy character; and a low volatile fragrance may be associated with a woody character. Each group of fragrance materials can include synthetic materials or natural materials. The volatility of the fragrance materials can be in reference to an individual fragrance material. Alternatively, in cases where a combination of materials produce a fragrance, for example a natural oil, the volatility may be in reference to that aggregation.
[38] As described herein, the “fragrance materials” or “fragrance components” have been classified as low, moderate or high volatile fragrance materials according to their volatility by their vapor pressure. This method of classifying fragrance materials by their vapor pressure avoids the problem of different classifications for the same fragrance material according to the traditional approach that relies on their subjective characteristic character. In the case that the fragrance materials are a natural oil, extract or absolute, which comprises a mixture of several compounds, the vapor pressure of the complete oil should be treated a mixture of the individual perfume raw material components using the reference program cited above. The individual components and their level, in any given natural oil or extract, can be determined by direct injection of the oil into a GC-MS column for analysis as known by one skilled in the art. In the scenario that the fragrance materials are a proprietary specialty accord, so called ‘bases’, the vapor pressure, 11
380526.NL.02-967.475NL2 using the reference program cited above, should preferably be obtained from the supplier.
However, it is understood by one skilled in the art that they can physically analyze the composition of a full fragrance oil available commercially to identity the fragrance raw materials and their levels using standard GC-MS techniques. This would be irrespective of whether they had been added to the fragrance oil as individual chemicals, as components of naturals or from proprietary bases. Although proprietary bases and naturals are included in our examples, when analyzing a commercially available fragrance via GC-MS one could simply identify the components of the base or natural oil as part of the overall fragrance mixture and their levels, without being able to identify which proprietary base or natural oil the fragrance had come from.
[39] A pH of the composition can be in a range of from about 4 to about 8, about 5 to about 7, less than, equal to, or greater than about 4, 5, 6, 7, or about 8. The ethanol concentration in any of the compositions described herein can be less than about 78 wt% ethanol, less than about 70 wt% ethanol, less than about 60 wt% ethanol, less than about 50 wt% ethanol, less than about 40 wt% ethanol, less than about 30 wt% ethanol, less than about 20 wt% ethanol, less than about 10 wt% ethanol, or free of ethanol. (1) Low Volatile Fragrance Materials
[40] The fragrance component may comprise at least one low volatile fragrance material. Individual low volatile fragrance materials or aggregate low volatile fragrance materials are those having a vapor pressure less than 0.001 Torr (0.000133 kPa) at 25 °C. According to some examples, the composition can include at least 3 low volatile fragrance materials, or at least 4 low volatile fragrance materials, or at least 5 low volatile fragrance materials, or at least 7 low volatile fragrance materials.
[41] If there are more than one low volatile fragrance materials, then the ranges provided hereinabove cover the total of all the low volatile fragrance materials. Examples of suitable low volatile fragrances materials are provided in Table 1A and 1B below.
[42] Preferably, the low volatile fragrance material is selected from at least 1 material, or at least 2 materials, or at least 3 materials, or at least 5 materials, at least 7, at least 8, at least 10, or at least 12 low volatile fragrance materials as disclosed in Table 1A. Natural fragrance 12
380526.NL.02-967.475NL2 materials or oils having an aggregrate vapour pressure less than 0.001 Torr (0.000133 kPa) at 25 °C are provided in Table 1B. Low Volatile Natural Oils.
Table 1A — Low Volatile Fragrance Materials
No. CAS Number | IUPAC Name Common Vapor a al at 25°C)* 3-0x0-2-(2Z)-2-penten-1- | jasmonate yl-, methyl ester, (1R,2R)- 2. 28219-60-5 2-Buten-l-ol, 2-methyl- | Hindinol 0.00096100 4-(2,2,3-trimethyl-3- cyclopenten-1-yl)- 3. 93-08-3 Ethanone, 1-(2- | Methyl beta- | 0.00095700 naphthalenyl)- naphthyl ketone 4. 67633-95-8 3-Decanone, 1-hydroxy- | Methyl 0.00095100
Lavender
Ketone 5. 198404-98-7 | Cyclopropanemethanol, | Javanol® 0.00090200 1-methyl-2-[(1,2,2- trimethylbicyclo[3.1.0]he x-3-yl)methyl]- 4-hydroxy- 7. 72403-67-9 3-Cyclohexene-1- Myraldylaceta | 0.00087900 methanol, 4-(4-methyl-3- | te penten-1-yl)-, 1-acetate
Ml [eee 3(4H)-one, 7-methyl- 139504-68-0 | 2-Butanol, 1-[[2-(1,1- | Amber core 0.00080300 dimethylethyl)cyclohexyl
Joxy]- 10. 502847-01-0 | Spiro[5.5]undec-8-en-1- | Spiro[5.5]und | 0.00073100 one, 2,2,7,9-tetramethyl- | ec-8-en-1-one, 2,2,7,9- tetramethyl- 11. 2570-03-8 Cyclopentaneacetic acid, | trans-Hedione | 0.00071000
EE ee ester, (1R,2R)-rel- 12. 24851-98-7 Cyclopentaneacetic acid, | Methyl 0.00071000 3-ox0-2-pentyl-, methyl | dihydrojasmo ester 13
380526.NL.02-967.475NL2
TT mt alternatives / 13. 101-86-0 Octanal, 2- | Hexyl 0.00069700
EL aldehyde 14. 365411-50-3 | Indeno[4,5-d]-1,3-dioxin, | Nebulone 0.00069200 4,4a,5,6,7,8,9,9b- octahydro-7,7,8,9,9- pentamethyl- 15. 37172-53-5 Cyclopentanecarboxylic | Dihydro Iso | 0.00067500 acid, 2-hexyl-3-oxo0-, | Jasmonate methyl ester 16. 65113-99-7 3-Cyclopentene-1- Sandalore® 0.00062500 butanol, 0,B,2,2,3- pentamethyl- 17. 68133-79-9 Cyclopentanone, 2-(3,7- | Apritone 0.00062000 dimethyl-2,6-octadien-1- yl)- 18. 7212-44-4 1,6,10-Dodecatrien-3-0l, | Nerolidol 0.00061600 ee [000 methyl-5-phenyl-, (27)- ethyl-o,a-dimethyl- 21. 77-53-2 1H-3a,7-Methanoazulen- | Cedrol Crude | 0.00056900
G-ol, octahydro-3,6,8,8- tetramethyl-, 3R,3aS,6R,7R 8aS)- 22. 68155-66-8 Ethanone, 1- | Iso Gamma | 0.00056500 (1,2,3,5,6,7,8,8a- Super octahydro-2,3,8,8- tetramethyl-2- naphthalenyl)- 23. 54464-57-2 Ethanone, 1- | Iso-E Super® | 0.00053800 (1,2,3,4,5,6,7,8- octahydro-2,3,8,8- tetramethyl-2- naphthalenyl)- tetrahydro-2- naphthalenyl)- 25. 141-92-4 2-Octanol, 8,8- | Hydroxycitro | 0.00052000 dimethoxy-2,6-dimethyl- | nellal
Dimethyl
Acetal 14
380526.NL.02-967.475NL2 26. 20665-85-4 Propanoic acid, 2-methyl- | Vanillin 0.00051200 , 4-formyl-2- | isobutyrate methoxyphenyl ester 27. 79-78-7 1,6-Heptadien-3-one, 1- | Hexalon 0.00049800 (2,6,6-trimethyl-2- cyclohexen-1-yl)- , hexyl ester Salicylate ester Benzoate 30. 153859-23-5 | Cyclohexanepropanol, Norlimbanol | 0.00046900 2,2.6-trimethyl-a-propyl- , (1R,65)- 2,2 6-trimethyl-a-propyl- | Norlimbanol 32. 68555-58-8 Benzoic acid, 2-hydroxy- | Prenyl 0.00045700 , 3-methyl-2-buten-1-yl | Salicylate ester 33. 950919-28-5 | 2H-1,5-Benzodioxepin- | Cascalone 0.00045500 3(4H)-one, 7-(1- methylethyl)- 34. 30168-23-1 Butanal, 4-(octahydro- | Dupical 0.00044100 4,7-methano-5H-inden-5- ylidene)- 35. 1222-05-5 Cyclopenta[g]-2- Galaxolide® | 0.00041400 benzopyran, 1,3,4,6,7.8- hexahydro-4,6,6,7,8,8- hexamethyl- 3,7,11-trimethyl- 37. 95962-14-4 Cyclopentanone, 2-[2-(4- | Nectaryl 0.00036700 methyl-3-cyclohexen-1- yl)propyl]- 38. 4674-50-4 2(3H)-Naphthalenone, Nootkatone 0.00035800 4,44,5,6,7,8-hexahydro- 4,4a-dimethyl-6-(1- methylethenyl)-, 4R 4aS,6R)- phenyl-, pentyl ester Cinnamate acetate Acetate hydroxy-2-methyl-
380526.NL.02-967.475NL2 42. 128119-70-0 | 1-Propanol, 2-methyl-3- | Bornafix 0.00033400 [(1,7,7- trimethylbicyclo[2.2.1]he pt-2-yloxy]- 43. 103614-86-4 | 1-Naphthalenol, Octalynol 0.00033200 octahydro-2,2,6,8- tetramethyl- 44. 7785-33-3 2-Butenoic acid, 2- | Geranyl 0.00033200 methyl-, (2E)-3,7- | Tiglate dimethyl-2,6-octadien-1 - yl ester, (2F)- 45. 117933-89-8 | 1,3-Dioxane, 2-(2,4- | Karanal 0.00033100 dimethyl-3-cyclohexen- 1-yl}-5-methyl-5-(1- methylpropyl)- 47. 67801-20-1 4-Penten-2-01, 3-methyl- | Ebanol 0.00028100 5-(2,2,3-trimethyl-3- cyclopenten-1-yl)- 48. 65416-14-0 Propanoic acid, 2-methyl- | Maltol 0.00028000 \ 2-methyl-4-ox0-4H- | Isobutyrate pyran-3-yl ester 49. 28219-61-6 2-Buten-1-0l, 2-ethyl-4- | Laevo 0.00028000 (2,2,3-trimethyl-3- Trisandol cyclopenten-1-yl)- 50. 5986-55-0 1,6-Methanonaphthalen- | Healingwood | 0.00027800 1(2H)-ol, octahydro- 4,84,9,9-tetramethyl-, (1R,4S,44S,6R, 8aS)- 51. 195251-91-3 |2H-1,5-Benzodioxepin- | Transluzone 0.00026500
Med ee dimethylethyl)- enone , (37)-3-hexen-1-yl ester | salicylate 3-hydroxy- methyl- , phenylmethyl ester salicylate 16
380526.NL.02-967.475NL2 57. 81783-01-9 6,8-Nonadien-3-one, Labienoxime | 0.00017300 pr ae oxime , cyclohexyl ester Salicylate 59. 91-87-2 Benzene, [2- | Amyl 0.00016300 (dimethoxymethyl)-1- Cinnamic hepten-1-yl]- Aldehyde
Dimethyl
Acetal 104864-90-6 | 3-Cyclopentene-1- Firsantol 0.00016000 butanol, B,2,2,3- tetramethyl-6-methylene- spiro[4.5]dec-7-en-7-yl- |e 62. 134-28-1 5-Azulenemethanol, Guaiyl 0.00013400 1,2,3,4,5,6,7,8- Acetate octahydro-a,0,3,8- tetramethyl-, 5-acetate, 3S,5R,8S)- 63. 236391-76-7 | Acetic acid, 2-(1- | Romandolide | 0.00012400 oxopropoxy)-, ~~ 1-(3,3-|® dimethylcyclohexyl)ethyl ester 64. 115-71-9 2-Penten-1-ol, S- | cis-alpha- 0.00011800 [(1R,3R,65)-2,3- Santalol dimethyltricyelo[2.2.1.02 ‚6]hept-3-y1]-2-methyl-, 7. 65. 107898-54-4 | 4-Penten-2-ol, 3,3- | Polysantol®™ 0.00011700 dimethyl-5-(2,2,3- trimethyl-3-cyclopenten- 1-yl)- 69486-14-2 5,8-Methano-2H-1- Florex® 0.00011000 id ethylideneoctahydro- 67. 84697-09-6 Heptanal, 2-[(4- | Acalea 0.00010100 methylphenyl)methylene]
Jr Joga ae [ro one, (4Z)- 32388-55-9 Ethanone, 1- | Vertofix® 0.00008490 [(3R,3aR,7R,8aS)- 2,3,4,7,8,8a-hexahydro- 3,6,8 8-tetramethyl-1H- 17
380526.NL.02-967.475NL2
DE yl]- 70. 131812-67-4 | 1,3-Dioxolane, 2,4- | Okoumal®™ 0.00007600 dimethyl-2-(5,6,7,8- tetrahydro-5,5,8,8- tetramethyl-2- naphthalenyl)- one 72. 141773-73-1 1-Propanol, ~~ 2-[1-(3,3- | Helvetolide® | 0.00005790 dimethylcyclohexyl)etho xy]-2-methyl-, 1- propanoate 73. 63314-79-4 5-Cyclopentadecen-1- Delta 0.00005650 pe i fo 74. 77-42-9 2-Penten-1-01, 2-methyl- | cis-beta- 0.00004810 5-[(15,2R,4R)-2-methyl- | Santalol 3- methylenebicyclo[2.2.1]h ept-2-yl]-, (22)- 75. 362467-67-2 | 2H-1,5-Benzodioxepin- | Azurone 0.00004770 3(4H)-one, 7-(3- methylbutyl)- 76. 28371-99-5 Ethanone, 1-(2,6,10- | Trimofix O 0.00004580 ee ome cyclododecatrien-1-yl)- 77. 16223-63-5 1H-3a,6- Khusimol 0.00004400
Methanoazulene-3- methanol, octahydro-7,7- dimethyl-8-methylene-, (3S,3aR,6R 8aS)- cyclohexylidene- 79. 90-17-5 Benzenemethanol, o- | Rosacetol 0.00004240 (trichloromethyl)-, 1- acetate 50607-64-2 Benzoic acid, 2-[(2- | Mevantraal 0.00004070
Ee e -, methyl ester dioxane phenylethyl ester Benzoate 18
380526.NL.02-967.475NL2 one 85. 66072-32-0 Cyclohexanol, 4-(1,7,7- | Iso Bornyl | 0.00003010 er Ee pt-2-y1)-
CT EEE carboxaldehyde, 4-(4- hydroxy-4- methylpentyl)- 87. 21145-77-7 Ethanone, 1-(5,6,7,8- | Musk Plus 0.00002860 tetrahydro-3,5,5,6,8,8- hexamethyl-2- naphthalenyl)- 88. 21145-77-7 Ethanone, 1-(5,6,7,8- | Fixolide 0.00002860 tetrahydro-3,5,5,6,8,8- hexamethyl-2- naphthalenyl)- one, 3-methyl- a all il one 91. 101-94-0 Benzeneacetic acid, 4-| Para Cresyl | 0.00002330 methylphenyl ester Phenyl
Acetate 92. 102-20-5 Benzeneacetic acid, 2- | Phenyl Ethyl | 0.00002300 phenylethyl ester Phenyl
Acetate
B-methyl- an 94. 103-41-3 2-Propenoic acid, 3- | Benzyl 0.00001050 ee Ea joe ester 95. 4707-47-5 Benzoic acid, 2.4- | Veramoss / | 0.00001050 dihydroxy-3,6-dimethyl-, | LRG201 / methyl ester Evernyl 6(7H)-one, 8,9-dihydro- 1,5,8-trimethyl-, (8R)- 97. 102-17-0 Benzeneacetic acid, (4-| Para Anisyl | 0.00000813
EAT ester Acetate 19
380526.NL.02-967.475NL2 120-11-6 Benzene, 2-methoxy-1- | Benzyl Iso | 0.00000676 le propen-1-yl)- 99. 102-22-7 Benzeneacetic acid, (2F)- | Geranyl 0.00000645 3,7-dimethyl-2,6- Phenylacetate octadien-1-yl ester 2-one, (12F)- 100% , 2-phenylethyl ester Salicylate 102. 78-37-5 2-Propenoic acid, 3- | Linalyl 0.00000174 phenyl-, 1-ethenyl-1,5- | Cinnamate dimethyl-4-hexen-1-yl ester 2-one 2-0ne, (8Z)- 105. | 3391-83-1 1,7- Musk RI 0.00000057
Dioxacycloheptadecan-8- one indol-1-yl)-2,6-dimethyl- 107. 89-43-0 Methyl 2-[(7-hydroxy- | Aurantinol 0.0000000100 3,7- dimethyloctylidene)amin o]benzoate
Dioxacyclohexadecane- 5,16-dione
Dioxacycloheptadecane- | Brassylate 5,17-dione 110. 3681-73-0 Hexadecanoic acid, (2F)- | Hexarose 0.00000000300 lll octadien-1-yl ester (benzoyloxy)-1-propen- | benzoate 1-y1]-2-methoxy- 112. | 144761-91-1 | Benzoic acid, 2-[(1- | Trifone DIPG | 0.00000000093 hydroxy-3- phenylbutyl)amino]-, methyl ester
380526.NL.02-967.475NL2 ! Non-limiting examples of alternative qualities from various suppliers can be purchased under the following tradenames: Kharismal® Super (IFF), Kharismal® (IFF), Hedione" (Firmenich),
Hedione® HC (Firmenich), Paradisone (Firmenich), Cepionate (Zenon), Super cepionate (Zenon),
Claigeon® (Zenon). * Vapor Pressures are acquired as described in the Test Methods Section. ** Origin: The low volatile fragrance materials may be obtained from one or more of the following companies: Firmenich (Geneva, Switzerland), Symrise AG (Holzminden, Germany), Givaudan (Argenteuil, France), IFF (Hazlet, New Jersey), Bedoukian (Danbury, Connecticut), Sigma
Aldrich (St. Louis, Missouri), Millennium Specialty Chemicals (Olympia Fields, Illinois),
Polarone International (Jersey City, New Jersey), and Aroma & Flavor Specialties (Danbury,
Connecticut).
Table 1B -Low Volatile Natural Oils. o [omc J ee [wt 21
380526.NL.02-967.475NL2
Suppliers:
Firmenich, Geneva, Switzerland
Global Essence Inc, New Jersey, USA
H. Reynaud & Fils, Montbrun-les-Bains, France
IFF, Hazlet, New Jersey, USA
Mane, Le Bar-sur-Loup, France
Robertet, Grasse, France
[43] Exemplary low volatile fragrance materials selected from the group of Tables 1A or IB Low Volatile Fragrance Materials are preferred. However, it is understood by one skilled in the art that other low volatile fragrance materials, not recited in Tables 1A or 1B, would also fall within the scope of the present invention, so long as they have a vapor pressure less than 0.001
Torr (0.000133 kPa) at 25 °C. (11) Moderate Volatile Fragrance Materials
[44] The fragrance component may include at least one moderate volatile fragrance material or aggregate of volatile fragrance materials having a vapor pressure in the range of 0.1
Torr to 0.001 Torr (0.0133 kPa to 0.000133 kPa) at 25 °C. In some examples, the composition according to the present disclosure can include at least 3 moderate volatile fragrance materials, or at least 5 moderate volatile fragrance materials, or at least 7 moderate volatile fragrance materials.
If there are more than one moderate volatile fragrance materials, then the ranges provided hereinabove cover the total of all of the moderate volatile fragrance materials. Suitable examples of moderate volatile fragrances materials are provided in Table 2A and 2B below.
[45] Preferable examples of moderate volatile fragrance materials having a vapor pressure in the range of 0.1 Torr to 0.001 Torr (0.0133 kPa to 0.000133 kPa) at 25 °C are provided in Table 2A and 2B. Preferably, the moderate volatile fragrance material 1s selected from at least 1 material, or at least 2 materials, or at least 3 materials, or at least 5 materials, or at least 7 moderate volatile fragrance materials as disclosed in Table 2A. Natural fragrance materials or oils having an 22
380526.NL.02-967.475NL2 aggregate vapor pressure between 0.1 Torr to 0.001 Torr (0.0133 kPa to 0.000133 kPa) at 25 °C are provided in Table 2B. Moderate Volatile Natural Oils.
Table 2A — Moderate Volatile Fragrance Materials
Name** Pressure (Torr at 25 °C)* 24168-70-5 Pyrazine, 2- | Methoxyisobutylp | 0.09950000 ee methylpropyl)- 89-79-2 Cyclohexanol, 5- | Iso-Pulegol 0.09930000 2. methyl-2-(1- methylethenyl)-, 1R,25,5R)- 112-12-9 2-Undecanone Methyl Nonyl | 0.09780000 3. Ketone 103-05-9 Benzenepropanol, Phenyl Ethyl | 0.09770000 4. a,0-dimethyl- Dimethyl
Carbinol 125-12-2 Bicyclo[2.2.1]heptan | Iso Bornyl | 0.09590000 5. -2-ol, 1,7,7- | Acetate trimethyl-, 2-acetate, (1R,2R 4R)-rel- 78-70-6 1,6-Octadien-3-ol, Linalool 0.09050000 3,7-dimethyl- 101-97-3 Benzeneacetic acid, | Ethyl Phenyl | 0.08970000 7. ethyl ester Acetate 100-86-7 Benzeneethanol, q,0- | Dimethyl Benzyl | 0.08880000 re Em oT pe ylic acid, (3Z)-3- hexen-1-yl ester 67634-25-7 3-Cyclohexene-1- Floralate 0.08500000 re ER me dimethyl-, 1-acetate 112-44-7 Undecanal Undecyl 0.08320000 11. Aldehyde 23
380526.NL.02-967.475NL2 32669-00-4 Ethanone, 1-(3- | Tanaisone® 0.08150000 12. cycloocten-1-yl)- 98-53-3 Cyclohexanone, 4- | Patchi 0.07780000 13. (1, I-dimethylethyl)- 35854-86-5 6-Nonen-l-ol, (6Z)- | cis-6-None-1-0l 0.07770000 pes [ere meer fm 5331-14-6 Benzene, (2- | Butyl phenethyl | 0.07760000 15. butoxyethyl)- ether 80-57-9 Bicyclo[3.1.1]hept- | Verbenone 0.07730000 16. 3-en-2-one, 4,6,0- trimethyl- 22471-55-2 Cyclohexanecarboxy | Thesaron 0.07670000 17. lic acid, 2,2,6- trimethyl-, ethyl ester, (1R,65)-rel- 60-12-8 Benzeneethanol Phenethyl alcohol | 0.07410000 re me 106-26-3 2,6-Octadienal, 3,7- | Neral 0.07120000 19. dimethyl, (27)- 5392-40-5 2,6-Octadienal, 3,7- | Citral 0.07120000 20. dimethyl- 89-48-5 Cyclohexanol, 5- | Menthyl Acetate | 0.07070000 21. methyl-2-(1- methylethyl)-, 1- acetate, (1R,25,5R)- rel- 119-36-8 Benzoic acid, 2- | Methyl salicylate | 0.07000000 ee ee er ester
Ee 23. 104-46-1 methoxy-4-(1E)-1- propen-1-yl- 7549-37-3 2,6-Octadiene, 1,1-| Citral Dimethyl | 0.06780000
Be dimethyl- 25225-08-5 Cyclohexanemethan | Aphermate 0.06780000 1-formate 24
380526.NL.02-967.475NL2 = 3913-81-3 2-Decenal, (2E)- 0.06740000 26. 15373-31-6 3-Cyclopentene-1- Cantryl® 0.06700000 27. acetonitrile, 2,2.3- trimethyl- 6485-40-1 2-Cyclohexen-1-one, | Laevo carvone 0.06560000 28. 2-methyl-5-(1- methylethenyl)-, (SR) 16587-71-6 Cyclohexanone, 4- | Orivone 0.06490000 29. (1,1- dimethylpropyl)- 62406-73-9 6,10- Opalal CI 0.06290000 30. Dioxaspiro[4.5]deca ne, 8,8-dimethyl-7- 1-methylethy1)- 3720-16-9 2-Cyclohexen-1-one, | Livescone 0.06270000 31. 3-methyl-5-propyl- 13816-33-6 Benzonitrile, 4-(1- | Cumin Nitrile 0.06230000 32. methylethyl)- 67019-89-0 2,6-Nonadienenitrile | Violet Nitrile 0.06200000 33. 53398-85-9 Butanoic acid, 2- | cis-3-Hexenyl 0.06130000 34. methyl-, (3Z)-3- | Alpha Methyl hexen-1-yl ester Butyrate 208041-98-9 | n/a Jasmonitrile 0.05920000 35. 16510-27-3 Benzene, 1- | Toscanol 0.05870000 36. (cyclopropylmethyl) -4-methoxy- 111-80-8 2-Nonynoic acid, | Methyl Octine | 0.05680000 37. methyl ester Carbonate 103-45-7 Acetic acid, 2- | Phenyl Ethyl | 0.05640000 38. phenylethyl ester Acetate 2550-26-7 2-Butanone, 4- | Benzyl Acetone 0.05570000 39. phenyl-
380526.NL.02-967.475NL2 13491-79-7 Cyclohexanol, 2- | Verdol 0.05430000
EE
7786-44-9 2,6-Nonadien-1-01 2,6-Nonadien-1- | 0.05370000 41. ol 103-28-6 Propanoic acid, 2- | Benzyl Iso | 0.05130000
EE fe henylmethyl ester 104-62-1 Formic acid, 2- | Phenyl Ethyl | 0.05050000 43. phenylethyl ester Formate 28462-85-3 Bicyclo[2.2.1]heptan | Humus Ether 0.04870000 44. -2-01, 1,2,3,3- tetramethyl-,
LR,2R,4S)-rel- 122-03-2 Benzaldehyde, 4-(1- | Cuminic 0.04820000 45. methylethyl)- Aldehyde 358331-95-0 | 2,5-Octadien-4-one, | Pomarose 0.04810000
Ee 2F)- 562-74-3 3-Cyclohexen-1-ol, | Terpinenol-4 0.04780000 47. 4-methyl-1-(1- methylethyl)- 68527-77-5 3-Cyclohexene-1- Isocyclogeraniol | 0.04640000 48. methanol, 2,4,6- trimethyl- 35852-46-1 Pentanoic acid, (3Z)- | Cis-3-Hexenyl 0.04580000 49. 3-hexen-1-yl ester Valerate 2756-56-1 Bicyclo[2.2.1]heptan | Iso Bornyl | 0.04540000 50. -201, 1,7,7- | Propionate trimethyl-, 2- propanoate, 1R,2R,4R)-rel- 14374-92-6 Benzene, 1-methyl- | Verdoracine 0.04460000 51. 4-(1-methylethyl)-2- (1-propen-1-yl)- 6784-13-0 3-Cyclohexene-1- Limonenal 0.04380000
Ep dimethyl- 8000-41-7 2-(4-methyl-1- Alpha Terpineol | 0.04320000 enyl)propan-2-ol 26
380526.NL.02-967.475NL2 41884-28-0 1-Hexanol, 5- | Tetrahydro 0.04230000
Em methylethyl)-, (2R)- 22457-23-4 3-Heptanone, 5- | Stemone®™ 0.04140000 55. methyl-, oxime 104-50-7 2(3H)-Furanone, 5- | Gamma 0.04080000 56. butyldihydro- Octalactone 143-08-8 1-Nonanol Nonyl Alcohol 0.04070000 3613-30-7 Octanal, 7-methoxy- | Methoxycitronell | 0.04020000 58. 3,7-dimethyl- al 67634-00-8 Acetic acid, 2-(3- | Allyl Amyl | 0.04000000 59. methylbutoxy)-, 2- | Glycolate propen-1-yl ester 464-45-9 Bicyclo[2.2.1]heptan | 1-Borneol 0.03980000 60. -2-0l, 1,7,7- trimethyl-, 15,2R 4S5)- 124-76-5 Bicyclo[2.2.1]heptan | 1.7.7-Trimethyl- | 0.03980000 61. -2-ol, 1,7,7- | Bicyclo-1.2.2- trimethyl-, Heptanol-2 (LR, 2R AR)-rel- 67874-72-0 Cyclohexanol, 2- | Coniferan 0.03980000 62. (1,1- dimethylpropyl)-, 1- acetate 80-26-2 3-Cyclohexene-1- Terpinyl Acetate | 0.03920000 63. methanol, 0,0,4- trimethyl-, 1-acetate 498-81-7 Cyclohexanemethan | Dihydro 0.03920000
EE fe ee 112-45-8 10-Undecenal Undecylenic 0.03900000 65. aldehyde 35044-57-6 2,4-Cyclohexadiene- | Ethyl Safranate 0.03880000 l-carboxylic acid, 2,6,6-trimethyl-, ethyl ester ee oonene 67. dimethyl- 27
380526.NL.02-967.475NL2 84560-00-9 Cyclopentanol, 2- | Cyclopentol 0.03790000 pentyl- 82461-14-1 Furan, tetrahydro- | Rhubafuran® 0.03780000 69. 2,4-dimethyl-4- henyl- 56011-02-0 Benzene, [2-(3- | Phenyl Ethyl | 0.03690000 70. methylbutoxy)ethyl] | Isoamyl Ether 103-37-7 Butanoic acid, | Benzyl Butyrate | 0.03660000 71. phenylmethyl ester 6378-65-0 Hexyl hexanoate Hexyl hexanoate | 0.03490000 72. 118-61-6 Benzoic acid, 2- | Ethyl salicylate 0.03480000 73. hydroxy-, ethyl ester 98-52-2 Cyclohexanol, 4- | Patchon 0.03480000 74. (1,1-dimethylethyl)- 115-99-1 1,6-Octadien-3-ol, Linalyl Formate 0.03440000 75. 3,7-dimethyl-, 3- formate 112-54-9 Dodecanal Lauric Aldehyde | 0.03440000 76. 53046-97-2 3,6-Nonadien-1-0l, 3,6 Nonadien-1-o0l | 0.03360000 77. (3Z,6Z)- 76649-25-7 3,6-Nonadien-1-ol 3,6-Nonadien-1- | 0.03360000 78. ol 141-25-3 3,7-Dimethyloct-6- | Rhodinol 0.03290000 79. en-1-ol © ee 2216-51-5 Cyclohexanol, 5- | L-Menthol 0.03230000 81. methyl-2-(1- methylethyl)-, (1R,2S,5R)- 28
380526.NL.02-967.475NL2 3658-77-3 4-hydroxy-2,5- Pineapple Ketone | 0.03200000 82. dimethylfuran-3-one 103-93-5 Propanoic acid, 2- | Para Cresyl iso-| 0.03120000 83. methyl-, 4- | Butyrate methylphenyl ester 24717-86-0 Propanoic acid, 2- | Abierate 0.03110000 84. methyl-, (1R,2S,4R)- 1,7,7- trimethylbicyclo[2.2. 1]hept-2-yl ester, rel- 67845-46-9 Acetaldehyde, 2-(4- | Aldehyde XI 0.03090000 85. methylphenoxy)- 67883-79-8 2-Butenoic acid, 2- | Cis-3-Hexenyl 0.03060000 methyl-, (3Z)-3- | Tiglate hexen-1-yl ester, 2F)- 33885-51-7 Bicyclo[3.1.1]hept- | Pino 0.03040000 87. 2-ene-2-propanal, Acetaldehyde 6,6-dimethyl- 105-85-1 6-Octen-1-0l, 3,7- | Citronellyl 0.03000000 88. dimethyl-, I-formate | Formate 70214-77-6 2-Nonanol, 6,8- | Nonadyl 0.03010000 dimethyl- 215231-33-7 | Cyclohexanol, 1- | Rossitol 0.02990000 methyl-3-(2- methylpropyl)- 120-72-9 1H-Indole Indole 0.02980000 91. 2463-77-6 2-Undecenal 2-Undecene-1-al | 0.02970000 92. 675-09-2 2H-Pyran-2-0ne, Levistamel 0.02940000 93. 4,6-dimethyl- 98-55-5 3-Cyclohexene-1- Alpha-Terpineol | 0.02830000 94. methanol, 0,0,4- trimethyl- 81786-73-4 3-Hepten-2-one, Koavone 0.02750000 95. 3,4,5,6,6- pentamethyl-, (3Z)- 29
380526.NL.02-967.475NL2 122-97-4 Benzenepropanol Phenyl Propyl | 0.02710000 re JE ee pT RE [Sie De 97. butyldihydro-4- Octalactone methyl- 53767-93-4 7-Octen-2-ol, 2,6- | Dihydro Terpinyl | 0.02690000 dimethyl-, 2-acetate | Acetate 35044-59-8 1,3-Cyclohexadiene- | Ethyl Safranate 0.02660000 l-carboxylic acid, 2,6,6-trimethyl-, ethyl ester 104-55-2 2-Propenal, 3- | Cinnamic 0.02650000 100. phenyl- Aldehyde 144-39-8 1,6-Octadien-3-ol, Linalyl 0.02630000 101. 3,7-dimethyl-, 3- | Propionate propanoate 61931-80-4 1,6-Nonadien-3-ol, 3,7-Dimethyl-1,6- | 0.02630000 re i me acetate acetate 102-13-6 Benzeneacetic acid, | Iso Butyl | 0.02630000 103. 2-methylpropyl ester | Phenylacetate 65443-14-3 Cyclopentanone, Veloutone 0.02610000 104. 2,2, 5-trimethyl-5- pentyl- 141-12-8 2,6-Octadien-1-ol, Neryl Acetate 0.02560000 105. 3,7-dimethyl-, 1- acetate, (22)- 105-87-3 2,6-Octadien-1-ol, Geranyl acetate 0.02560000 er ee ree acetate, (2E)- on | ame na 107. dimethoxy-2- Acetaldehyde methyl- Dimethyl Acetal 2206-94-2 Benzenemethanol, a- | Indocolore 0.02550000 ree Ee BR me acetate 10528-67-3 Cyclohexanepropan | Cyclohexylmagno | 0.02550000 in | [Pres
I Fr ll 09 110. methoxy-
380526.NL.02-967.475NL2 57576-09-7 Cyclohexanol, 5- | Iso Pulegol | 0.02480000 111. methyl-2-(1- Acetate methylethenyl)-, 1- acetate, (1R,2.5,5R)- 51566-62-2 6-Octenenitrile, 3,7- | Citronellyl Nitrile | 0.02470000 112. dimethyl- 60335-71-9 2H-Pyran, 3,6- | Rosyrane Super 0.02470000 113. dihydro-4-methyl-2- phenyl- 30385-25-2 6-Octen-2-0l, 2,6- | Dihydromyrcenol | 0.02440000 114. dimethyl- 101-84-8 Benzene, 1,1’- | Diphenyl Oxide 0.02230000 115. oxybis- 136-60-7 Benzoic acid, butyl | Butyl Benzoate 0.02170000 116. ester 93939-86-7 5,8-Methano-2H-1- | Rhuboflor 0.02120000 117. benzopyran, 6- ethylideneoctahydro 83926-73-2 Cyclohexanepropan | Coranol 0.02100000 118. ol, a,a-dimethyl- 125109-85-5 | Benzenepropanal, B- | Florhydral 0.02070000 119. methyl-3-(1- methylethyl)- 104-21-2 Benzenemethanol, 4- | Anisyl Acetate 0.02050000 120. methoxy-, 1-acetate 1365-19-1 2-Furanmethanol, 5- | Linalool Oxide 0.02050000 121. ethenyltetrahydro- 0,0, 5-trimethyl- 137-03-1 Cyclopentanone, 2- | Frutalone 0.02040000 122. heptyl- 2563-07-7 Phenol, 2-ethoxy-4- | Ultravanil 0.02030000 123. methyl- 1128-08-1 2-Cyclopenten-1- Dihydrojasmone | 0.02020000 124. one, 3-methyl-2- entyl- 31
380526.NL.02-967.475NL2 7493-57-4 Benzene, [2-(1- | Acetaldehyde 0.01990000 125. propoxyethoxy)ethyl ]- 141-25-3 7-Octen-1-0l, 3,7- | Rhodinol 0.01970000 126. dimethyl- 216970-21-7 | Bicyclo[4.3.1]decan | 3-Methoxy-7,7- 0.01960000 127. e, 3-methoxy-7,7- | dimethyl-10- dimethyl-10- methylenebicyclo methylene- [4.3.1]decane 319002-92-1 | Propanoic acid, 2- | Sclareolate® 0.01960000 128. (1,1- dimethylpropoxy)-, propyl ester, (2S)- 85-91-6 Benzoic acid, 2- | Dimethyl 0.01930000 129. (methylamino)-, anthranilate methyl 13828-37-0 Cyclohexanemethan | Mayol 0.01920000 130. ol, 4-(1- methylethyl)-, cis- 26330-65-4 (E)-6-ethyl-3- Super Muguet 0.01850000 131. methyloct-6-en-1-ol 7540-51-4 6-Octen-1-0l, 3,7- | L-Citronellol 0.01830000 132. dimethyl-, (35)- 106-22-9 6-Octen-l-ol, 3.7- | Citronellol 0.01830000 133. dimethyl- 543-39-5 7-Octen-2-ol, 2- | Myrcenol 0.01820000 134. methyl-6-methylene- 7775-00-0 Benzenepropanal, 4- | Cyclemax 0.01820000 135. (1-methylethyl)- 18479-54-4 4,6-Octadien-3-ol, Muguol 0.01800000 136. 3,7-dimethyl- 29214-60-6 Octanoic acid, 2- | Gelsone 0.01790000 137. acetyl-, ethyl ester 1209-61-6 5- Tobacarol 0.01730000 138. Oxatricyclo[8.2.0.04 ,6]dodecane, 32
380526.NL.02-967.475NL2
TEE tetramethyl- 57934-97-1 2-Cyclohexene-1- Givescone 0.01710000 139. carboxylic acid, 2- ethyl-6,6-dimethyl-, ethyl ester 14901-07-6 3-Buten-2-0ne, 4- | Beta-Ionone 0.01690000 140. (2,6,6-trimethyl-1- cyclohexen-1-yl)-,
GE)- 64001-15-6 4,7-Methano-1H- Dihydro Cyclacet | 0.01630000 141. inden-5-ol, octahydro-, 5-acetate 95-41-0 2-Cyclopenten-1- Iso Jasmone T 0.01600000 142. one, 2-hexyl- 134-20-3 Benzoic acid, 2- | Methyl 0.01580000 143. amino-, methyl ester | Anthranilate 100-06-1 Ethanone, 1-(4- | Para Methoxy | 0.01550000 144. methoxyphenyl)- Acetophenone 105-86-2 2,6-Octadien-1-01, Geranyl Formate | 0.01540000 145. 3,7-dimethyl-, 1- formate, (2F)- 154171-77-4 | Spiro[1,3-dioxolane- | Ysamber K* 0.01470000 146. 2.8’ (5’H)-[2H- 2,4a]methanonaphth alene], hexahydro- 1’,1°,5°,5- tetramethyl-, (2°8,4°a8,8’as)- (9C1) 154171-76-3 | Spiro[1,3-dioxolane- | Ysamber 0.01470000 147. 2.8’ (5’H)-[2H- 2,4a|methanonaphth alene], 127-41-3 3-Buten-2-0ne, 4- | Alpha-Tonone 0.01440000 148. (2,6,6-trimethyl-2- cyclohexen-1-yl)-, (3E)- 151-05-3 Benzeneethanol, a,0- | Dimethyl Benzyl | 0.01390000 149. dimethyl-, 1-acetate | Carbinyl Acetate 33
380526.NL.02-967.475NL2 2500-83-6 4,7-Methano-1H- Flor Acetate 0.01370000 150. inden-5-0l, 3a,4,5,6,7,7a- hexahydro-, 5- acetate 150-84-5 6-Octen-1-ol, 3,7- | Citronellyl acetate | 0.01370000 151. dimethyl-, 1-acetate 30310-41-9 2H-Pyran, Pelargene 0.01350000 152. tetrahydro-2-methyl- 4-methylene-6- phenyl- 68845-00-1 Bicyclo[3.3.1]nonan | Boisiris 0.01350000 153. e, 2-ethoxy-2,6,6- trimethyl-9- methylene- 106-24-1 2,6-Octadien-1-0l, Geraniol 0.01330000 154. 3,7-dimethyl-, (2E)- 106-25-2 2,6-Octadien-1-o0l, Nerol 0.01330000 155. 3,7-dimethyl-, (2Z)- 75975-83-6 Bicyclo[7.2.0]undec | Vetyvenal 0.01280000 156. -4-ene, 4,11,11- trimethyl-8- methylene-, 1R,4E,9S)- 19870-74-7 1H-3a,7- Cedryl methyl | 0.01280000 157. Methanoazulene, ether octahydro-6- methoxy-3,6,8,8- tetramethyl-, (3R,3aS,6S, 7R,8aS)- 87-44-5 Bicyclo[7.2.0]undec | Caryophyllene 0.01280000 158. -4-ene, 4,11,11- | Extra trimethyl-8- methylene-,
LR 4L,98)- 54440-17-4 1H-Inden-1-one, 2,3- | Safraleine 0.01260000 159. dihydro-2,3,3- trimethyl- 110-98-5 2-Propanol, 1,1’- | Dipropylene 0.01250000 160. oxybis- Glycol 34
380526.NL.02-967.475NL2 41890-92-0 2-Octanol, 7- | Osyrol® 0.01250000 161. methoxy-3,7- dimethyl- 71077-31-1 4,9-Decadienal, 4,8- | Floral Super 0.01230000 162. dimethyl- 65-85-0 Benzoic Acid Benzoic Acid 0.01220000 163. 61444-38-0 3-Hexenoic acid, | cis-3-hexenyl-cis- | 0.01220000 164. (3Z)-3-hexen-1-yl 3-hexenoate ester, (3Z)- 116044-44-1 | Bicyclo[2.2.l]hept- | Herbanate 0.01210000 165. 5-ene-2-carboxylic acid, 3-(1- 104-54-1 2-Propen-1-ol, 3- | Cinnamic Alcohol | 0.01170000 166. phenyl- 78-35-3 Propanoic acid, 2- | Linalyl 0.01170000 167. methyl-, 1-ethenyl- | Isobutyrate 1,5-dimethyl-4- hexen-1-yl ester 23495-12-7 Ethanol, 2-phenoxy-, | Phenoxy Ethyl | 0.01130000 168. 1-propanoate Propionate 103-26-4 2-Propenoic acid, 3- | Methyl 0.01120000 169. phenyl-, methyl ester | Cinnamate 67634-14-4 Benzenepropanal, 2- | Florazon (ortho- | 0.01110000 170. ethyl-o,a-dimethyl- | isomer) 5454-19-3 Propanoic acid, | N-Decyl 0.01100000 171. decyl ester Propionate 93-16-3 Benzene, 1,2- | Methyl Iso | 0.01100000 172. dimethoxy-4-(1- Eugenol propen-1-yl)- 81782-77-6 3-Decen-5-ol, 4- | 4-Methyl-3- 0.01070000 173. methyl- decen-5-0l 67845-30-1 Bicyclo[2.2.2]oct-5- | Maceal 0.01060000 174. ene-2- carboxaldehyde, 6- methyl-8-(1- methylethyl)-
380526.NL.02-967.475NL2 97-53-0 Phenol, 2-methoxy- | Eugenol 0.01040000 re ERE ee 120-57-0 1,3-Benzodioxole-5- | Heliotropin 0.01040000 176. carboxaldehyde 93-04-9 Naphthalene, 2- | Beta Naphthyl | 0.01040000 rm
Extra 99 20407-84-5 2-Dodecenal, (2F)- | Aldehyde 0.01020000 179. Mandarin 5462-06-6 Benzenepropanal, 4- | Canthoxal 0.01020000 oe Ee er 94-60-0 1,4- Dimethyl 1,4- | 0.01020000 181. Cyclohexanedicarbo | cyclohexanedicar xylic acid, 1,4- | boxylate dimethyl ester 57378-68-4 2-Buten-1-one, 1- | delta-Damascone | 0.01020000 182. (2,6,6-trimethyl-3- cyclohexen-1-yl)- 17283-81-7 2-Butanone, 4- | Dihydro Beta | 0.01020000 183. (2,6,6-trimethyl-1- Ionone cyclohexen-1-yl)- 1885-38-7 2-Propenenitrile, 3- | Cinnamalva 0.01010000 184. phenyl-, (2F)- 103-48-0 Propanoic acid, 2- | Phenyl Ethyl Iso | 0.00994000 oe phenylethyl ester me 186. one, 3-methyl-2- (2Z)-2-penten-1-yl- 7492-67-3 Acetaldehyde, 2- | Citronellyloxyace | 0.00967000 ee octen-1-yloxy]- 68683-20-5 1-Cyclohexene-1- Iso Bergamate 0.00965000 methylethyl)-, 1- formate 3025-30-7 2,4-Decadienoic Ethyl 2,4- | 0.00954000 189. acid, ethyl ester, | Decadienoate 2E,4Z)- 36
380526.NL.02-967.475NL2 103-54-8 2-Propen-1-ol, 3- | Cinnamyl Acetate | 0.00940000 190. phenyl-, 1-acetate on | ety ee 191. 1,1-dimethylethyl)- 3738-00-9 Naphtho[2,1- Ambrox® or | 0.00934000 192. b]furan, Cetalox* or dodecahydro- Synambran 3a,6,6,9a- tetramethyl- 51519-65-4 1,4- Tamisone 0.00932000 193. Methanonaphthalen- 5(1H)-one, 4,4a,6,7,8,8a- hexahydro- 148-05-1 Dodecanoic acid, 12- | Dodecalactone 0.00931000 194. hydroxy-, A-lactone 6CI,7CI); 1,12- 6790-58-5 (3aR,5a5,9a5,9bR)- | Ambronat* or | 0.00930000 195. 34,6,6,9a- Ambroxan® tetramethyl- 2,4,5,52,7,8,9,9b- octahydro-1H- benzo[e][ 1]benzofur an 86-26-0 1,1’-Biphenyl, 2- | Methyl Diphenyl | 0.00928000 196. methoxy- Ether 68738-94-3 2- Cyclomyral® 0.00920000 197. Naphthalenecarboxa
Idehyde, octahydro- 8,8-dimethyl on TEE Jae 198. oic acid, 2-propen-1- | Cyclohexane yl ester Propionate 7011-83-8 2(3H)-Furanone, 5- | Lactojasmone® 0.00885000 ul i methyl- an |" nei 200. Nonadienenitrile, 3,7-dimethyl- 692-86-4 10-Undecenoic acid, | Ethyl 0.00882000 201. ethyl ester Undecylenate 37
380526.NL.02-967.475NL2 103-95-7 Benzenepropanal, o- | Cymal 0.00881000 202. methyl-4-(1- methylethyl)- 13019-22-2 9-Decen-1-ol Rosalva 0.00879000 203. 94201-19-1 1- Methyl Laitone | 0.00872000 204. Oxaspiro[4.5]decan- | 10% TEC 2-one, 8-methyl- 104-61-0 2(3H)-Furanone, y-Nonalactone 0.00858000 205. dihydro-5-pentyl- 706-14-9 2(3H)-Furanone, 5- | y -Decalactone 0.00852000 206. hexyldihydro- 24720-09-0 2-Buten-1-one, 1- | a-Damascone 0.00830000 207. (2,6,6-trimethyl-2- cyclohexen-1-yl})-, 2F)- 39872-57-6 2-Buten-1-one, 1- | Isodamascone 0.00830000 208. (2,4,4-trimethyl-2- cyclohexen-1-yl)-, 2F)- 705-86-2 2H-Pyran-2-one, Decalactone 0.00825000 209. tetrahydro-6-pentyl- 67634-15-5 Benzenepropanal, 4- | Floralozone 0.00808000 210. ethyl-a,a-dimethyl- 40527-42-2 1,3-Benzodioxole, 5- | Heliotropin 0.00796000 211. (diethoxymethyl)- Diethyl Acetal 56973-85-4 4-Penten-1-one, 1- | Neobutenone a 0.00763000 212. (5,5-dimethyl-1- cyclohexen-1-yl)- 128-51-8 Bicyclo[3.1.1]hept- | Nopyl Acetate 0.00751000 213. 2-ene-2-ethanol, 6,6- dimethyl-, 2-acetate 103-36-6 2-Propenoic acid, 3- | Ethyl Cinnamate | 0.00729000 214. phenyl-, ethyl ester 5182-36-5 1,3-Dioxane, 2,4,6- | Floropal® 0.00709000 215. trimethyl-4-phenyl- 42604-12-6 Cyclododecane, Boisambrene 0.00686000 216. methoxymethoxy)- 38
380526.NL.02-967.475NL2 rr rr 0] 33885-52-8 Bicyclo[3.1.1]hept- | Pinyl Iso Butyrate | 0.00685000 217. 2-ene-2-propanal, Alpha 0,0,6,6-tetramethyl- 92015-65-1 2(3H)- Natactone 0.00680000 hexahydro-3,6- dimethyl- 63767-86-2 Cyclohexanemethan | Mugetanol 0.00678000 i re Ee methylethyl)- 3288-99-1 Benzeneacetonitrile, | Marenil CI 0.00665000 220. 4-(1,1- dimethylethyl)- 35044-68-9 2-Buten-1-one, 1- | beta-Damascone 0.00655000 221. (2,6,6-trimethyl-1- cyclohexen-1-yl)- 41724-19-0 1,4- Plicatone 0.00652000 6(2H)-one, octahydro-7-methyl 75147-23-8 Bicyclo[3.2.1]octan- | Buccoxime" 0.00647000 223. 8-one, 1,5-dimethyl-, oxime 25634-93-9 2-Methyl-5- Rosaphen® 0.00637000 224. phenylpentan-1-ol 600064 55066-48-3 3-Methyl-5- Phenyl Hexanol 0.00637000 225. phenylpentanol g 226. dimethyl-4-hexen-1- ylidene)-1-methyl- 2785-87-7 Phenol, 2-methoxy- | Dihydro Eugenol | 0.00624000 i rer EE ores an [Te Se MT 228. hydroxy-, 2- | Salicylate methylpropyl ester 4430-31-3 2H-1-Benzopyran-2- | Octahydro 0.00586000 229. one, octahydro- Coumarin 38462-22-5 Cyclohexanone, 2- | Ringonol 50 TEC | 0.00585000 ee ee ee 39
380526.NL.02-967.475NL2 mE methyl-
77-83-8 2-Oxiranecarboxylic | Ethyl Methyl 0.00571000 or Em phenyl-, ethyl ester
37677-14-8 3-Cyclohexene-1- Iso Hexenyl | 0.00565000 232. carboxaldehyde, 4- | Cyclohexenyl
(4-methyl-3-penten- | Carboxaldehyde 1-yl)-
103-60-6 Propanoic acid, 2- | Phenoxy Ethyl | 0.00562000 233. methyl-, 2- | 1so-Butyrate phenoxyethyl ester
18096-62-3 Indeno[1,2-d]-1,3- Indoflor® 0.00557000 234. dioxin, 4,44,5,9b-
tetrahydro-
63500-71-0 2H-Pyran-4-ol, Florosa Q/ Florol | 0.00557000 235. tetrahydro-4-methyl-
2-(2-methylpropyl)-
65405-84-7 Cyclohexanebutanal, | Cetonal® 0.00533000 236. 0,2,6,6-tetramethyl-
171102-41-3 | 4,7-Methano-1H- Flor Acetate 0.00530000 237. inden-6-ol,
34,4,5,6,7,7a- hexahydro-8,8- dimethyl-, 6-acetate
10339-55-6 1,6-Nonadien-3-ol, Ethyl linalool 0.00520000 238. 3,7-dimethyl-
23267-57-4 3-Buten-2-one, 4- | lonone Epoxide | 0.00520000 239. (2,2,6-trimethyl-7- Beta oxabicyclo[4.1.0]he pt-1-yl)-
97-54-1 Phenol, 2-methoxy- | Isoeugenol 0.00519000 re Rr me aa | lint TT 241. hexyldihydro-4-
methyl-
33885-52-8 Bicyclo[3.1.1]hept- | Pinyl Iso Butyrate | 0.00512000 ee Ep rg
0,0,6,6-tetramethyl-
23696-85-7 2-Buten-1-0ne, 1- | Damascenone 0.00503000 cyclohexadien-1-yl)-
380526.NL.02-967.475NL2 80-71-7 2-Cyclopenten-1- Maple Lactone 0.00484000
EE ner methyl- 67662-96-8 Propanoic acid, 2,2- | Pivarose Q 0.00484000 245. dimethyl-, 2- phenylethyl ester 2437-25-4 Dodecanenitrile Clonal 0.00480000 re [EE ee 141-14-0 6-Octen-1-o0l, 3,7- | Citronellyl 0.00469000 247. dimethyl-, 1- | Propionate propanoate 54992-90-4 3-Buten-2-one, 4- | Myrrhone 0.00460000 248. (2,2,3,6- tetramethylcyclohex yl)- 55066-49-4 Benzenepentanal, B- | Mefranal 0.00455000 i ree fm 7493-74-35 Acetic acid, 2-| Allyl Phenoxy | 0.00454000 250. phenoxy-, 2-propen- | Acetate 1-yl ester 80-54-6 Benzenepropanal, 4- | Lilial® 0.00444000 251. (1,1-dimethylethyl)- a-methyl- 86803-90-9 4,7-Methano-1H- Scentenal® 0.00439000 252. indene-2- carboxaldehyde, octahydro-5- methoxy- 68991-97-9 2- Melafleur 0.00436000 253. Naphthalenecarboxa dehyde, 1,2,3,4,5,6,7,8- octahydro-8,8- dimethyl- 18871-14-2 Pentitol, 1,5- | Jasmal 0.00434000 254. anhydro-2,4- dideoxy-2-pentyl-, 3-acetate 58567-11-6 Cyclododecane, Boisambren Forte | 0.00433000 255. (ethoxymethoxy)- so MM [nee 256. bJoxirene, 41
380526.NL.02-967.475NL2 1a,2,3,4,5,6,7,7a- octahydro- 1a,3,3,4,6,6- hexamethyl-, laR,4S,7aS-rel- oe 257. (2,5,6,6-tetramethyl- 2-cyclohexen-1-yl}- 65442-31-1 Quinoline, 6-(1- | Iso Butyl | 0.00408000 er EE we 87731-18-8 Carbonic acid, 4- | Violiff 0.00401000 259. cycloocten-1-yl methyl ester 173445-65-3 | 1H-Indene-5- Hivernal (A- | 0.00392000 260. propanal, 2,3- | isomer) dihydro-3,3- dimethyl- 23911-56-0 Ethanone, 1-(3- | Nerolione 0.00383000 261. methyl-2- benzofuranyl)- 52474-60-9 3-Cyclohexene-1- Precyclemone B | 0.00381000 262. carboxaldehyde, 1- methyl-3-(4-methyl- 3-penten-1-yl)- 139539-66-5 | 6-Oxabicyclo Cassifix 0.00381000 263. [3.2.1]octane, 5- methyl-1-(2,2,3- trimethyl-3- cyclopenten-1-yl)- 80858-47-5 Benzene, [2- | Phenafleur 0.00380000 264. (cyclohexyloxy)ethy 1]- 32764-98-0 2H-Pyran-2-0ne, Jasmolactone 0.00355000 re Ee ear ae penten-1-yl)- 78417-28-4 2,4,7-Decatrienoic Ethyl 2,4,7- | 0.00353000 266. acid, ethyl ester decatrienoate 140-26-1 Butanoic acid, 3- | Beta Phenyl Ethyl | 0.00347000
EN phenylethyl ester 105-90-8 2,6-Octadien-1-01, Geranyl 0.003360000 268. 3,7-dimethyl-, 1- | Propionate propanoate, (2£)- 42
380526.NL.02-967.475NL2 41816-03-9 Spiro[1,4- Rhubofix® 0.00332000 269. methanonaphthalene -2(1H),2’ -oxirane], 3.4,4a,5,8,8a- hexahydro-3’,7- dimethyl- 7070-15-7 Ethanol, 2- | Arbanol 0.00326000 270. [[(1R.2R,4R)-1,7,7- trimethylbicyclo[2.2.
L]hept-2-yl]oxy]-, rel- 93-29-8 Phenol, 2-methoxy- | Iso Eugenol | 0.00324000 271. 4-(1-propen-1-yl)-, | Acetate l-acetate 476332-65-7 | 2H-Indeno[4,5- Amber Xtreme | 0.00323000 272. b]furan, decahydro- | Compound 1 2,2,6,6,7,8,8- heptamethyl- 68901-15-5 Acetic acid, 2- | Cyclogalbanate 0.00323000 273. (cyclohexyloxy)-, 2- propen-1-yl ester 107-75-5 Octanal, 7-hydroxy- | Hydroxycitronella | 0.00318000 274. 3,7-dimethyl- 1 68611-23-4 Naphtho[2,1- Grisalva 0.00305000 275. b]furan, 9b- ethyldodecahydro- 34,7, 7-trimethyl- 313973-37-4 | 1,6-Heptadien-3- Pharaone 0.00298000 276. one, 2-cyclohexyl- 137-00-8 5-Thiazoleethanol, Sulfurol 0.00297000 or re er on [TS 278. (2,6,6-trimethyl-2- cyclohexen-1-yl)- 127-51-5 3-Buten-2-one, 3- | Isoraldeine Pure 0.00282000 279. methyl-4-(2,6,6- trimethyl-2- cyclohexen-1-yl)- 72903-27-6 1,4- Fructalate™ 0.00274000 280. Cyclohexanedicarbo xylic acid, 1,4- diethyl ester 43
380526.NL.02-967.475NL2 7388-22-9 3-Buten-2-0ne, 4- | Tonone Gamma | 0.00272000 ee methylenecyclohexy 1)-3-methyl- 104-67-6 2(3H)-Furanone, 5- | gamma- 0.00271000 282. heptyldihydro- Undecalactone racemic) 1205-17-0 1,3-Benzodioxole-5- | Helional 0.00270000 283. propanal, a-methyl- 33704-61-9 4H-Inden-4-one, Cashmeran 0.00269000 284. 1,2,3,5,6,7- hexahydro-1,1,2,3,3- pentamethyl- mr ee 285. (1-ethoxyethenyl)- 3.3,5,5-tetramethyl- 97384-48-0 Benzenepropanenitri | Citrowanil® B 0.00265000 286. le, a-ethenyl-a- methyl- 141-13-9 9-Undecenal, 2,6,10- | Adoxal 0.00257000 287. trimethyl- 2110-18-1 Pyridine, 2-(3- | Corps Racine VS | 0.00257000 288. phenylpropyl)- 27606-09-3 Indeno[1,2-d]-1,3- Magnolan 0.00251000 289. dioxin, 4,44,5,9b- tetrahydro-2,4- dimethyl- re [Je J acetate acetate 67634-20-2 Propanoic acid, 2- | Cyclabute 0.00244000 290. methyl-, 34,4,5,6,7,7a- hexahydro-4,7- methano-1H-mden- 5-yl ester 65405-72-3 1-Naphthalenol, Oxyoctaline 0.00236000 291. 1,2,3,4,44,7,8,8a- Formate octahydro-2,44,5,8a- tetramethyl-, 1- formate ao || mentee” | Aldus OO 292. (phenylmethylene)- | Aldehyde 44
380526.NL.02-967.475NL2 rr rr 0] 103694-68-4 | Benzenepropanol, Majantol® 0.00224000 293. B,B,3-trimethyl- 13215-88-8 2-Cyclohexen-1-one, | Tabanone Coeur | 0.00223000 ylidene)-3,5,5- trimethyl- 25152-85-6 3-Hexen-1-o0l, 1- | Cis-3-Hexenyl 0.00203000 295. benzoate, (3Z)- Benzoate 406488-30-0 | 2-Ethyl-N-methyl-N- | Paradisamide 0.00200000 296. (m-tolyl)butanamide 121-33-5 Benzaldehyde, 4- | Vanillin 0.00194000 297. hydroxy-3-methoxy- 77-54-3 1H-3a,7- Cedac 0.00192000 298. Methanoazulen-6-ol, octahydro-3,6,8,8- tetramethyl-, 6- acetate, (3R,3a5S,6R, 7R,8aS)- 76842-49-4 4,7-Methano-1H- Frutene 0.00184000 299. inden-6-ol, 34,4,5,6,7,7a- hexahydro-8,8- dimethyl-, 6- propanoate 121-39-1 2-Oxiranecarboxylic | Ethyl Phenyl | 0.00184000 300. acid, 3-phenyl-, ethyl | Glycidate ester 211299-54-6 | 4H-4a,9- Ambrocenide® 0.00182000 301. Methanoazuleno[5,6 -d]-1,3-dioxole, octahydro- 2,2,5,8,8,9a- hexamethyl-, (4aR,5R,7aS,9R)- 285977-85-7 | (2,5-Dimethyl-1,3- | Lilyflore 0.00180000 re EE )methanol 10094-34-5 Butanoic acid, 1,1- | Dimethyl Benzyl | 0.00168000 303. dimethyl-2- Carbinyl Butyrate phenylethyl ester
380526.NL.02-967.475NL2 40785-62-4 Cyclododeca[c] Muscogene 0.00163000 304. furan, 1,3,34,4,5,6,7, 8,9,10,11,13a- dodecahydro- 75490-39-0 Benzenebutanenitril | Khusinil 0.00162000 pe Ee 55418-52-5 2-Butanone, 4-(1,3- | Dulcinyl 0.00161000 306. benzodioxol-5-yl})- 3943-74-6 Benzoic acid, 4- | Carnaline 0.00157000 307. hydroxy-3-methoxy- , methyl ester 72089-08-8 3-Cyclopentene-1- | Brahmanol® 0.00154000 308. butanol, B,2,2,3- tetramethyl- 2-
Methyl-4-(2,2,3- trimethyl-3- cyclopenten-1- yl)butanol 3155-71-3 2-Butenal, 2-methyl- | Boronal 0.00147000 309. 4-(2,6,6-trimethyl-1- cyclohexen-1-yl)- 2050-08-0 Benzoic acid, 2- | Amyl Salicylate | 0.00144000 310. hydroxy-, pentyl ester 41199-20-6 2-Naphthalenol, Ambrinol 0.00140000 311. decahydro-2,5,5- trimethyl- 12262-03-2 ndecanoic acid, 3- | Iso Amyl | 0.00140000 312. methylbutyl ester Undecylenate 107-74-4 1,7-Octanediol, 3,7- | Hydroxyol 0.00139000 313. dimethyl- 91-64-5 2H-1-Benzopyran-2- | Coumarin 0.00130000 ee 68901-32-6 1,3-Dioxolane, 2-[6- | Glycolierral 0.00121000 315. methyl-8-(1- methylethyl)bicyclo[ 2.2.2]oct-5-en-2-yl]- 68039-44-1 Propanoic acid, 2,2- | Pivacyclene 0.00119000 316. dimethyl-, 34,4,5,6, 7,7a-hexahydro-4,7- 46
380526.NL.02-967.475NL2 methano-1H-inden- 6-yl ester 106-29-6 Butanoic acid, (2£)- | Geranyl Butyrate | 0.00116000 317. 3,7-dimethyl-2,6- octadien-1-yl ester 5471-51-2 2-Butanone, 4-(4- | Raspberry ketone | 0.00106000 318. hydroxyphenyl)- 109-42-2 10-Undecenoic acid, | Butyl 0.00104000 319. butyl ester Undecylenate 320. | 2785-89-9 4-Ethyl-2- 4-Ethylguaiacol 0.02000000 methoxyphenol 27538-10-9 2-ethyl-4-hydroxy- | Homofuronol 0.01210000
S-methylfuran-3-one * Vapor Pressures are acquired as described in the Test Methods Section. ** Origin: Same as for Table 1 hereinabove.
Table 2B--Moderate Volatile Natural Oils.
Cade Oil H. Reynaud & Fils
Clove Leaf Oil Rectified H. Reynaud & Fils
B Clove Stem Oil H. Reynaud & Fils
Li LC. 47
380526.NL.02-967.475NL2
Suppliers:
Citrus & Allied Essences, New York, USA
H. Reynaud & Fils, Montbrun-les-Bains, France
IFF, Hazlet, New Jersey, USA
Robertet, Grasse, France
[46] Moderate volatile fragrance materials can be selected from the group of Tables 2A or 2B. However, it is understood by one skilled in the art that other moderate volatile fragrance materials, not recited in Tables 2A or 2B, would also fall within the scope of the present invention, so long as they have a vapor pressure of 0.1 to 0.001 Torr at 25 °C. (i1) High Volatile Fragrance Materials
[47] The fragrance component may include at least one high volatile fragrance material having a vapor pressure greater than 0.1 Torr (0.0133 kPa) at 25 °C. In some examples, the high volatile fragrance material can include at least 2 high volatile fragrance materials, 3 high volatile fragrance materials, or at least 5 high volatile fragrance materials, or at least 7 high volatile fragrance materials. If there are more than one high volatile fragrance materials, then the ranges provided hereinabove cover the total of all of the high volatile fragrance materials. Suitable examples of high volatile fragrances materials are provided in Tables 3A and 3B below.
[48] Preferably, the high volatile fragrance material is selected from at least 1 material, or at least 2 materials, or at least 3 materials, or at least 5 materials, at least 7 materials, or at least 9 high volatile fragrance materials as disclosed in Table 3A. Natural fragrance materials or oils having an aggregate vapor pressure greater than 0.1 Torr (0.0133 kPa) at 25 °C are provided in
Table 3B. Moderate Volatile Natural Oils. 48
380526.NL.02-967.475NL2
Table 3A — High Volatile Fragrance Materials
No. CAS IUPAC Name Common Name** | Vapor
Number Pressure (Torr at 25 °C)* 107-31-3 Formic acid, | Methyl Formate 732.00000000 1. methyl ester 75-18-3 Methane, 1,1°- | Dimethyl Sulfide | 647.00000000 2. thiobis- 1.0% In DEP 141-78-6 Acetic acid ethyl | Ethyl Acetate 112.00000000 3. ester 105-37-3 Propanoic acid, | Ethyl Propionate 44.50000000 4. ethyl ester 110-19-0 Acetic acid, 2- | Isobutyl Acetate 18.00000000 5. methylpropyl ester 105-54-4 Butanoic acid, | Ethyl Butyrate 13.90000000 ethyl ester a 14765-30-1 Butyl Alcohol 8.52000000 7. 7452-79-1 Butanoic acid, 2- | Ethyl-2-Methyl 7.85000000 methyl-, ethyl | Butyrate ester 123-92-2 1-Butanol, 3- | Iso Amyl Acetate 5.68000000 9. methyl-, 1- acetate 66576-71-4 | Butanoic acid, 2- Iso Propyl 2- | 5.10000000 10. methyl-, 1- | Methylbutyrate methylethyl ester 110-43-0 2-Heptanone Methyl Amyl | 473000000 11. Ketone 6728-26-3 2-Hexenal, (2F)- | Trans-2 Hexenal 4.62000000 12. 123-51-3 1-Butanol, 3- | Isoamyl Alcohol 4.16000000 13. methyl- 49
380526.NL.02-967.475NL2 1191-16-8 2-Buten-l-ol, 3- | Prenyl acetate 3.99000000 14. methyl-, 1- acetate 57366-77-5 | 1,3-Dioxolane-2- | Methyl Dioxolan 3.88000000 15. methanamine, N- methyl- 7785-70-8 Bicyclo[3.1.1]he | Alpha Pinene 3.49000000 16. pt-2-ene, 2,6,6- trimethyl-, (1R,5R)- 79-92-5 Bicyeclo[2.2.1]he | Camphene 3.38000000 17. ptane, 2,2- dimethyl-3- methylene- 94087-83-9 | 2-Butanethiol, 4- | 4-Methoxy-2- 3.31000000 18. methoxy-2- Methyl-2- methyl- Butanenthiol 39255-32-8 | Pentanoic acid, | Manzanate 2.91000000 19. 2-methyl-, ethyl ester 3387-41-5 Bicyclo[3.1.0]he | Sabinene 2.63000000 20. xane, 4- methylene-1-(1- methylethyl)- 127-91-3 Bicyclo[3.1.1]he | Beta Pinene 2.40000000 21. ptane, 6,6- dimethyl-2- methylene- 105-68-0 1-Butanol, 3- | Amyl Propionate 2.36000000 22. methyl-, 1- propanoate 123-35-3 1,6-Octadiene, 7- | Myrcene 2.29000000 23. methyl-3- methylene- 124-13-0 Octanal Octyl Aldehyde 2.07000000 24. 7392-19-0 2H-Pyran, 2- | Limetol 1.90000000 25. ethenyltetrahydr 0-2,6,6- trimethyl- 111-13-7 2-Octanone Methyl Hexyl | 1.72000000 26. Ketone
380526.NL.02-967.475NL2 123-66-0 Hexanoic acid, | Ethyl Caproate 1.66000000 27. ethyl ester 470-82-6 2- Eucalyptol 1.65000000 28. Oxabicyclo[2.2.2
Joctane, 1,3,3- trimethyl- 99-87-6 Benzene, 1- | Para Cymene 1.65000000 29. methyl-4-(1- methylethyl)- 104-93-8 Benzene, 1- | Para Cresyl Methyl | 1.65000000 30. methoxy-4- Ether methyl- 13877-91-3 | 1,3,6-Octatriene, | Ocimene 1.56000000 31. 3,7-dimethyl- 138-86-3 Cyclohexene, 1- | dl-Limonene 1.54000000 32. methyl-4-(1- methylethenyl)- 5989-27-35 Cyclohexene, 1- | d-limonene 1.54000000 33. methyl-4-(1- methylethenyl)-, (4R)- 106-68-3 3-Octanone Ethyl Amyl Ketone | 1.50000000 34. 110-41-8 Undecanal, 2- | Methyl Nonyl | 1.43000000 35. methyl- Acetaldehyde 142-92-7 Acetic acid, | Hexyl acetate 1.39000000 36. hexyl ester 110-93-0 5-Hepten-2-one, | Methyl Heptenone | 1.28000000 37. 6-methyl- 81925-81-7 | 2-Hepten-4-one, | Filbertone 1% in | 1.25000000 38. 5-methyl- TEC 3681-71-8 3-Hexen-l-ol, 1- | cis-3-Hexenyl 1.22000000 39. acetate, (3Z)- acetate 97-64-3 Propanoic acid, | Ethyl Lactate 1.16000000 40. 2-hydroxy-, ethyl ester 51
380526.NL.02-967.475NL2 586-62-9 Cyclohexene, 1- | Terpineolene 1.13000000 41. methyl-4-(1- methylethylidene )- 51115-64-1 | Butanoic acid, 2- | Amyl butyrate 1.09000000 42. methylbutyl ester 106-27-4 Butanoic acid, 3- | Amyl Butyrate 1.09000000 43. methylbutyl ester 99-85-4 1,4- Gamma Terpinene | 1.08000000 44. Cyclohexadiene, 1-methyl-4-(1- methylethyl)- 18640-74-9 | Thiazole, 2-(2- | 2-Isobutylthiazole 1.07000000 45. methylpropyl)- 928-96-1 3-Hexen-1-ol, cis-3-Hexenol 1.04000000 46. (3Z)- 100-52-7 Benzaldehyde Benzaldehyde 0.97400000 47. 141-97-9 Butanoic acid, 3- | Ethyl Acetoacetate | 0.89000000 48. oxo-, ethyl ester 928-95-0 2-Hexen-1-ol, Trans-2-Hexenol 0.87300000 49. (2E)- 928-94-9 2-Hexen-1-ol, Beta Gamma | 0.87300000 50. (2Z)- Hexenol 24691-15-4 | Cyclohexane, 3- | Herbavert 0.85200000 51. ethoxy-1,1,5- trimethyl-, cis- 9CI 19872-52-7 | 2-Pentanone, 4- | 4-Methyl-4- 0.84300000 52. mercapto-4- Mercaptopentan-2- methyl- one ppm TEC 3016-19-1 2,4,6-Octatriene, | Allo-Ocimene 0.81600000 53. 2,6-dimethyl-, 4E,6E)- 69103-20-4 | Oxirane, 2,2- | Myroxide 0.80600000 54. dimethyl-3-(3- 52
380526.NL.02-967.475NL2
TEE, pentadien-1-yl)- 189440-77- | 4,7-Octadienoic | Anapear 0.77700000 re me ester, (4E)- 67633-96-9 | Carbonic acid, | Liffarome™ 0.72100000 56. (3Z)-3-hexen-1- yl methyl ester 123-68-2 Hexanoic acid, 2- | Allyl Caproate 0.67800000 57. propen-1-yl ester 106-72-9 S-Heptenal, 2,6- | Melonal 0.62200000 58. dimethyl- 106-30-9 Heptanoic acid, | Ethyl Oenanthate 0.60200000 59. ethyl ester
He li 1- carboxaldehyde, 2,4-dimethyl- o | ie, 61. dimethoxyethyl)- | Acetaldehyde
Dimethyl Acetal 16409-43-1 | 2H-Pyran, Rose Oxide 0.55100000 62. tetrahydro-4- methyl-2-(2- methyl-1- propen-1-yl)- 925-78-0 3-Nonanone Ethyl Hexyl Ketone | 0.55100000 63. 100-47-0 Benzonitrile Benzyl Nitrile 0.52400000 64. 589-98-0 3-Octanol Octanol-3 0.51200000 [ee 58430-94-7 | 1-Hexanol, Iso Nonyl Acetate | 0.47000000 66. 3,5,5-trimethyl-, 1-acetate 10250-45-0 | 4-Heptanol, 2,6- | Alicate 0.45400000 67. dimethyl-, 4- acetate 53
380526.NL.02-967.475NL2 105-79-3 Hexanoic acid, 2- | Iso Butyl Caproate | 0.41300000 oT Eee ester 2349-07-7 Propanoic acid, | Hexyl isobutyrate 0.41300000 69. 2-methyl-, hexyl ester 23250-42-2 | Cyclohexanecarb | Cyprissate 0.40500000 70. oxylic acid, 1,4- dimethyl-, methyl ester, trans- 122-78-1 Benzeneacetalde | Phenyl 0.36800000 71. hyde acetaldehyde 5405-41-4 Butanoic acid, 3- | Ethyl-3-Hydroxy 0.36200000 72. hydroxy-, ethyl | Butyrate ester 105-53-3 Propanedioic Diethyl Malonate 0.34400000 73. acid, 1,3-diethyl ester 93-58-3 Benzoic acid, | Methyl Benzoate 0.34000000 74. methyl ester 16356-11-9 | 1,3,5- Undecatriene 0.33600000 75. Undecatriene 65405-70-1 | 4-Decenal, (4E)- | Decenal (Trans-4) | 0.33100000 76. 54546-26-8 | 1,3-Dioxane, 2- | Herboxane 0.33000000 77. butyl-4,4,6- trimethyl- 13254-34-7 | 2-Heptanol, 2,6- | Dimethyl-2 6- | 0.33000000 78. dimethyl- Heptan-2-ol 98-86-2 Ethanone, 1- | Acetophenone 0.29900000
J
EE [ee hyde, a-methyl- | aldehyde 80118-06-5 | Propanoic acid, | Iso Pentyrate 0.28500000 81. 2-methyl-, 1,3- dimethyl-3- buten-1-yl ester 54
380526.NL.02-967.475NL2 557-48-2 2,6-Nonadienal, |E Z-2,6-Nonadien- | 0.28000000 ee Eee 24683-00-9 | Pyrazine, 2- | 2-Methoxy-3- 0.27300000 83. methoxy-3-(2- Isobutyl Pyrazine methylpropyl)- 104-57-4 Formic acid, | Benzyl Formate 0.27300000
Sal “alas ester 104-45-0 Benzene, 1- | Dihydroanethole 0.26600000 85. methoxy-4- propyl- 491-07-6 Cyclohexanone, | Iso Menthone 0.25600000 86. 5-methyl-2-(1- methylethyl)-, 2R,5R)-rel- 89-80-5 Cyclohexanone, | Menthone Racemic | 0.25600000 87. 5-methyl-2-(1- methylethyl)-, 2R,58)-rel- 2463-53-8 2-Nonenal 2 Nonen-1-al 0.25600000 88. 55739-89-4 | Cyclohexanone, | Thuyacetone 0.25000000 89. 2-ethyl-4,4- dimethyl- 150-78-7 Benzene, 1,4- | Hydroquinone 0.25000000 dimethoxy- Dimethyl Ether 64988-06-3 | Benzene, 1- | Rosacene 0.24600000 91. (ethoxymethyl)- 2-methoxy- wT 92. ptan-2-one, 1,7,7-trimethyl- 67674-46-8 | 2-Hexene, 6,6- | Methyl 0.21400000
Ee trimethyl- 112-31-2 Decanal Decyl Aldehyde 0.20700000 94. 16251-77-7 | Benzenepropanal | Trifernal 0.20600000 95. ‚ B-methyl-
380526.NL.02-967.475NL2 93-92-5 Benzenemethano | Methylphenylcarbi | 0.20300000
TE acetate or |" |e ee [970000 97. nonyl ester 122-00-9 Ethanone, 1-(4- | Para Methyl | 0.18700000 98. methylphenyl)- | Acetophenone 24237-00-1 | 2H-Pyran, 6- | Gyrane 0.18600000 99. butyl-3,6- dihydro-2,4- dimethyl- 41519-23-7 | Propanoic acid, | Hexenyl Isobutyrate | 0.18200000 100. 2-methyl-, (3Z)- 3-hexen-1-yl ester 93-89-0 Benzoic acid, | Ethyl Benzoate 0.18000000 101. ethyl ester 20780-48-7 | 3-Octanol, 3,7- | Tetrahydro Linalyl | 0.18000000
Ee acetate 101-41-7 Methyl 2- | Methylphenyl 0.17600000 103. phenylacetate acetate 40853-55-2 | 1-Hexanol, 5- | Tetrahydro 0.17300000 104. methyl-2-(1- Lavandulyl Acetate methylethyl)-, 1- acetate 933-48-2 Cyclohexanol, Trimethylcyclohexa | 0.17300000 105. 3.3,5-trimethyl-, | nol 1R,5R)-rel- 35158-25-9 | 2-Hexenal, 5- | Lactone of Cis | 0.17200000 106. methyl-2-(1- Jasmone methylethyl)- 18479-58-8 | 7-Octen-2-ol, Dihydromyrcenol 0.16600000 io [oe Eee 140-11-4 Acetic acid, | Benzyl acetate 0.16400000 108. phenylmethyl ester 14765-30-1 | Cyclohexanone, | 2-sec-Butyl Cyclo | 0.16300000 109. 2-(1- Hexanone methylpropyl)- 56
380526.NL.02-967.475NL2 20125-84-2 | 3-Octen-1-ol, Octenol 0.16000000 re 142-19-8 Heptanoic acid, | Allyl Heptoate 0.16000000 111. 2-propen-1-yl ester 100-51-6 Benzenemethano | Benzyl Alcohol 0.15800000 ee ee 10032-15-2 | Butanoic acid, 2- | Hexyl-2-Methyl 0.15800000 113. methyl-, hexyl | Butyrate ester 695-06-7 2(3H)-Furanone, | Gamma 0.15200000 114. S-ethyldihydro- | Hexalactone 21722-83-8 | Cyclohexaneetha | Cyclohexyl Ethyl | 0.15200000 115. nol, 1-acetate Acetate 111-79-5 2-Nonenoic acid, | Methyl-2- 0.14600000 116. methyl ester Nonenoate 16491-36-4 | Butanoic acid, | Cis 3 Hexenyl | 0.13500000 117. (3Z)-3-hexen-1- | Butyrate yl ester 111-12-6 2-Octynoic acid, | Methyl Heptine | 0.12500000 118. methyl ester Carbonate 59323-76-1 | 1,3-Oxathiane, 2- | Oxane 0.12300000 119. methyl-4-propyl- , (2R,4S)-rel- om [7 120. methoxy-2,6- dimethyl- 13851-11-1 | Bicyclo[2.2.1]he | Fenchyl Acetate 0.11700000 121. ptan-2-ol, 1,3,3- trimethyl-, 2- acetate 115-95-7 1,6-Octadien-3- | Lmalyl acetate 0.11600000 oe Te 3-acetate oo [EE er Re 123. dimethyl- Myrcenol 78-69-3 3,7- Tetra-Hydro 0.11500000 fe ol 57
380526.NL.02-967.475NL2 111-87-5 1-Octanol Octyl Alcohol 0.11400000 or ore oo [i 126. 1-methanethiol, mercaptan a, 0, 4-trimethyl- 80-25-1 Cyclohexanemet | Menthanyl Acetate | 0.10300000 127. hanol, o,o,4- trimethyl-, 1- acetate 88-41-5 Cyclohexanol, 2- | Verdox™ 0.10300000 128. (1,1- dimethylethyl)-, 1-acetate 32210-23-4 | Cyclohexanol, 4- | Vertenex 0.10300000 129. (1,1- dimethylethyl)-, 1-acetate 112-44-7 Undecanal n-Undecanal 0.10200000 130. 124-19-6 Nonanal Nonanal Aldehyde | 0.53200000 131. C-9 929253-05- | 6-methoxy-2,6- | 6-methoxy-2,6- 0.04020000 132. | 4 dimethyloctanal | dimethyl octanal 68039-47-4 | 2-propan-2- Phenethyl Isopropyl | 0.24900000 133. yloxyethylbenze | Ether ne 6413-10-1 ethyl 2-(2- | Apple Ketal 0.21900000 134. methyl-1,3- dioxolan-2- yl)acetate 106-23-0 3,7-dimethyloct- | citronellal 0.21500000 135. 6-enal
Pyrazine-2,3,5 23.5 * Vapor Pressures are acquired as described in the Test Methods Section. *% Origin: Same as for Table 1 hereinabove.
Table 3B— High Volatile Natural Materials 58
380526.NL.02-967.475NL2 a aen fe
Ke [wma 59
380526.NL.02-967.475NL2 25. Olibanum Oil Pyrogenous
Suppliers
Biolandes, Le Sen, France
Capua, Campo Calabro, Italy
Citrus & Allied Essences, New York, USA
Firmenich, Geneva, Switzerland
Global Essence Inc, New Jersey, USA
H. Reynaud & Fils, Montbrun-les-Bains, France
IFF, Hazlet, New Jersey, USA
Kerry, Co. Kerry, Ireland
Mane, Le Bar-sur-Loup, France
Misitano & Stracuzzi, Messina, Italy
Robertet, Grasse, France
Simone Gatto, San Pierre Niceto, Italy 60
380526.NL.02-967.475NL2
[49] Exemplary high volatile fragrance materials selected from the group of Tables 3A or 3B are preferred. However, it is understood by one skilled in the art that other high volatile fragrance materials, not recited in Tables 3A or 3B, would also fall within the scope of the present invention, so long as they have a vapor pressure of greater than 0.1 Torr (0.0133 kPa) at 25 °C.
[59] The individual fragrance materials can be present in various concentrations of the fragrance component. For example in a “diamond construction” the low volatile material can be present in a range of from about 0 wt% to about 30 wt% of the fragrance component, about 10 wt% to about 20 wt%, less than equal to or greater than about 0 wt%, 5, 10, 15, 20, 25, or 30 wt%; the moderate volatile component can be present in a range of from about 30 wt% to about 70 wt% of the fragrance component, about 40 wt% to about 60 wt%, less than, equal to, or greater than about 30 wt%, 35, 40, 45, 50, 55, 60, 65, or about 70 wt%; the high volatile fragrance component can be present in a 0 wt% to about 30 wt% of the fragrance component, about 10 wt% to about 20 wt%, less than equal to or greater than about 0 wt%, 5, 10, 15, 20, 25, or 30 wt%.
[51] The composition can further include at least one modulator as described herein below. Suitable examples of the fragrance modulators include: the compound according to Formula I:
OH
Aw
R' (1): a polymer including a repeating unit derived from the compound according to Formula II:
NT R4
R3 R® (TT); or a mixture thereof. RI. R?, R’, RY, and R5, are independently chosen from -H, -OH, or substituted or unsubstituted (Ci-Cao)hydrocarbyl. In some further embodiments, R!, R2, R3, R*, and R5, are independently chosen from (C1-C>o)alkyl, (C2-Cao)alkeneyl, (C:-C9)eycloalkyl, (Ci-
Can)alkoxyl, (Ci-Cao)aryl, or a combination thereof. In some specific embodiments, the modulator 61
380526.NL.02-967.475NL2 component includes pentylene glycol, polycitronellol, or a mixture thereof. In some embodiments, the polycitronellol can include 2-8 repeating units and can have a weight-average-molecular weight in a range of from about 460 g/mol to about 1500 g/mol. In some embodiments, the modulator component can include a mixture of pentylene glycol and polycitronellol and a molar ratio of pentylene glycol to polycitronellol is in a range of from about 5:1 to about 1:5, about 4:1 to about 1:4, about 3:1 to about 1:3, or about 2:1 to about 1:2, or about 1:1. In some embodiments, the modulator component can include at least some PPG-20 methyl glucose ether mixed with any of the aforementioned modulators. Alternativly, the modulator component can be free of (include 0 wt%) PPG-20 methyl glucose. If PPG-20 methyl glucose is present, it can be in range of from about 1 wt% to about 15 wt% of the modulator component, about 5 wt% to about 10 wt% of the modulator component, less than, equal to, or greater than about 1 wt%, 2,3, 4,5, 6, 7,8, 9, 10, 11, 12, 13, 14, or about 15 wt%.
[52] In some further examples, the modulator component can include other modulators included in addition to pentylene glycol, polycitronellol, or a mixture thereof. Examples of the additional modulators can include those listed herein below in Tables 4(a) and 4(b).
Tables 4(a) and 4(b) provide lists of suitable non-odorous fragrance modulators.
Table 4(a}): Substantially Non-Odorous Fragrance Modulators
Number 2.
PPG-20 Methyl Glucose Ether ’ | 61849-72-7
Ether *
Po eee fe 5. Undecyl Glucoside *< (France) 62
380526.NL.02-967.475NL2
Ashland (b) Isocetyl Alcohol * 36653-82-4 | Speciality
Ingredients (c) Neopentyl Glycol 28510-23-8 | Lubrizol
Diethylhexanoate ‘
Alfa
Sucrose Laurate 25339-99-5 | Chemicals
Ltd. (UK)
Alfa 10. Sucrose dilaurate 25915-57-5 | Chemicals (d) Ltd. (UK)
Mitsubishi 11. Sucrose Myristate 27216-47-3
Chemicals
Chemicals 13. Sucrose Stearate 25168-73-4
Ltd. (UK)
Mitsubishi 14. Sucrose Distearate 27195-16-0 | Chemicals (IP)
Mitsubishi 27923063- 15. Sucrose Tristearate 3 Chemicals (JP) (E)1-2.2.6-
Takasago 16. (e) trimethylcyclohexyl)oct-1-en-3- (Japan) one * 2-(1-menthoxy)ethane-1-ol * - , Takasago (f) 1-(1-menthoxy)propane-2-ol * - (Japan) 3-(1-menthoxy)propane-1-ol * - 63
380526.NL.02-967.475NL2 50 3-(1-menthoxy)propane-1,2- ' diol ” 2-methyl-3-(1- 21. . menthoxy)propane-1,2-diol ° 4-(1-menthoxy) butane-1-ol ° - 1,1,4,4-tetramethyl-6-acetyl-7- 23. formyl-1,2,3,4- /
Givaudan tetrahydronaphthalene (8) (Switzerland 1,1,2,4,4-pentamethyl-6-acetyl- ) 24. 7-formyl-1,2,3,4- tetrahydronaphthalene ’°
Hyaluronic acid disaccharide Sigma 25. 9004-61-9 (h) sodium salt 77 Aldrich
Sodium Hyaluronate ’/ 9067-32-7 | (UK) , Mono-o-(linalyl)-glucopyranose 27. i
Di-o-(linalyl)-glucopyranose *° -
Tri-o-(linalyl)-glucopyranose ** - . Tetra-o-(linalyl)-glucopyranose 30. D 3 Penta-o-(linalyl)-glucopyranose £2 Kanebo (1)
Mono-o-(cis-3-hexenyl)- (Japan) 32 glactopyranose ’? 3 Di-o-(cis-3-hexenyl)- glactopyranose *
Tri-o0-(cis-3-hexenyl)- 34. , glactopyranose 7
Tetra-o-(cis-3-hexenyl)- glactopyranose /2 64
380526.NL.02-967.475NL2 a | =e glactopyranose ee glucopyranose ’> ee glucopyranose ’? re glucopyranose ’* eere glucopyranose’?
Bis-0-(3,6-dioxaoctanyl)- are eee galactopyranose ’° galactopyranose’’ ra galactopyranose ’* pas xylopyranose * ice xylopyranose ** stome xylopyranose *
Bis-0-(3,6-dioxadodecanyl)- pl ee glucopyranose * 65
380526.NL.02-967.475NL2
Tetrakis-0-(3,6- 50. dioxadodecanyl)-glucopyranose 13
Pentakis-0-(3,6- 51. dioxadodecanyl)- glucopyranose’”
Hydroquinone beta-D-glycoside oo 52. (k) 4 497-76-7 Shiseido
Propylene Glycol Propyl Ether | 1569-01-3 | Sigma
Aldrich 54. Dicetyl Ether 4113-12-6 (UK)
Solvay 55. Polyglycerin-4 Ethers 25618-55-7
Chemicals
Isoceteth-10 69364-63-2 | Nihon 60. | Isoceteth-15 69364-63-2 | Company
Isoceteth-20 69364-63-2 | Ltd.
Isoceteth-30 69364-63-2
Disodium 64. —_— 68929-04-4 | Rhodia
Lauroamphodipropionate
Sigma
Hexaethylene glycol 65. 3055-96-7 | Aldrich monododecyl ether (UK)
Neopentyl Glycol } 27841-07-2 | Symrise (m) Diisononanoate ’° : (Germany)
Cetearyl Ethylhexnoate ‘° 90411-68-0 66
380526.NL.02-967.475NL2
Co Takasago 68. (n) 2-ethylhexyloxypropanediol ’” | 70455-33-9 (IP)
DSM
# Nutritional 69. Panthenol Ethyl Ether * 667-83-4
Products, (0)
Inc. (USA)
Roche Inc. 70. DL-Panthenol 16485-10-2 (USA)
Diisobutyl Adipate ** 141-04-8 Sigma (p) / ) Aldrich 72. Diisoamyl Adipate ’ 6624-70-0 (UK)
PPG-11 Stearyl Ether °° 25231-21-4 | Kao (JP)
N-hexadecyl n-nonanoate 7% 74. 72934-15-7 ©) (e.g., cetyl nonanoate) Symrise
T os Noctadecyl n-nonanoate 7 | 107647-13- | (Germany) (e.g., stearyl nonanoate) 2 16 methanone, (morphonyl) tricyclo[3.3.1.1%7]dec-1-yl- 79 77 methanone, (piperidinyl) tricyclo[3.3.1.1%"]dec-1-yl- ?/ 78 methanone, (pyrrolidinyl) tricyclo[3.3.1.1%"]dec-1-yl 77 methanone, (azetidinyl) Unilever 79. (s) 23 , tricyclo[3.3.1.1°"]dec-1-yl- ** (UK) methanone, (hexahydroazepinyl) tricyclo[3.3.1.13"]dec-1-y1-" methanone, (4-cyano- 81. piperidinyl)tricyclo[3.3.1.1%7]de c-1-yl- 67
380526.NL.02-967.475NL2 methanone, (4-amido-
82. piperidinyl}tricyclo[3.3.1.1°”]de c-I-yl- 2 methanone,
83. (Trieyclo[3.3.1. 1%7Jdecanyl)-N- tricyclo[3.3.1.1%?]dec-1-yl- +7 methanone,
84. (decahydroisoquinolinyl)tricycl o[3.3.1.1°’Jdec-1-yl- *7 methanone,
85. (decahydroisoquinolinyl)tricycl 0[3.3.1.1%"]dec-1-yl- 27 methanone,
86. (decahydroquinolinyl)tricyclo[3 3.1.1%7]dec-1-y1-20 methanone, (3,3-dimethyl-1-
87. piperidinyl)tricyclo[3.3.1.1%7] dec-1-yl- °° methanone, (2-methyl-1-
88. piperidinyl)tricyclo[3.3.1.1%7] dec-1-yl- *’ methanone, (4-methyl-1- piperidinyl)tricyclo[3.3.1.1°7] dec-1-yl- #* methanone, (3-methyl-1- piperidinyl)tricyclo[3.3.1.1%] dec-1-yl- °9 methanone, (3,5-dimethyl-1-
91. piperidinyl)tricyclo[3.3.1.1*7] dec-1-yl- *
68
380526.NL.02-967.475NL2 methanone, (4-methyl-4-ethy- 92. piperidinyl}trieyclo[3.3.1.1°7] dec-1-yl- 2 methanone, (3,3-diethyl-1- 93. pyrrolidinyl)tricyclo[3.3.1.1%7] dec-1-yl- 29 04 methanone, (VN, N-diisopropyl) tricyclo[3.3.1.1%"]dec-1-yl- 77 methanone, (3,3- 95. dimethylbutylaminyl) tricyclo[3.3.1.13"]dec-1-yl- #* methanone, (2,2- 96. dimethylpropylaminyl) tricyclo[3.3.1.1%"]dec-1-yl- ?/ methanone, (1,1-dimethyl-3,3- 97. dimethylbutylaminyl) tricyclo[3.3.1.1%"]dec-1-yl- °9 methanone, (1,3-dimethyl- butylaminyl) tricycle[3.3.1.1°7]dec-1-yl- 29
PolymerExp
Bis-methoxy PEG-13 PEG- 936645-35- | ert S.A. (1) 438/PPG-110 SMDI Copolymer 1 (Pessac,
France) propyl {4-[2-(diethylamino)-2-
Sigma 100. (u) oxoethoxy]-3- 61791-12-6 … Aldrich (US) methoxyphenyl}acetate “ 3-((2-ethylhexyl)oxy)propane- 101. (v) Co — 70445-33-9 1,2-diol © 69
380526.NL.02-967.475NL2 34 102. propylheptyl)oxy)propane-1,2- diol ” 1-amin0-3-({2- 103. 99509-00-9 emee ! available as GLUCAMTM P-20. ? available as Glucam™ E-20. * available as Plantacare® 810 UP. “available as Simulsol® SL 11W. “available as CERAPHYL" ICA. > available as Tegosoft™ APM. 9 available as Schercemol™ NGDO. 7 disclosed in U.S.
Patent No. 6,737,396B2 (Firmenich), column 1, lines 43-47. * diclosed as compound 1°i in U.S.
Patent No. 6,440,400B1 (Takasago Int.
Corp.), col. 5. 34 diclosed in U.S.
Patent No. 4,313,855 (Dragoco Gerberding & Co.
GmbH), col. 1, lines 12-13. ? disclosed in U.S.
Patent No. 7,538,081B2 (Takasago Int.
Corp.), column 7, lines 50-53. 19 disclosed in U.S.
Patent No. 6,147,049 (Givaudan Roure), col. 5, line 24, to col. 6, line 17. 17 disclosed in PCT Publication No.
WO85/04803 (Diagnostic), pg. 2, line 1 to pg. 4, line 2. 15’? disclosed in JP Patent No. 61-083114 (Kanebo). 13 disclosed in JP Patent No. 61-063612 (Kanebo). 1 disclosed in JP Patent No. 62-084010 (Shiseido). 1 available as: Laureth-6. disclosed in U.S.
Patent Publication No. 2011/0104089A1 (Symrise), para. [0001]. 79 available as PCL-Liquid® 100. 7 disclosed in U.S.
Patent No. 7,196,052 (Takasago Int.
Corp.). col. 4, lines 34-35. 1% disclosed in EP Patent Publication No. 616800A2 (Givaudan), pg. 2, lines 12-25. 9 disclosed in U.S.
Patent No. 4,110,626 (Shiseido), column 3, lines 54-56. 4 disclosed in PCT Publication No.
WO2014/155019 (LVMH). 1% disclosed in U.S.
Patent No. 9,050,261 (Symrise). 70
380526.NL.02-967.475NL2 79 disclosed as compounds C1-C22 in WO2014/139952 (Unilever).
I available as Expert Gel® EGS6. 2? available as Kolliphor® EL. 73 disclosed in U.S. Patent No. 9,050,261 (Symrise).
Further examples of non-odorous fragrance modulator is selected from the group of materials disclosed in Table 4(b).
Table 4(b): Substantially Non-Odorous Fragrance Modulators
No. Chemical or INCI
Trade Name CAS Number | Supplier
Name
Tergitol® 15-S- Sigma Aldrich 1. C12-14 Sec-Pareth-3 68131-40-8 7 (UK)
Poly(ethylene glycol- ‚ | Iycol) PPG-7-Buteth- 0038.95.3 Sigma Aldrich 2 ran-propylene glyco -95- (UK) monobutyl ether
PPG-4-Ceteth-10 Nikkel PBC-33 | 37311-01-6 Chemical Navi
Ethox Chemicals, 4. Deceth-4 Ethal DA-4 5703-94-6
Inc.
A & E Connock
AEC PPG-5- 5. PPG-5-Ceteth-20 9087-53-0 (Perfumery &
Ceteth-20
Cosmetics) Ltd.
Neodol 45-7
Shell Chemical
C14-15 Pareth-7 alcohol 68951-67-7
Company ethoxylate
Linear alcohol (C12-15)
Stephan Company 7. Pareth-3ethoxylate, Bio-soft N25-7 | 68131-39-5 (USA)
POE-7 71
380526.NL.02-967.475NL2
Linear alcohol (C12-13) | __
Bio-soft N23-
Pareth-3ethoxylated, 65 66455-14-9
POE-6.5)
Polyethylene glycol 9. 1100 Cremophor® A Sigma Aldrich 68439-49-6 mono(hexadecyl/octade | 25 (UK) cyl) ether
Linear alcohol (C9-11)
Stephan Company 10. ethoxylated POE -8 | Bio-soft N91-8 | 68439-46-3 (USA)
Pareth-3
Coceth-10 or . Sigma Aldrich 11. Polyoxyethylene (10) | Genapol® C-100 | 61791-13-7 (UK) dodecyl ether
Alcohols, C12-14, | Rhodasurf® LA | Solvay Solutions 12. 68439-50-9 ethoxylated 30 Italia S.p.A.
Poly(ethylene
Poly(ethylene glycol) Sigma Aldrich 13. glycol) methyl | 9004-74-4 methyl ether (UK) ether
N Shell Chemical 14. C10-16 Pareth-1 Neodol* PC 110 | 68002-97-1
Company
ArlamolTM 15. PPG-11 Stearyl Ether 25231-21-4 Croda (UK)
PSIIE en Sigma Aldrich 16. Steareth-100 Brij» S100 9005-00-9 (UK)
Polyethylene glycol . Sigma Aldrich
Brij® C-58 9004-95-9 17. hexadecyl ether (UK) 72
380526.NL.02-967.475NL2 ‚ oe Sigma Aldrich 18. Pluronic” F-127 Pluronic® F-127 | 9003-11-6 (UK)
Linear Alcohol (Cl1)| _ Stepan Canada
Bio-soft N1-5 34398-01-1 19. Ethoxylate, POE-5 Inc.
Intrasol FA Evonik Industries 20. Laureth-10 6540-99-4 12/18/10 AG
Polyoxyethylen
Decaethylene glycol Sigma Aldrich 21. e (10) lauryl | 9002-92-0 mono-dodecyl ether (UK) ether
Ethylene glycol | 2- Sigma Aldrich 22. 109-86-4 monomethyl ether Methoxyethanol (UK)
Grau Aromatics
Homulgator 920 23. Myreth-4 G 27306-79-2 GmbH &
Company KG
Oleth-16 Alkoxylated Toho Chemical 24. Pegnol O-16A | 25190-05-0
Alcohols Industry Co., Ltd.
Nihon Emulsion 25. Isosteareth-5 Emalex 1805 52292-17-8
Company, Ltd.
Arlamol™ 26. PPG-10 Cetyl Ether 9035-85-2 Croda (UK)
PC10
Polyoxy(ethylene Poly(ethylene
Sigma-Aldrich 27. glycol) (18) tridecyl | glycol) (18) | 24938-91-8 (UK)
K ether tridecyl ether 73
380526.NL.02-967.475NL2
Poly(oxy-1,2- ©
ALFONIC® 10- Sasol Chemicals 28. ethanediyl), a-decyl-w- 26183-52-8 8 Ethoxylate (USA) LLC hydroxy-
Mackam™ 29. Laureth- 1 4536-30-5 Rhodia (DE) 2LSF
PEG-5 Hydrogenated Ethox Chemicals, 30. Ethox HTAM-5 | 61791-26-2
Tallow Amine Inc.
Nikkol Nikko Chemicals 31. PEG-15 Oleamine 26635-93-8
TAMNO-15 Co. Ltd.
Polyoxyethylene (20) ~ Sigma Aldrich 32. Brij® 020-SS 9004-98-2 oleyl ether (UK)
Cetoleth-10 Bri® CO10 8065-81-4
Sanyo Chemical 34. Talloweth-7 Emulmin 70 61791-28-4
Industries Ltd.
Isobutoxypropanol Isobutoxypropa 35. 34150-35-1 MolPort
Alcohols nol
Isobutoxypropanol Isobutoxypropa AKos Consulting 36. YPrOp YPIoP 23436-19-3
Alcohols nol & Solutions
Diethylene Glycol Twincide EDG | 111-46-6 74
380526.NL.02-967.475NL2
Toho Chemical 38. Methoxyethanol Hisolve MC 109-86-4
Industry Co., Ltd.
Ethoxyethanol 2- Sigma-Aldrich 39. 110-80-5
Alcohols Ethoxyethanol (UK)
The Dow
Methoxyisopropanol 40. Dowanol™ PM | 107-98-2 Chemical
Alcohols
Company
Toho Chemical 41. Methoxyethanol Hisolve MC 32718-54-0
Industry Co., Ltd.
Methylal Dimethoxymeth Sigma-Aldrich 42. 109-87-5
Ethers ane (UK)
Hans
Methoxybutano 43. 3-Methoxybutanol | 2517-43-3 Schwarzkopf
GmbH / Co. KG
Shell Chemical 44. Butoxyethanol Butyl OXITOL | 111-76-2
Company
The Dow
Propylene Glycol n- 5131-66- 45. Dowanol™ PnB Chemical
Butyl Ether 8/29387-86-8
Company
Propylene
Propylene Glycol Butyl Sigma Aldrich 46. Glycol Butyl | 15821-83-7
Ether (UK)
Ether
Diethylene / / 2-(2- Sigma Aldrich 47. glycol butyl | 112-34-5 butoxyethoxy ethanol (UK) ether 75
380526.NL.02-967.475NL2
CrodafosTM 48. Deceth-4 Phosphate 52019-36-0 Croda, Inc.
D4A
Ethylene glycol 2- © Sigma-Aldrich 49. | monohexadecyl | 2136-71-2 (Hexadecyloxy)ethanol (UK) ether
Poly(propylene
Poly(propylene glycol) Sigma-Aldrich 50. glycol) 9003-13-8 monobutyl ether (UK) monobutyl ether
The Dow
Propylene Glycol 51. DowanolTM PnP | 30136-13-1 Chemical
Propyl Ether
Company
The Dow
Propylene Glycol n- 29387-86- 52. Dowanol™ PnB Chemical
Butyl Ether 8/5131-66-8
Company
Di(propylene 53. Dipropylene lycol | glycol) methyl Sigma Aldrich propy gly glycol, | y 34590-94-8 monomethyl ether ether, mixture of (UK) isomers
Di 1 Glycol | Proglyde™ The bow ipropylene ycol | Proglyde 54. 111109-77-4 | Chemical
Dimethyl Ether DMM
Company
The Dow
Dowanol™ 55. PPG-2 Methyl Ether 13429-07-7 Chemical
DPM
Company
Methoxydiglycol OriStar 56. 111-77-3 Orient Stars LLC
Ethers DEGME 76
380526.NL.02-967.475NL2
Di(ethylene
Diethylene glycol ethyl Sigma Aldrich 57. glycol) ethyl | 111-90-0 ether (UK) ether
Dimethoxydiglycol Dimethyldiglyc 58. 111-96-6 H&V Chemicals
Ethers ol
The Dow
DowanolTM 59. PPG-3 Methyl Ether 37286-64-9 Chemical
TPM
Company 224286
Methyl Morpholine | ALDRICH
Sigma-Aldrich
Oxide 4- 7529-22-8 oo | (UK)
Amine Oxides Methylmorpholi ne N-oxide . Croda Europe, 61. Oleth-3 Brij“ O3 5274-66-8
Ltd.
Tri(propylene glycol) n- | DowanolTM Sigma-Aldrich 62. (pray yen) 55934-93-5 = butyl ether TPnB (UK)
Tripropylene Sigma-Aldrich 63. Tripropylene Glycol 24800-44-0
Glycol (UK)
The Dow
PPG-3 Methyl Ether Dowanol™ 64. 25498-49-1 Chemical
Alkoxylated Alcohols | TPM
Company
Sigma Aldrich 65. Triethylene glycol Triglycol 112-27-6 (UK) 77
380526.NL.02-967.475NL2
Toho Chemical
PEG-3 Methyl Ether HymolTM 112-35-6
Industry Co., Ltd.
A & E Connock 67. Laureth-3 AEC Laureth-3 | 3055-94-5 (Perfumery &
Cosmetics) Ltd. “ Ethylhexylglycerin AG-G-75008 70445-33-9 Angene Chemical
Tetraethylene Sigma Aldrich
Tetra(ethylene glycol) 112-60-7 glycol (UK) or oe
Nihon Emulsion 71. Ceteth-3 Emalex 103 4484-59-7
Company, Ltd.
Myreth-3 26826-30-2 Vevy Europe SpA
Alfonic® TDA- Sasol North 73. Trideceth-3 3 Ethoxylate America, Inc.
Co Croda Europe, 74. Ceteth-2 Brij* C2 5274-61-3
Ltd. or 78
380526.NL.02-967.475NL2
Cetoleth-10 Brij* CO10 8065-81-4
Trimethyl
Trimethyl Pentanol 78. Pentanol
Hydroxyethyl Ether 68959-25-1 Angene Chemical
Hydroxyethyl
Alcohols
Ether
Steareth-10 Allyl Ether | Salcare® SC80 | 109292-17-3 | BASF material ID-
TEA-Lauryl Ether 1733-93-3 Angene Chemical
AG-J-99109
Polyglyceryl-2 Oleyl 81. ú Chimexane NB | 71032-90-1 Chimex
Ether
B402 | Sigma-Aldrich 82. Batyl Alcohol 544-62-7
ALDRICH (UK) 15879 Sigma-Aldrich 83. Octaethylene Glycol 5117-19-1
ALDRICH (UK)
Triglycerol 84. ~ CithrolTM 66082-42-6 Croda (UK) diisostearate
Sakamoto 85. Diglycerin Diglycerin 801 | 59113-36-9 Yakuhin Kogyo
Co., Ltd. 79
380526.NL.02-967.475NL2
Sakamoto
Polyglycerin
Polyglycerin #310 4310 25618-55-7 Yakuhin Kogyo
Co. Ltd.
Sasol Germany 87. Distearyl Ether Cosmacol® SE | 6297-03-6
GmbH
Caprylyl AKos Consulting 88. Caprylyl Glyceryl Ether 10438-94-5
Glyceryl Ether & Solutions
Nikko Chemicals
Chimyl Alcohol Chimyl Alcohol | 506-03-6
Co. Ltd.
Dipentaerythrityl .
Liponate® DPC- Lipo Chemicals, 90. Hexacaprylate/Hexacap 68130-24-5 6 Inc. rate 394467 Sigma-Aldrich 91. Morpholine 110-91-8
ALDRICH (UK)
The Dow 92. Dimethyl Oxazolidine | OXABAN™ -A | 51200-87-4 Chemical
Company 4-
Ethyl Hydroxymethyl 93. | Oxazolemethan | 68140-98-7 Angene Chemical
Oleyl Oxazoline ol
Methyl Hydroxymethyl | Adeka Nol GE- Adeka 94. | 14408-42-5
Oleyl Oxazoline RF Corporation
Pramoxine HCI OriStar PMHCL | 637-58-1 Orient Stars LLC 80
380526.NL.02-967.475NL2
Allantoin 96. Allantoin Ascorbate 57448-83-6 ABI Chem
Ascorbate
Stearamidopropyl Mackalene™ 97. 55852-14-7 Rhodia Inc.
Morpholine Lactate 326 — Lambiotte & CIE
Dioxolane Elcotal DX 646-06-0
S.A.
Sigma Aldrich
Glycerol Formal Glycerol Formal | 5464-28-8 (UK)
Stearamidopropyl 100. Mackine 321 55852-13-6 Rhodia Inc.
Morpholine
Poly(melamine- 2,4,6- 101. oo co- Sigma-Aldrich
Tris[bis(methoxymethy 68002-20-0 oo formaldehyde) (UK)
Damino]-1,3,5-triazine methylated
Poloxamine 1307 Pluracare* 1307 | 11111-34-5 BASF
Nonoxynol-8 Igepal® CO-610 | 27177-05-5 Rhodia Inc.
Nonoxynol-10 Igepal® CO-710 | 27177-08-8 Rhodia Inc.
Nikko Chemicals
Octoxynol-10 Nikkol OP-10 2315-66-4 105. Co., Ltd. 81
380526.NL.02-967.475NL2
Nonoxynol-9 Igepal® CO-630 | 68987-90-6 Rhodia Inc.
Nonoxynol-9 107. | Nonoxynol-9 Iodine oo 94349-40-3 Angene Chemical iodine
Octylphenoxy 108. | poly(ethyleneoxy)ethan | Igepal® CA-630 | 68987-90-6 Rhodia Inc. ol, branched
The Dow
Sodium Octoxynol-2 109. Triton™ X-200 | 55837-16-6 Chemical
Ethane Sulfonate
Company
Lanxess 110. | Benzylhemiformal Preventol D2 14548-60-8
Corporation
Nonoxynol-2 Igepal® CO-210 | 27176-93-8 Rhodia Inc.
The Dow 112. | Octoxynol-3 Igepal* CA-420 | 2315-62-0 Chemical
Company
Sasol Germany 113. | Nonoxynol-3 Marlophen NP 3 | 27176-95-0
GmbH
Alkoxylated Alcohols | Alkasurf NP-4 | 7311-27-5 Rhodia Inc.
Triethylene Santa Cruz
Nonoxynol-3 51437-95-7 115. Glycol Mono(p- Biotechnology 82
380526.NL.02-967.475NL2 nonylphenyl)
Ether
Jos. H. 116. | Nonoxynol-7 Lowenol 2689 | 27177-03-3 Lowenstein &
Sons, Inc.
Nonoxynol-6 Igepal* CO-530 | 27177-01-1
Igepal* CO-520 | 20636-48-0 Rhodia Inc.
Nonoxynol-5 Igepal® CO-520 | 26264-02-8 Rhodia Inc.
Nonoxynol-4 Alkasurf NP-4 | 27176-97-2
Polyglyceryl-10 Nikkol Nikko Chemicals 121. | 102051-00-3
Trioleate Decaglyn 3-OV Co., Ltd.
Polyglyceryl-10 Nikkol Nikko Chemicals 122. 33940-99-7
Dioleate Decaglyn 2-0 Co. Ltd.
Polyglyceryl-10 Abitec 123. Caprol 10G40 | 34424-98-1
Tetraoleate Corporation
Nikkol
Polyglyceryl-10 Nikko Chemicals 124. Decaglyn 1-SV | 79777-30-3
Stearate Co., Ltd.
EX
83
380526.NL.02-967.475NL2
Sakamoto
S-Face O-1001 125. | Polyglyceryl-10 Oleate p 79665-93-3 Yakuhin Kogyo
Co. Ltd.
Nikkol
Polyglyceryl-10 Nikko Chemicals 126. | Decaglyn 1-MV | 87390-32-7
Myristate Co., Ltd.
EX
Rn Dermofeel® G oo 127. | Dermofeel* G10L (OL 34406-66-1 Dr. Straetmans
NIKKOL
128. | Polyglyceryl-6 Laurate 51033-38-6 Chemical Navi
Hexaglyn I-L
Sakamoto
Polyglyceryl-6 129. S-Face IS-601 P | 126928-07-2 | Yakuhin Kogyo
Isostearate
Co. Ltd. == Nihon Emulsion 130. | Choleth-10 Emalex CS-10 | 27321-96-6
Company, Ltd.
Steareth-10 Allyl 131. | Ether/Acrylates Salcare* SC80 | 109292-17-3 | BASF
Copolymer
Phoenix 132. | Polyvinyl Stearyl Ether | Giovarez®1800 | 9003-96-7
Chemical, Inc.
Cosmacol Ether Sasol Germany 133. | Dicetyl Ether 16 GmbH
Pola Chemical 134. | PPG-23-Steareth-34 Unisafe 345-23 | 9038-43-1
Industries, Inc. 84
380526.NL.02-967.475NL2
Stearoxypropyl Farmin DM E- 135. 17517-01-0 Kao Corp.
Dimethylamine 80
Sasol Germany 136. | Distearyl Ether Cosmacol SE 6297-03-6
GmbH
AEC A & E Connock 137. | Polyquaternium-10 Polyquaternium | 55353-19-0 (Perfumery & -10 Cosmetics) Ltd.
Sigma Adlrich 138. | Octyl ether Dioctyl ether 629-82-3 (UK)
Ethyl Ether Diethyl Ether EMD Chemicals
Methyl Hexyl Ether methyl hexyl 140. 4747-07-3 TCI AMERICA
Ethers ether
Nihon Emulsion 141. | Ceteth-12 Emalex 112 94159-75-8
Company, Ltd.
Ceteth-10 or cetyl 142. Jeecol CA-10 14529-40-9 Jeen International alcohol POE-10
Steareth-10 Jeecol SA-10 13149-86-5
Nonaethylene glycol | Nonaethylene Sigma Aldrich 144. 3055-99-0 monododecyl ether glycol (UK) 85
380526.NL.02-967.475NL2 monododecyl ether
Oleth-10 Brij* O10 71976-00-6
Oleth-10 Brij* 010 24871-34-9
The Dow
Carbowax™ 147. PEG-12 6790-09-6 Chemical
PEG 600
Company
PEG-9 Sabopeg 400 3386-18-3
DECAETHYL
149. PEG-10 5579-66-8 MolPort
ENE GLYCOL
The Dow
CarbowaxTM 150. | PEG-6 2615-15-8 Chemical
PEG 300
Company
Glycerol | Sigma Aldrich 151. | Glycerol propoxylate 25791-96-2 propoxylate (UK)
Glycerol Sigma Aldrich 152. | Glycerol ethoxylate 31694-55-0 ethoxylate (UK)
A & E Connock 153. | Laureth-8 AEC Laureth-8 | 3055-98-9 (Perfumery &
Cosmetics) Ltd. 86
380526.NL.02-967.475NL2
Nihon Emulsion 154. | Oleth-8 Emalex 508 27040-03-5
Company, Ltd.
Alfonic
Sasol North 155. | Laureth-7 1216CO-7 3055-97-8
America, Inc.
Ethoxylate
Polyoxyethylen 156. | Steareth-7 e (7) stearyl | 66146-84-7 Sigma Aldrich ether
Alfonic 1012- Sasol North 157. | Deceth-6 5168-89-8 6.0 Ethoxylate America, Inc.
Nihon Emulsion 158. Steareth-6 Emalex 606 2420-29-3
Company, Ltd.
Hexaethylene 159. | Hexaethylene lycol | glycol Sigma-Aldrich y = Sy 3055-96-7 monododecyl ether monododecyl (UK) ether
Hexaethylene 160. | Hexaethylene slycol | glycol Sigma-Aldrich y Sy Sy 5168-91-2 monohexadecyl ether monohexadecyl (UK) ether
Nikko Chemicals 161. | Beheneth-5 Nikkol BB-5 136207-49-3
Co., Ltd.
Myreth-5 92669-01-7 Vevy Europe SpA 87
380526. NL.02-967.475NL2
Jeen International 163. | Steareth-5 Jeecol SA-5 71093-13-5
Corporation
Nihon Emulsion 164. Ceteth-5 Emalex 105 4478-97-1
Company, Ltd.
Safol® 23E5 Sasol North 166. Laureth-5 3055-95-6
Ethoxylate America, Inc.
Jeen International 167. | Steareth-4 Jeecol SA-4 59970-10-4
Corporation vr or
Grau Aromatics
Homulgator 920 169. Myreth-4 G 39034-24-7 GmbH &
Company KG
Protameen 170. | Ceteth-4 Procol CA-4 5274-63-5
Chemicals
Oleth-4 Chemal OA-4 5353-26-4
Oleth-4 Chemal OA-4 103622-85-1 88
380526.NL.02-967.475NL2 en Aquaflex™ XL- 173. | Polyimide-1 20 497926-97-3 | Chemwill
Polymethoxy Bicyclic | Caswell No. 174. - 56709-13-8 Angene Chemical
Oxazolidine 494CA
Hydroxymethyl Angus Chemical 175. | | ZoldineTM ZT 6542-37-6 7
Dioxoazabicyclooctane Company 5-Ethyl-1-aza-
Dihydro-7a- 176. 3,7- Sigma Aldrich ethyloxazolo[3,4- 7747-35-5 dioxabicyclo[3. (UK) cloxazole 3.0]octane m oe Roquette 177. | Dibenzylidene Sorbitol | Disorbene* 32647-67-9
America, Inc.
Dimethyldibenzylidene a Milliken 178. | Millad® 3988 135861-56-2
Sorbitol Chemicals
Alfonic
Sasol North 179. | Laureth-2 1216CO-2 3055-93-4
America, Inc.
Ethoxylate 2{2-
Piperonyl | Sigma-Aldrich 180. | Butoxyethoxy)ethyl (6- 51-03-6
Butoxide (UK) propylpiperonyl) ether
Menthone Glycerin | Frescolat® 181. 63187-91-7 Symrise
Acetal MGA
Propylene Glycol | Mackaderm 68332-79-6 Rhodia Inc. 182. | Caprylate PGC 89
380526.NL.02-967.475NL2
LL
Takasago
Alcohols
Corporation 2-Diphenylmethoxy- 185. | N,N- Diphenhydrami Sigma-Aldrich dimethylethylamine ne HCI 147240 (UK) hydrochloride 34(2- 186. | ethylhexyl)oxy)propan 70445-33-9 e-1,2-diol 342 187. | propylheptyl)oxy)propa ne-1,2-diol l-amino-3-((2- 188. | ethylhexyljoxy)propan- 99509-00-9 2-01 1-{1-Methyl-2- Di(propylene 189. | propoxyethoxy)-2- glycol) propyl | 29911-27-1 Sigma Aldnen propanol ether (Uk)
[53] According to some examples, the modulator(s) can be characterized as being “low odor”, “substantially non-odorous”, or non-odorous. In some examples, if the modulator is present at | wt% or less, no odor may be detected from the modulator.
[54] In some examples, the fragrance modulator is biodegradable. This can make the fragrance composition to which it is included a “green” or environmentally friendly fragrance composition. Additionally, the stability of a fragrance composition that includes the substantially 90
380526.NL.02-967.475NL2 non-odorus fragrance modulator can be increased. The increase in stability can be shown by observing that the composition undergoes undesirable color formation (e.g., yellowing) at a slower rate.
[55] The fragrance modulator component can be present in an amount of from about 0.1 wt% to about 27 wt% relative to the total weight of the composition of the composition, about 0.5 wt% to about 18 wt%, about 2.5 wt% to about 15 wt%, or less than, equal to, or greater than about 0.1 wt%, 0.5,1,1.5,2,25,3,35,4,45,5,55,6,65,7,75,8,85,9,95,10,10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15, 15.5, 16, 16.5, 17, 17.5, 18, 18.5, 19, 19.5, 20 wt%. If there are more than one fragrance modulators, then the ranges provided hereinabove cover the total of all of the fragrance modulators.
[56] The fragrance modulator can be a liquid at temperatures lower than 100 °C, such as at ambient temperature. The fragrance modulators may be fully miscible with the fragrance materials to form a single phase liquid. However, if the fragrance materials are not entirely miscible, or are immiscible, then co-solvents (e.g., dipropylene glycol (DPG), triethyl citrate, or others well known to those skilled in the art) can be added to aid in the solubility of the fragrance materials.
[57] According to various examples, the effect of the fragrance modulator on the fragrance profile, particularly the characters of the fragrance profile which is attributable to the high and moderate volatile fragrance materials, can be improved. By “improved” it is meant that the fragrance profile of the composition, particular the components contributed by at least one of the high and moderate volatile fragrance materials, can be perceived by a panel of experts or professional evaluators or individual experts or professional evaluators at later time points such as, for example, 15 mins, 30 mins, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 10 hours, and possibly all the way up to 30 hrs after application as compared to controls, eg, lacking any of the disclosed non-odorous fragrance modulators such as pentylene glycol, polycitronellol or an equivalent traditional fragrance construction.
[58] Alternatively, by “improved” it can mean that the perception, by a panel of experts or professional evaluators or individual experts or professional evaluators, of the fidelity of the fragrance profile contributed by the high and moderate volatile fragrance materials is markedly increased or enhanced as compared to the controls. “Increased” or “enhanced” means that a panel 91
380526.NL.02-967.475NL2 of experts or professional evaluators or individual experts or professional evaluators perceives the fragrance profile, preferably the characters attributable to the high and/or moderate volatile fragrance materials, of a composition as not changing from its initial impression or the changes are minimal from when the composition was first applied to when it dissipates. In other words, the fidelity of the perceived fragrance profile of the composition is maintained over time. In contrast the composition lacking any of the disclosed non-odorous fragrance modulators or an equivalent traditional fragrance construction will undergo a rapid loss of the characters attributable to the high and/or moderate volatile fragrance materials.
[59] Such a solution as presented herein provides enhanced or improved fidelity and/or longevity of the fragrance profile, particularly amongst those composition formulated from volatile fragrance materials having moderate to high vapor pressure ranges (greater than or equal to 0.001
Torr (0.000133 kPa) at 25 °C), without having to rely on the presence or significant amounts of the low volatile fragrance materials, which has a tendency to overpower and alter the overall fragrance profile, particularly over time. As a result, the present disclosure provides the perfumer options to formulate compositions having new fragrance profiles not possible before.
[60] Specific modulators that can be useful include pentylene glycol, polycitronellol,
PPG-20 methyl glucose ether, methyl glucoside polyol, ethyl glucoside polyol, propyl glucoside polyol, or a mixture thereof.
[61] In some aspects, the fragrance composition can include a carrier. The carrier can be an aqueous carrier, organic carrier, or a mixture thereof. The organic carrier can be ethanol, dipropylene glycol, benzyl benzoate, diethyl phthalate, isopropyl myristate, (C1-C>0)alkyl, (Ci-
Cao)alkenyl, (C1-Cao)alkynyl, (C1-C20)hydroxyl, or mixtures thereof. Additionally, the carrier can be any of, solutions, aerosols, emulsions (including oil-in-water or water-in-oil), gels, and liposomes.
[62] The fragrance composition can include an active component. The active component is in a range of from about0.0001 wt% to about 35 wt% of the cosmetic formula, about 20 wt% to about 30 wt%, less than, equal to, or greater than 15 wt%, 16, 171, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or about 35 wt%. The active component can include any component or mixture of components to achieve a desired result. Examples of active components include lactic acid, a hyaluronic acid, vitamin E, saccharomyces/xylinum/black tea ferment, 92
380526.NL.02-967.475NL2 diglucosyl gallic acid, adenosine, panthenol, dimethylmethoxy chromanol, alpha-glucan oligosaccharide, thermus thermophilus ferment, hydrolyzed hyaluronic acid, caffeine, acetyl di- peptide-1 cetyl ester, glycerin, niacinamide, swertia chirata extract, creatine, or a mixture thereof.
The mixture of gels described and surfactant(s) herein above, allow for the relatively high amount of active component. The ability of the formulation to have a high amount of active component can enhance the formulation’s effectiveness.
[63] In some examples, the formulation can include a chelant or a mixture of two or more chelants. Examples of suitable chelants can include tetrasodium glutamate diacetate (GLDA), ethylenediaminetetraacetic acid (EDTA), ethylenediamine-N, N’-disuccinic acid (EDDS), NTA, EDDS, IDS, methylglycinediacetic acid (MGDA), L-glutamic acid N,N-diacetic acid (GLDA), ethylenediamine-N,N-diglutaric acid (EDDG), ethylenediamine-N,N’-dimalonic acid (EDDM), 3-hydroxy-2,2-iminodisuccinic acid (HIDS), 2-hydroxyethyliminodiacetic acid (HEIDA), methylglycine N,N-diacetic acid trisodium salt (MGDA), sodium gluconate, or a mixture thereof.
[64] The formulas herein can contain a variety of other optional components suitable for rendering such compositions more cosmetically or aesthetically acceptable or to provide them with additional usage benefits. Such conventional optional ingredients are well-known to those skilled in the art. These include any cosmetically acceptable ingredients such as those found in the CTFA
International Cosmetic Ingredient Dictionary and Handbook, 7th edition, edited by Wenninger and
McEwen, (The Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, D.C., 1997). As used herein “cosmetically acceptable” means a material (e.g., compound or composition) which is suitable for use in contact with skin, hair or other suitable substrate.
The fragrance composition can include a cyclodextrin, a film former or a mixture thereof.
According to some examples, the film former comprises anionic compounds or polymers, non- ionic compounds or polymers, amphoteric compounds or polymers, zwitterionic compounds or polymers, cationic compounds or polymers, proteins, viscosity modifiers, polyacrylates, polymethacrylates, polyacrylate copolymers, polymethacrylate copolymers, polyamides, polyaminoamides, polyesters, polysaccharides, polyacrylamides, starches, gums, or a mixture thereof. The cyclodextrin can include, but is not limited to, a-cyclodextrin, B-cyclodextrin, gamma-cyclodextrin, methyl-a-cyclodextrin, methyl-B-cyclodextrin, hydroxypropyl-o- 93
380526.NL.02-967.475NL2 cyclodextrin hydroxypropyl-B-cyclodextrin, and mixtures thereof . Most preferred examples of cyclic oligosaccharides for use herein are methyl-a-cyclodextrin and methyl-B-cyclodextrin. These are available from Wacker-Chemie GmbH Hanns-Seidel-Platz 4, Munchen, DE under the tradename Alpha W6 M and Beta W7 M respectively.
[65] There are many benefits associated with various fragrance compositions associated with the instant disclosure. For example, it is suspected that the fragrance component is detectable for an amount of time longer than a corresponding fragrance composition that free of the extract solution. That is the fragrance materials can be perceived for a long amount of time and thus a user may not have to constantly apply the fragrance composition.
[66] Additionally, according to various aspects, it 1s suspected that a user will perceive that the fragrance composition is more comfortable than a corresponding fragrance composition that free of the extract solution. For example, a user may perceive the fragrance composition as not feeling too oily, greasy, or dry.
[67] Additionally, according to various aspects, it 1s suspected that the fragrance composition will be more effective at reducing or eliminating malodor (e.g., of an odor that is unpleasant or offensive to the human nose) than a corresponding composition that 1s free of the extract solution.
[68] Additionally, according to various aspects, it is suspected that modulation of the fragrance composition is increased relative to a corresponding composition that is free of the extract solution and comprises a cyclodextrin, PPG 20 methyl glucose ether, a chelator, or a mixture thereof. That 1s the extract can help to increase the intensity of the fragrance materials.
[69] Additionally, according to various aspects, it 1s suspected that the fragrance composition can be effective for decreasing skin sensitizing potency of the fragrance component.
That 1s if the fragrance composition includes the extract solution and it is possible that a user’s tendency to be sensitized to the fragrance component can be decreased. The fragrance composition may also prevent irritation or allergy inducement when applied to an intimate area. According to various aspects, the use of a combination of methyl glucose ether and an extract solution comprising nymphaea coerulea flower extract; and nelumbo nucifera flower extract may decrease fragrance sensitization likelihood and/or severity. Any portion of the aforementioned constitutes can be combined in any desirable manner to produce many different types of cosmetic 94
380526.NL.02-967.475NL2 compositions. The cosmetic compositions can be applied to the epithelial layer of a user’s skin.
For example the cosmetic composition can be a pretreatment formulation, make-up formulation, a foundation, a sunscreen, or any other cosmetic applied to a user’s epithelial tissue. Additionally, any portion of the aforementioned constituents can be combined to create a cosmetic formulation that can be applied to a keratinous tissue of a user. For example, the cosmetic formulation can be a mascara, hair dye, nail polish, lip gloss, lipstick or other pigmented/colored cosmetic formulation intended to be a long-wear formulation.
[70] Various embodiments of the present invention can be better understood by reference to the following Examples which are offered by way of illustration. The present invention 1s not limited to the Examples given herein.
[71] EVALUATIONS:
[72] Evaluations are performed on skin, with a 50uL application of product (one reference and one tested sample). The sample to evaluate and the reference sample are applied on the same wearer. Evaluators are asked to smell the 2 samples randomly and blind. Then they are asked to rate the tested sample versus the reference according to the following scales and following the evaluation protocol:
[73] Evaluated at 3 different time points: Fresh; 2h 6h (Note: exception of the water- resistant test. Which is evaluated at Fresh and 2h.
[74] Character evaluation following the “Odor Grading Scale” presented below: 5 ->
Perfume unchanged. 4 -> Slight perfume character change. 3 -> Moderate perfume change but similar character . Not consumer noticeable. 2 > Large difference in perfume change, consumer noticeable (unacceptable). 1 -> Total difference in perfume character (unacceptable)
[75] Intensity evaluation following “Intensity scale” +2 -> Very Strong (tested sample is much more intense than the reference); +1 -> Strong; 0 -> Same intensity (reference); -1 ->
Weaker; -2 -> Very weak (tested sample is much less intense than the reference)
[76] A minimum of 3 expert panelists and 8 panelists in total are participating in each evaluation, to obtain conclusive results. 95
380526.NL.02-967.475NL2
[77] The averages of the character and intensity difference are calculated. The conclusions are based on the following:
[78] The character result values above 3 are considered as: no character change
[79] The intensity result values from -0.3 to +0.3 are considered as: no significant difference between the tested sample and the references
[80] We tested 4 fragrance accords (Accord 1 (fruity), Accord 2 (citrus), Accord 3 (fougere), Accord 4 (floral) in the patent) covering 4 of the biggest olfactive fragrances families.
Full fine fragrances were tested as well.
[81] NELUPURE Formulas and Skin evaluation results:
[82] Alcoholic chassis (EAT):
[83] Nelupure is added in the water and then mixed with the ethanol / fragrance oil. Full formula here below: [Reece [Tested spe
Alcohol - EtOH 55-70 50-70
Fragrance Accord *
[84] Results of the evaluations as per the protocol described above. i . . Ch t Intensit
Fragrance oil/accord change er pa Technology effect
No character change,
Accord 1 Fresh 3.50 0.5 more intense
No character change, no 2h 3.63 0.1 significant difference in intensity oh 3.25 08 Neo character change, less intense
No character change, no
Accord 2 Fresh 3.75 -0.1 significant difference in intensity 96
380526.NL.02-967.475NL2
No character change, no 2h 3.63 -0.3 significant difference in intensity 6h 395 05 No character change, less intense
No character change, no
Accord 3 Fresh 3.63 0.0 significant difference in intensity oh 3.88 04 No character change, less intense 6h 338 04 No character change, less intense
No character change, no
Accord 4 Fresh 3.25 -0.1 significant difference in intensity
No character change, no 2h 3.25 0.3 significant difference in intensity
No character change, no 6h 3.38 -0.3 significant difference in intensity
Fresh 330 04 Neo character change, less intense
No character change, no 2h 3.30 -0.3 significant difference in intensity
No character change, no 6h 3.30 0.3 significant difference in intensity
No character change, no
Perfume 2 Fresh 3.70 -0.1 significant difference in intensity oh 3.80 0.5 No character change, more intense 6h 3.50 05 No character change, less intense
No character change, no
Perfume 3 Fresh 4.00 -0.3 significant difference in intensity 97
380526.NL.02-967.475NL2
No character change, no 2h 4.00 0.2 significant difference in intensity
No character change, no 6h 4.00 -0.1 significant difference in intensity
[85] Alcoholic chassis with Cyclodextrin
Nelupure is added in the water and then mixed with the ethanol / fragrance oil/cyclodextrin solution. Full formula here below:
EE
Alcohol “EOF 50
Nede
Fragrance Accord *
Min SSP 100 Nia 3 GSP 100
Cavasol (Methyl Cyclodextrin and | 0.5 - 25 05-25 water and alcohol)
GLDA solution 0.0005 - 0.003 0,0005 — 0.003
[87] The samples were activated with water afterwards.
Fragrance Charact Intenst 5 Time point er | v Technology effect oil/accord difference change
No ch: 7 chang
Fresh 3.43 0.7 No € aracter change, more intense oo No ct ter ch: [ 2h pre activation 3.86 0.6 “9 character change, more intense oo No cl ter change, 2h post activation | 3.00 -0.7 (0 chatactel change, fess mntense
No character change, no 6h pre activation 3.86 0.3 significant difference in intensity
CL No character ch: 1 6h post activation 3.29 -1.3 ‚ © character change, less intense 98
380526.NL.02-967.475NL2
No character change, no
Perfume 4 Fresh 3.86 0.1 significant difference in intensity
Character change, no 2h pre activation 2.86 -0.3 significant difference in intensity 2h post activation | 3.29 -0.4 No character change, less intense 6h pre activation 3.57 -0.4 No character change, less intense
No character change, no 6h post activation | 3.14 -0.3 significant difference mn intensity [Reese [TewdSampe
Nope Jo orm]
Cavasol (Methyl Cyclodextrin and 0,5-25 rio ME
Intensit r change .
Perfume 3 No character change, no (Nelupure vs | Fresh 4.11 -0.1 significant difference in
No character change, no oe 2h 4.11 0.1 significant difference in intensity
CL No character change, 6h pre activation 4.00 0.4 : more intense 6hpostactivation |288 16 Crater change, more intense
Alcoholic chassis with Glucam: 99
380526.NL.02-967.475NL2
[88] Nelupure is added in the water and then mixed with the ethanol / fragrance oil/glucam solution. Full formula here below:
Ree [TowdSample
Newpwe Jo Term
PPG-20 Methyl Glucose Ether 0,5-25 (Guam
Character Intensity Technology effect change difference
No character change, no
Perfume 5 Fresh 3.78 -0.1 significant difference in oh 400 04 No character change, less intense 6h 413 08 No character change, less intense
No character change, no
Perfume 6 Fresh 3.67 0.3 significant difference in ==
No character change, no 2h 3.78 0.1 significant difference in intensity
No character change, no 6h 3.75 -0.1 significant difference in intensity
Alcoholic chassis with Dermacryl 79/Acrylates/Octylacrylamide Copolymer:
[90] Nelupure is added in the water and then mixed with the ethanol / fragrance oil/cyclodextrin solution. Full formula here below: 100
380526.NL.02-967.475NL2
Alcohol - EtOH 65-80 65- 80
Fragrance Accord *
Min 2 GSF 100 in ZGSF 100
Dermaeryl 7 . . . Cl t Intensit
Fragrance oil/accord | Time point iaracter n ensity Technology effect change difference
No character cl 1
Fresh 3.63 08 No character change, less mtense
No character change, no 2h 3.86 -0.3 significant difference in intensity 6h 3.63 06 Neo character change, less intense
[91] Water-base fine fragrance:
[92] Nelupure is added in the water base fine fragrance and mixed together with the Fragrance oil added afterwards. Full formula here below:
I
Tested Sample
Neue 0 [01-53
Fragrance Accord
GSP [sei
[93] Results of the evaluations as per the protocol described above. : : Cl t Intensi
Fragrance oil/accord te Technology effect
Fresh 3 86 04 No character change, less intense 101
380526.NL.02-967.475NL2 oh 3.57 07 No character change, less intense oh 3.43 0.9 Ne character change, less
Intense
No character change, no
Accord 2 Fresh 3.86 0.1 significant difference in intensity
No character change, no 2h 3.86 -0.1 significant difference in intensity 6h 3.29 04 No character change, more mtense
Fresh 3 57 0.7 No character change, more
Intense oh 371 06 No character change, more intense 6h 357 07 No character change, more intense
No character change, no
Accord 4 Fresh 4.14 0.3 significant difference in intensity
No character change, no 2h 3.71 0.0 significant difference mn intensity
No character change, no 6h 3.71 0.0 significant difference In intensity
No character change, no
Perfume 1 Fresh 3.50 0.3 significant difference mn intensity
No character change, no 2h 3.70 -0.2 significant difference in intensity
No character change, no 6h 3.80 0.0 significant difference in intensity
Fresh 330 07 No character change, less
Intense 102
380526.NL.02-967.475NL2 oh 3.70 04 No character change, less intense oh 4.00 0.5 Neo character change, less intense
No character change, no
Perfume 4 3.25 0.1 significant difference mn intensity 3.43 04 Ne character change, less tense
No character change, no 3.38 0.1 significant difference in intensity
[94] Waterproof evaluation Process:
[95] "The following test is carried out to demonstrate the improved or enhanced retention of a fragrance of a composition of the present invention In particular, the test measures the film forming and fixative effect on fragrance materials of a composition apphed to an mm-vitro substrate {e.g., glass slide). The properties are triggered after exposure fo water. The amount of fragrance materials left on the substrate 1s evaluated by an expert panel”
[96] A test composition comprising ethanol, water, one or more fragrances and Nelupue.
A control composition to the test composition is made with ethanol, water, and the same one of mare fragrances used in the test composition.
A hotplate 18 set to a temperature of 32 °C. A glass shide, with dimensions of about 76X26 mum, is placed on the hotplate. SOuL of the test or control composition is dispensed on a test area of the glass slide using a mucropipeite. The time at whuch this takes place is deternuned to be time zero (Le, T=10}
The solution is left to evaporate on the glass slide at 32°C for 10min from T=0. The glass shde is then onmersed in water having 4 teraperature around 20-27°C for 4 minutes, The excess water is dabbed carefully avoiding the test area, and the glass slide is left to further dry for at 32°C ona hotplate for 2h
After Zh, the glass slide 1s again tomersed 10 water having a temperature around 20-27°C for 4 nunutes. The excess water 1s dabbed carefully avoiding the test area, and the glass shde is left to further dry until given to the expert panel for evaluation,
The procedure 13 repeated for the "Fresh" tene point. In thus case, samples are given to the expert panel after the first UTunersion In water, [Ree [Towne]
Nee Jo Jor 103
380526.NL.02-967.475NL2
Fragrance Accord? i . . Ch t Intensit
Fragrance oil/accord change et i oro Technology effect
N haract h: more tense on 400 03 No character change, more intense
Unperfumed water base used as a primer
[98] Nelupure is added in unperfumed water base used as a primer, meaning it is first applied on skin and then a standard EDT 1s sprayed on top of the primer.
Full formula here below:
Tee Tvhwes
Tested Sample
GSF 100
Nelpue Jo [01-10
[84] Malodour is evaluated at the following times — note comments are directed towards a EDT solution with 5% Nelupure versus a EDT solution without Nelupure:
Tested Technology | tested Evaluated time sample % accord point Evaluators comment
NeluPur .
Accord 1 | Fresh Less plastic 2h 6h
Accord 2 | Fresh 104
380526.NL.02-967.475NL2 oh Less fatty sweaty note a fatty sweaty note 6h
Accord 3 | Fresh Less mossy plastic 2h Less mossy plastic
[85] Indicia indicating malodour include: plastic; fatty / sweaty; mossy plastic notes.
Example 3: Sensitizing potency using GARDskin
[86] In addition to a longevity of a fragrance, users are concerned with skin sensitization potency of cosmetic fragrance formulations. Skin sensitization potency, i.e. Adverse Outcome
Pathway, is measured herein with a GARDskin Dose-Response assay. This assay 1s a modification of the validated GARDskin protocol , OECD TGP 4.106, that incorporates dose response analysis.
[87] The GARDskin assay employs a gene expression biomarker to identify skin sensitizers in a human myeloid dendritic-like cell line. The GARDskin Dose-Response investigates the GARDSKIN response values in a titrated range of multiple concentrations in a dose-response manner to find a concentration threshold required to induce a positive decision value. The concentration threshold is used to estimate the inherent sensitizing potency of a chemical. A low value indicates a high inherent skin sensitizing potency and a high value indicates a low inherent skin sensitizing potency. The readout is a cDVO value, describing the lowest concentration required to generate a positive classification. This value correlates with potency and can be used to rank test items by their relative sensitizing potency. This assay allows to evaluate mixtures and delivers continuous potency predictions, crucial point for comparing the modulator’s effect on the formulations’ skin sensitizing potency. One description of the method is described in this article: Quantitative assessment of sensitizing potency using a dose-response adaptation of
GARDskin, R. Gradin et al., Scientific Reports, 18904 (2021).
[88] The potential of a lotus flower extract to reduce the skin sensitizing potency of fragrance formulations containing different concentrations of fragrance oils was investigated using the GARDskin protocol.
[89] The GARDskin Dose-Response assay is based on the validated protocols of
GARDskin (OECD TG 442E) and incorporates dose-response measurements to derive continuous potency predictions. The readout of the assay corresponds to the lowest concentration required to 105
380526.NL.02-967 475NL2 exceed the binary classification threshold in GARDskin (DV= 0), referred to as the cDVO value.
This concentration is inversely correlated to skin sensitizing potency and can be used to predict a corresponding LLNA EC3/human NESIL value in, for instance, micrograms per square centimeter, or be directly interpreted on its own to compare differences in skin sensitizing potency between investigated samples.
[90] In this study, fragrance formulations with and without 2% Nelupure will be evaluated. The purpose of the study will be to investigate Nelupure’s efficacy for reducing skin sensitization. Table I: TESTED SAMPLES:
IE I
Perfume 1 EDT WITHOUT GLUCAM Negative control
Perfume 1 EDT + 2% NELUPURE Nelupure alone
Results are shown below, with the sample containing Nelupure designated as MP23008, indicating a lower inherent skin sensitizing potency for a sample containing Nelupure. testen Opel Moon | Su tiove | Le | EN 3 sob Hem # JD Epe) | £3 OY 3% £3 BYE Cp) | Category | NOEL fend)
PORR ENE 1d § : ì ) ; A : | ; Esha 3
MSR es SA 1 RAID MT sne, DCN
GARDskin DOSE RESPONSE METHOD:
[91] The ability of each sample tested to modulate the sensitization potency will be measured using a GARDskin dose response method. The GARDskin dose response method 1s an in vitro test based on human dendritic-like cell cline, SenzaCell, a set of 200 genes known as the
GARD Prediction Signature and a prediction model developed with machine learning technology.
A summary of the GARDskin method is shown in FIG. 1. A test sample that includes at least one test substance is prepared and different concentrations of the test sample are grown in cells obtained from SenzaGen AB. A determination is made of the concentration of the test substance where cells react and 90 percent of cells survive. Then, a fresh batch of quality controlled cells are exposed to the determined concentration wherein cells react and 90% survive. 106
380526.NL.02-967.475NL2
[92] After exposure to the test sample, total RNA will be isolated from SenzaCells.
Gene expression will be quantified and analyzed by pattern recognition using a machine learning algorithm based on a fixed set of reference samples. The genes that will be measured are well characterized and are related to several skin sensitization methanistic events. The resulting classification is that of a sensitizer or non-sensitizer. Additional information about the method can be found in a Nature article, “Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskin,” Nature, article no. 18904 (2021).
[93] It 1s hypothesized that the lowest concentration required to exceed the binary classification threshold (DV > 0} and generate a positive classification, referred to as the cDVy concentration, would be mformative of sensitizing potency. As such, the proposed dose response measurements would also be aligned with common toxicological principles for potency assessments, where the response value {DV}, the binary threshold (BV 20}, and the derved cDVo concentrations may be viewed as an analogue to the response value (stimulation index {SI}, the binary threshold (812 3}, and the EC3 concentrations m the LLNA assay, respectively.
Exemplary Embodiments.
[94] The following exemplary embodiments are provided, the numbering of which is not to be construed as designating levels of importance:
[95] Aspect 1 provides a fragrance composition comprising; a fragrance component; and an extract solution comprising: nymphaea coerulea flower extract; and nelumbo nucifera flower extract.
[96] Aspect 2 provides the fragrance composition of Aspect 1, wherein the fragrance component present in an amount in a range of from about 0.04 wt% to about 40 wt% of the fragrance composition.
[97] Aspect 3 provides the fragrance composition of any of Aspects | or 2, wherein the fragrance component present in an amount in a range of from about 0.5 wt% to about 30 wt% of the fragrance composition.
[98] Aspect 4 provides the fragrance composition of any of Aspects 1-3, wherien the extract solution is present in an amount of at least 2 wt% of the fragrance composition. 107
380526.NL.02-967.475NL2
[99] Aspect 5 provides the fragrance composition of any of Aspects 1-4, further comprising a modulator component.
[100] Aspect 6 provides the fragrance composition of Aspect 5, wherein the modulator component is present in an amount in a range of from about 0.04 wt% to about 40 wt% of the fragrance composition.
[101] Aspect 7 provides the fragrance composition of any of Aspects 5 or 6, wherein the modulator component 1s present in a range of from about 0.1 wt% to about 27 wt%.
[102] Aspect 8 provides the fragrance composition of any of Aspects 5-7, wherien the modulator component comprises: the compound according to Formula I:
OH
A
R' (I): a repeating unit derived from the compound according to Formula II:
NTN Re
R3 R® (IT); or a mixture thereof, wherein
R!, R% RY R* and R®, are independently chosen from -H, -OH, or substituted or unsubstituted (C-
Cap)hydrocarbyl.
[103] Aspect 9 provides the fragrance composition of any of Aspects 5-8, wherien the modulator component comprises pentylene glycol, polycitronellol, PPG-20 methyl glucose ether, methyl glucoside polyol, ethyl glucoside polyol, propyl glucoside polyol, or a mixture thereof. 108
380526.NL.02-967.475NL2
[104] Aspect 10 provides the fragrance composition of any of Aspects 5-9, wherien the modulator component is substantially non-odorous.
[105] Aspect 11 provides the fragrance composition of any of Aspects 1-10, wherein the fragrance component comprises at least of: at least one low volatile fragrance material having a vapor pressure less than 0.001 Torr (0.000133 kPa) at 25 °C; at least one moderate volatile fragrance material having a vapor pressure in the range of 0.1 Torr to 0.001 Torr (0.0133 kPa to 0.000133 kPa) at 25 °C; and at least one high volatile fragrance material having a vapor pressure greater than 0.1 Torr (0.0133 kPa) at 25 °C.
[106] Aspect 12 provides the fragrance composition of Aspect 11, wherein the at least one low volatile fragrance material is present in a range of from about 0 wt% to about 30 wt% of the fragrance component; the at least one moderate volatile fragrance material 1s present in a range of from about 30 wt% to about 70 wt% of the fragrance component; and the at least one high volatile fragrance material is present in a range of from about 0 wt% to about 30 wt% of the fragrance component.
[107] Aspect 13 provides the fragrance composition of any of Aspects 11 or 12, wherein the at least one low volatile fragrance material 1s present in a range of from about 30 wt% to about 70 wt% of the fragrance component; the at least one moderate volatile fragrance material is present at greater than about 30 wt% of the fragrance component; and the at least one high volatile fragrance material is present in a range of from about 0.1 wt% to about 30 wt% of the fragrance component.
[108] Aspect 14 provides the fragrance composition of any of Aspects 11-13, wherein the at least one low volatile fragrance material is present in a range of from about 0.1 wt% to about 30 wt% of the fragrance component; the at least one moderate volatile fragrance material is present in a range of from about 30 wt% to about 70 wt% of the fragrance component; and 109
380526.NL.02-967.475NL2 the at least one high volatile fragrance material is present at greater than about 30 wt% of the fragrance component.
[109] Aspect 15 provides the fragrance composition of any of Aspects 11-14, wherein the at least one low volatile fragrance material is present in a range of from about 30 wt% to about 35 wt% of the fragrance component; the at least one moderate volatile fragrance material 1s present in a range of from about 30 wt% to about 35 wt% of the fragrance component; and the at least one high volatile fragrance material 1s present in a range of from about 30 wt% to about 35 wt% of the fragrance component.
[110] Aspect 16 provides the fragrance composition of any of Aspects 11-15, wherein the at least one low volatile fragrance material is present in a range of from about 0 wt% to about 35 wt% of the fragrance component; the at least one moderate volatile fragrance material is present in a range of from about 40 wt% to about 60 wt% of the fragrance component; and the at least one high volatile fragrance material is present in a range of from about 0 wt% to about 30 wt% of the fragrance component.
[111] Aspect 17 provides the fragrance composition of any of Aspects 11-16, wherein the at least one low volatile fragrance material is present in a range of from about 25 wt% to about 50 wt% of the fragrance component; the at least one moderate volatile fragrance material 1s present in a range of from about 0 wt% to about 35 wt% of the fragrance component; and the at least one high volatile fragrance material is present in a range of from about 0.1 wt% to about 35 wt% of the fragrance component.
[112] Aspect 18 provides the fragrance composition of any of Aspects 11-17, wherein the at least one low volatile fragrance material is present in a range of from about 25 wt% to about 60 wt% of the fragrance component; the at least one moderate volatile fragrance material is present in a range of from about 0 wt% to about 35 wt% of the fragrance component; and the at least one high volatile fragrance material is present in a range of from about 25 wt% to about 60 wt% of the fragrance component. 110
380526.NL.02-967.475NL2
[113] Aspect 19 provides the fragrance composition of any of Aspects 11-18, wherein the at least one low volatile fragrance material is present in a range of from about 25 wt% to about 60 wt% of the fragrance component; the at least one moderate volatile fragrance material 1s present in a range of from about 25 wt% to about 60 wt% of the fragrance component; and the at least one high volatile fragrance material 1s present in a range of from about 25 wt to about 60 wt% of the fragrance component
[114] Aspect 20 provides the fragrance composition of any of Aspects 11-19, wherein the high volatile fragrance material is chosen from any of the materials or combinations of materials listed in any of Tables 3A and 3B; the low volatile fragrance material is chosen from chosen from any of the materials or combinations of materials listed in any of Tables 1A and 1B; and the moderate volatile fragrance material is chosen from chosen from any of the materials or combinations of materials listed in any of Tables 2A and 2B.
[115] Aspect 21 provides the fragrance composition of any of Aspects 1-20, further comprising a carrier.
[116] Aspect 22 provides the fragrance composition of Aspect 21, wherein the carrier is an aqueous carrier, an organic carrier, or a mixture thereof.
[117] Aspect 23 provides the fragrance composition of any of Aspects 21 or 22, wherein the organic carrier is ethanol, dipropylene glycol, benzyl benzoate, diethyl phthalate, isopropyl myristate, (Ci-Cao)alkyl, (Ci-Cao)alkenyl, (C1-C29)alkynyl, (Ci-Cao)hydroxyl, or mixtures thereof.
[118] Aspect 24 provides the fragrance composition of any of Aspects 1-23, wherien the fragrance component is detectable for an amount of time longer than a corresponding fragrance composition that free of the extract solution.
[119] Aspect 25 provides the fragrance composition of any of Aspects 1-24, wherien the fragrance component 1s more comfortable than a corresponding fragrance composition that free of the extract solution.
[120] Aspect 26 provides the fragrance composition of any of Aspects 1-25, further comprising lactic acid, a hyaluronic acid, vitamin E, saccharomyces/xylinum/black tea ferment, 111
380526.NL.02-967.475NL2 diglucosyl gallic acid, adenosine, panthenol, dimethylmethoxy chromanol, alpha-glucan oligosaccharide, thermus thermophilus ferment, hydrolyzed hyaluronic acid, caffeine, acetyl di- peptide-1 cetyl ester, glycerin, niacinamide, swertia chirata extract, creatine, or a mixture thereof
[121] Aspect 27 provides the fragrance composition of any of Aspects 1-26, further comprising niacinamide.
[122] Aspect 28 provides the fragrance composition of any of Aspects 1-27, further comprising a chelant.
[123] Aspect 29 provides the fragrance composition of Aspect 28, wherein the chelant comprises tetrasodium glutamate diacetate (GLDA), ethylenediaminetetraacetic acid (EDTA), ethylenediamine-N, N’-disuccinic acid (EDDS), NTA, EDDS, IDS, methylglycinediacetic acid (MGDA), L-glutamic acid N,N-diacetic acid (GLDA), ethylenediamine-N,N-diglutaric acid (EDDG), ethylenediamine-N,N’-dimalonic acid (EDDM), 3-hydroxy-2,2-iminodisuccinic acid (HIDS), 2-hydroxyethyliminodiacetic acid (HEIDA), methylglycine N‚N-diacetic acid trisodium salt (MGDA), sodium gluconate, or a mixture thereof.
[124] Aspect 30 provides the fragrance composition of any of Aspects 1-29, wherein the fragrance composition is more effective at reducing or eliminating malodor than a corresponding composition that is free of the extract solution.
[125] Aspect 31 provides the fragrance composition of any one of Aspects 1-30, wherien modulation of the fragrance composition is increased relative to a corresponding composition that is free of the extract solution and comprises a cyclodextrin, PPG 20 methyl glucose ether, a chelator, or a mixture thereof.
[126] Aspect 32 provides the fragrance composition of any one of Aspects 1-31, further comprising a cyclodextrin, a film former, or a mixture thereof.
[127] Aspect 33 provides the fragrance composition of Aspect 32, wherein the at least one film former is chosen from anionic compounds or polymers, non-ionic compounds or polymers, amphoteric compounds or polymers, zwitterionic compounds or polymers, cationic compounds or polymers, protems, viscosity modifiers, polyacrylates, polymethacrylates, polyacrylate copolymers, polymethacrylate copolymers, polyurethanes, polyamides, 112
380526.NL.02-967.475NL2 polyaminoamides, polyesters, polysaccharides, polyacrylamides, starches, gums, or mixtures thereof.
[128] Aspect 34 provides the fragrance composition of any one of Aspects 32 or 33, wherien the cyclodexrin comprises an a-cyclodextrin, a B-cyclodextrmn a gamma-cyclodextrin, or mixtures thereof.
[129] Aspect 35 provides a formulation for decreasing skin sensitizing potency of the fragrance, comprising one or more: fragrance components;
PPG 20 methyl glucose ether and ethanol; and an extract solution comprising: nymphaea coerulea flower extract; and nelumbo nucifera flower extract,
[130] Aspect 36 provides a method comprising: applying a sebum reducing composition comprising a topically acceptable vehicle and the fragrance composition of any of Aspects 1-35.
[131] Aspect 37 provides a method of treating skin with a component effective for functioning in a fragrance composition of Aspects 1-36, wherein the effectiveness of the component is determined by an assay for determining the levels of sebum, leptin, acetylcholine, or a mixture thereof in a sample that has been contacted with the extract or a composition including the extract.
[132] Aspect 38 provides a method of inhibiting acetylcholinesterase, the method comprising contacting the fragrance composition of any of Aspects 1-37, with a keratinous tissue.
[133] Aspect 39 provides a method of inhibiting a cholinergic receptor, the method comprising contacting the fragrance composition of any of Aspects 1-38, with a keratinous tissue. 113
Claims (24)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363500388P | 2023-05-05 | 2023-05-05 | |
| US202363500382P | 2023-05-05 | 2023-05-05 | |
| NL2035897A NL2035897B1 (en) | 2023-05-05 | 2023-09-27 | Fragrance compositions |
| US202363614226P | 2023-12-22 | 2023-12-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL2037620A true NL2037620A (en) | 2024-11-21 |
| NL2037620B1 NL2037620B1 (en) | 2025-06-17 |
Family
ID=91226839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL2037620A NL2037620B1 (en) | 2023-05-05 | 2024-05-03 | Fragrance compositions cross-reference to related application |
Country Status (2)
| Country | Link |
|---|---|
| NL (1) | NL2037620B1 (en) |
| WO (1) | WO2024233392A2 (en) |
Citations (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4024208A (en) | 1971-12-22 | 1977-05-17 | Klockner-Humboldt-Deutz Aktiengesellschaft | Device for carrying out physical and/or chemical reactions between liquids and gases |
| US4110626A (en) | 1976-01-30 | 1978-08-29 | Shiseido Co., Ltd. | Method for improving the quality of the fragrance of perfumes using aliphatic dibasic acid diesters |
| US4313855A (en) | 1978-02-22 | 1982-02-02 | Dragoco Gerberding & Co. Gmbh | Fixative for perfume compositions |
| WO1985004803A1 (en) | 1984-04-23 | 1985-11-07 | Diagnostic, Inc. | Hyaluronic acid/hyaluronate based fragrance products |
| JPS6163612A (en) | 1984-09-03 | 1986-04-01 | Kanebo Ltd | Adjusting agent for perfume |
| JPS6183114A (en) | 1984-09-28 | 1986-04-26 | Kanebo Ltd | Perfume fixative |
| JPS6284010A (en) | 1985-03-28 | 1987-04-17 | Shiseido Co Ltd | Cosmetic |
| EP0616800A2 (en) | 1993-03-22 | 1994-09-28 | Givaudan-Roure (International) S.A. | Odorant compositions with prolonged diffusion |
| US6147049A (en) | 1998-12-15 | 2000-11-14 | Givaudan Roure (International) Sa | Tetra-hydronaphthalenes |
| US6372239B1 (en) | 2000-01-28 | 2002-04-16 | Greentech, Inc. | Compositions and methods for controlling pests using synergistic cocktails of plant alkaloids |
| US6440400B1 (en) | 1998-02-02 | 2002-08-27 | Takasago International Corporation | Trimethylcylohexane derivatives and melanin-formation inhibitors and perfumeholding agents with the use of the same |
| US6737396B2 (en) | 2000-07-10 | 2004-05-18 | Firmenich Sa | Use of (1-ethoxyethoxy)cyclododecane in a perfume composition as perfume fixative and/or enhancer |
| US7196052B2 (en) | 2002-02-22 | 2007-03-27 | Takasago International Corporation | Fragrance composition |
| US7538081B2 (en) | 2000-09-12 | 2009-05-26 | Takasago International Corporation | Method and agent for enhancing diffusivity and long-lasting property of fragrance |
| US20110104089A1 (en) | 2009-11-02 | 2011-05-05 | Symrise Ag | Compositions comprising fragrance substances and neopentyl glycol diisononanoate |
| WO2014139952A2 (en) | 2013-03-13 | 2014-09-18 | Unilever Plc | Prolonged delivery of certain fragrance components from personal care compositions |
| WO2014155019A2 (en) | 2013-03-29 | 2014-10-02 | Lvmh Recherche | Fragrancing aqueous-alcoholic composition containing an aliphatic ether |
| US9050261B2 (en) | 2009-10-19 | 2015-06-09 | Symrise Ag | Compositions comprising fragrance substances and comprising cetyl nonanoate and/or stearyl nonanoate |
| WO2021081619A1 (en) * | 2019-10-31 | 2021-05-06 | Ec Labs Inc. | Hemp peptide compositions for nutraceutical and personal care products |
| WO2022192587A1 (en) * | 2021-03-12 | 2022-09-15 | Coty Inc. | Antiperspirant composition |
| CN115645290A (en) * | 2022-11-14 | 2023-01-31 | 上海臻臣化妆品有限公司 | Oil-control composite powder composition and water-powder dual-phase essence |
| WO2023055927A1 (en) * | 2021-09-30 | 2023-04-06 | Coty Inc. | Fragrance compositions and uses thereof |
-
2024
- 2024-05-03 WO PCT/US2024/027845 patent/WO2024233392A2/en active Pending
- 2024-05-03 NL NL2037620A patent/NL2037620B1/en active
Patent Citations (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4024208A (en) | 1971-12-22 | 1977-05-17 | Klockner-Humboldt-Deutz Aktiengesellschaft | Device for carrying out physical and/or chemical reactions between liquids and gases |
| US4110626A (en) | 1976-01-30 | 1978-08-29 | Shiseido Co., Ltd. | Method for improving the quality of the fragrance of perfumes using aliphatic dibasic acid diesters |
| US4313855A (en) | 1978-02-22 | 1982-02-02 | Dragoco Gerberding & Co. Gmbh | Fixative for perfume compositions |
| WO1985004803A1 (en) | 1984-04-23 | 1985-11-07 | Diagnostic, Inc. | Hyaluronic acid/hyaluronate based fragrance products |
| JPS6163612A (en) | 1984-09-03 | 1986-04-01 | Kanebo Ltd | Adjusting agent for perfume |
| JPS6183114A (en) | 1984-09-28 | 1986-04-26 | Kanebo Ltd | Perfume fixative |
| JPS6284010A (en) | 1985-03-28 | 1987-04-17 | Shiseido Co Ltd | Cosmetic |
| EP0616800A2 (en) | 1993-03-22 | 1994-09-28 | Givaudan-Roure (International) S.A. | Odorant compositions with prolonged diffusion |
| US6440400B1 (en) | 1998-02-02 | 2002-08-27 | Takasago International Corporation | Trimethylcylohexane derivatives and melanin-formation inhibitors and perfumeholding agents with the use of the same |
| US6147049A (en) | 1998-12-15 | 2000-11-14 | Givaudan Roure (International) Sa | Tetra-hydronaphthalenes |
| US6372239B1 (en) | 2000-01-28 | 2002-04-16 | Greentech, Inc. | Compositions and methods for controlling pests using synergistic cocktails of plant alkaloids |
| US6737396B2 (en) | 2000-07-10 | 2004-05-18 | Firmenich Sa | Use of (1-ethoxyethoxy)cyclododecane in a perfume composition as perfume fixative and/or enhancer |
| US7538081B2 (en) | 2000-09-12 | 2009-05-26 | Takasago International Corporation | Method and agent for enhancing diffusivity and long-lasting property of fragrance |
| US7196052B2 (en) | 2002-02-22 | 2007-03-27 | Takasago International Corporation | Fragrance composition |
| US9050261B2 (en) | 2009-10-19 | 2015-06-09 | Symrise Ag | Compositions comprising fragrance substances and comprising cetyl nonanoate and/or stearyl nonanoate |
| US20110104089A1 (en) | 2009-11-02 | 2011-05-05 | Symrise Ag | Compositions comprising fragrance substances and neopentyl glycol diisononanoate |
| WO2014139952A2 (en) | 2013-03-13 | 2014-09-18 | Unilever Plc | Prolonged delivery of certain fragrance components from personal care compositions |
| WO2014155019A2 (en) | 2013-03-29 | 2014-10-02 | Lvmh Recherche | Fragrancing aqueous-alcoholic composition containing an aliphatic ether |
| WO2021081619A1 (en) * | 2019-10-31 | 2021-05-06 | Ec Labs Inc. | Hemp peptide compositions for nutraceutical and personal care products |
| WO2022192587A1 (en) * | 2021-03-12 | 2022-09-15 | Coty Inc. | Antiperspirant composition |
| WO2023055927A1 (en) * | 2021-09-30 | 2023-04-06 | Coty Inc. | Fragrance compositions and uses thereof |
| CN115645290A (en) * | 2022-11-14 | 2023-01-31 | 上海臻臣化妆品有限公司 | Oil-control composite powder composition and water-powder dual-phase essence |
Non-Patent Citations (13)
| Title |
|---|
| "CTFA International Cosmetic Ingredient Dictionary and Handbook", 1997, THE COSMETIC, TOILETRY, AND FRAGRANCE ASSOCIATION, INC. |
| "Inhibitor of the leptin induced sebum production in cosmetic compositions", RESEARCH DISCLOSURE, KENNETH MASON PUBLICATIONS, HAMPSHIRE, UK, GB, vol. 626, no. 12, June 2016 (2016-06-01), pages 427, XP007144867, ISSN: 0374-4353, [retrieved on 20160503] * |
| "Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskin", NATURE, no. 18904, 2021 |
| B. ALBERTS ET AL.: "The Nervous System", 1989, GARLAND PUBLISHING, INC., article "Molecular Biology of the Cell", pages: 1075 |
| DATABASE GNPD [online] MINTEL; 12 August 2019 (2019-08-12), ANONYMOUS: "Oil-Free Hydrating Gel-Cream", XP093203998, retrieved from https://www.gnpd.com/sinatra/recordpage/6781225/ Database accession no. 6781225 * |
| DATABASE GNPD [online] MINTEL; 19 April 2023 (2023-04-19), ANONYMOUS: "Refreshing Roll On Body Lotion", XP093204234, retrieved from https://www.gnpd.com/sinatra/recordpage/10737564/ Database accession no. 10737564 * |
| DATABASE GNPD [online] MINTEL; 4 April 2019 (2019-04-04), ANONYMOUS: "Body Mist", XP093204012, retrieved from https://www.gnpd.com/sinatra/recordpage/6451685/ Database accession no. 6451685 * |
| DATABASE GNPD [online] MINTEL; 8 November 2021 (2021-11-08), ANONYMOUS: "Glow Illuminate SPF 30 Moisturiser", XP093209868, retrieved from https://www.gnpd.com/sinatra/recordpage/9108620/ Database accession no. 9108620 * |
| GRADIN ROBIN ET AL: "Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskin", SCIENTIFIC REPORTS, vol. 11, no. 1, 1 September 2021 (2021-09-01), US, pages 18904 - 18904, XP093105644, ISSN: 2045-2322, DOI: 10.1038/s41598-021-98247-7 * |
| JOURNAL OF ESSENTIAL OIL RESEARCH |
| PERFUME AND FLAVOURIST |
| R. GRADIN ET AL.: "Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskin", SCIENTIFIC REPORTS, no. 18904, 2021 |
| S. ARCTANDER: "Perfume and Flavor Chemicals", 1969, ALLURED PUBLISHING CORPORATION |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024233392A2 (en) | 2024-11-14 |
| NL2037620B1 (en) | 2025-06-17 |
| WO2024233392A3 (en) | 2024-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3141239B1 (en) | Fragrance compositions and uses thereof | |
| US20250152487A1 (en) | Fragrance compositions and uses thereof | |
| EP2961374B1 (en) | Fragrance compositions | |
| US20210032561A1 (en) | Fragrance compositions and uses thereof | |
| EP3307393B1 (en) | Fragrance composition | |
| US8557262B2 (en) | Divinyl ether derivatives capable of releasing active aldehydes and ketones and methods of use for perfuming surfaces | |
| US20190376001A1 (en) | Fragrance Fixatives and Compositions Comprising Thereof | |
| US11384312B2 (en) | Fragrance compositions and methods of use thereof | |
| US20180334637A1 (en) | Fragrance Compositions and Uses Thereof | |
| US20250127694A1 (en) | Fragrance compositions and uses thereof | |
| NL2036451B1 (en) | Fragrance compositions and uses thereof | |
| NL2037620B1 (en) | Fragrance compositions cross-reference to related application | |
| NL2035897B1 (en) | Fragrance compositions | |
| US20250127707A1 (en) | Fragrance formulation | |
| US20230285261A1 (en) | Fragrance composition comprising a fragrance componet and a non-odorous fragrance modulator | |
| US20220304914A1 (en) | Coating compositions |